Next Article in Journal
PKN1 Kinase: A Key Player in Adipocyte Differentiation and Glucose Metabolism
Previous Article in Journal
Midlife Life’s Simple 7, Psychosocial Health, and Physical Frailty, Hospital Frailty, and Comprehensive Frailty 10 Years Later
Previous Article in Special Issue
Bee Products and Colorectal Cancer—Active Components and Mechanism of Action
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:

Translational Research on Bee Pollen as a Source of Nutrients: A Scoping Review from Bench to Real World

Observatory of Drug-Herb Interactions, Laboratory of Pharmacognosy, Faculty of Pharmacy, University of Coimbra, Heath Sciences Campus, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal
Coimbra Chemistry Centre (CQC, FCT Unit 313), Faculty of Science and Technology, University of Coimbra, Rua Larga, 3004-516 Coimbra, Portugal
Author to whom correspondence should be addressed.
Nutrients 2023, 15(10), 2413;
Received: 27 March 2023 / Revised: 11 May 2023 / Accepted: 15 May 2023 / Published: 22 May 2023
(This article belongs to the Special Issue Bee Products in Human Health)


The emphasis on healthy nutrition is gaining a forefront place in current biomedical sciences. Nutritional deficiencies and imbalances have been widely demonstrated to be involved in the genesis and development of many world-scale public health burdens, such as metabolic and cardiovascular diseases. In recent years, bee pollen is emerging as a scientifically validated candidate, which can help diminish conditions through nutritional interventions. This matrix is being extensively studied, and has proven to be a very rich and well-balanced nutrient pool. In this work, we reviewed the available evidence on the interest in bee pollen as a nutrient source. We mainly focused on bee pollen richness in nutrients and its possible roles in the main pathophysiological processes that are directly linked to nutritional imbalances. This scoping review analyzed scientific works published in the last four years, focusing on the clearest inferences and perspectives to translate cumulated experimental and preclinical evidence into clinically relevant insights. The promising uses of bee pollen for malnutrition, digestive health, metabolic disorders, and other bioactivities which could be helpful to readjust homeostasis (as it is also true in the case of anti-inflammatory or anti-oxidant needs), as well as the benefits on cardiovascular diseases, were identified. The current knowledge gaps were identified, along with the practical challenges that hinder the establishment and fructification of these uses. A complete data collection made with a major range of botanical species allows more robust clinical information.

1. Introduction

Substantial research has been conducted on the composition and pharmacological bioactivities of bee pollen (BP), indicating both its usefulness and safety. Numerous studies have shown that BP has a rich and well-balanced composition to serve as a human food and supplement, while its richness of bioactive compounds, especially polyphenols, confers to it a large array of biological and pharmacological activities [1]. BP-related risks may mainly emanate from external factors [2], or from improper storage and processing conditions [1]. Allergic reactions are rare and BP is perceived as a safe product in most physiological situations including in childhood, in older age, and in disease recoveries [3,4]. BP from different floral sources has been reported to possess anesthetic, anti-allergic, anti-androgen, anti-atherosclerotic, anti-cancer (anticarcinogenic and anti-mutagenic), anti-inflammatory, antimicrobial (antibacterial, antifungal, and antiviral), antioxidant, antiulcer, and immunostimulant activities [5,6,7,8,9,10,11,12,13]. On metabolic pathophysiology, it has been shown to possess anti-obesity [12], antidiabetic [12], hypocholesterolemic [13], and hepatoprotective [7,12] effects. In the digestive system, it has been shown to maintain [5], ameliorate [6], and regulate [13] gut functions. In the cardiovascular system, it is able to reduce capillary fragility [5], and can improve overall cardiovascular health [6,13]. Some authors reported that BP may contribute to the prevention of and positively impact some degenerative processes such as neurodegeneration [6,14], overall aging [11,13], and cellular apoptosis [15], and may promote recovery from chronic diseases and possess chemo-preventive properties [7]. It has also been shown to improve skin health and reparation, encompassing many valuable cosmetic qualities [5,16].
Due to its established nutritional use, an ISO Norm (Technical Committee: ISO/TC 34/SC 19 Bee products) is being prepared to standardize the quality of bee pollen as a food product (; accessed on 14 May 2023). This clear interest in BP relies evidently on a solid background of evidence originating from ethnopharmacological heritage and the growingly cumulated experimental data. Although BP in its isolated pellets format may be relatively recent and emerged with the elaboration of mechanical pollen traps, bee bread and plant pollen have been used since ancient times. Ancient Egyptians described pollen as a “life-giving dust” [17], and Greeks believed that pollen and honey gave youth to kings [18]. Pollen was used for cosmetic purposes in ancient China [19]. It has been reported that ancient Egyptians, Greeks, native Americans, Chinese people, and Indians used BP for provisions and energy on long journeys, as well as for other health benefits [20]. Relying on this nutritional and ethnomedicinal history, BP use has been spreading at a very rapid pace during the last few years due to the emerging scientific evidence and the extensive development of the dietary supplement market all over the world. BP is widely commercialized as a stand-alone food and nutritional supplement benefiting from its rich and well-balanced composition. The global market is expected to reach around EUR 670 million next year, 2024 [21].
However, despite the rapid pace of basic and experimental research works on BP, translational and clinical research is still lacking. We have therefore deemed that the extent of currently available evidence may possibly warrant the necessity to step forward and ascertain the translational promises of this evidence. Such promises appear, presumably, to be very encouraging due to the many considerations that we will thoroughly develop during this work. However, reviews that assess such prospects, especially relating to BP’s nutritional but also pharmacological applications, are still lacking.
Hence, the goal of this work is to give an up-to-date review on the evidence-based nutritional values of BP and explore its possible applications in preventing and managing certain nutrition-associated disorders, viz. digestive, metabolic, and cardiovascular disorders, by translating the cumulated experimental and preclinical evidence into clinically relevant insights. We will mainly discuss some chronically evolving disease risk factors such as nutrient deficiencies, oxidative stress, and inflammation, and then focus on pathophysiological conditions that are closely related to nutritional factors such as digestive, metabolic, and cardiovascular diseases.

2. Materials and Methods

Due to the lack of interventional studies investigating the clinical use and outcomes of BP in humans, we decided to undertake a scoping review of the currently available evidence supporting the nutritional interest of BP in normal and pathophysiological conditions. We deemed that the current level of evidence and stage of research advancement on BP interest in human health is still in its very early phases, and a literature review is therefore needed to guide future works at all research stages. Scoping reviews are a relatively new approach in evidence synthesis [22,23,24,25]. This review type is especially emerging as a valid methodology in approaching broadly diversified topics that also impose an analysis of a wide range of data and topics [26]. This is perfect for the case of BP composition and applications in human health.
Able to encompass all stages of pharmaceutical, medical, and biomedical research including experimental, preclinical, translational, clinical, and real-world evidence phases, a scoping review was then preferable from our point of view to tackle the nutritional value of BP. This is mainly due to the fact that published works on this product are characterized by very rapid expansion, especially in very recent years (a search on PubMed with “bee pollen” as a keyword returns more than 2200 publications throughout the last century, with more than 1000 publications, strikingly, dated in the last five years). We therefore aimed to rationally assess the extent of the evidence, define current knowledge gaps, and formulate adapted recommendations for future research. Although not mandatory in scoping reviews [27], we will make some critical appraisals throughout this research work when we deem it necessary, especially regarding the clinical relevance of reported or discussed findings.
In spite of the fact that scoping reviews are recent in research practice, diverse well-conceived approaches and standardization attempts have been made to frame them and normalize their conditions, accomplishment, and reporting [22,23,25,27,28,29]. Among the guidelines for such purposes is the guidelines checklist of the “Preferred Reporting Items for Systematic Reviews and Meta-Analysis extension for Scoping Reviews” (PRISMA-ScR), which was formulated according to the guidelines of the “Enhancing the quality and transparency of health research” (EQUATOR) group and published in 2018 [29]. Note that PRISMA guidelines for systematic reviews were also updated and replaced in 2021 by “The PRISMA 2020 Statement” to include “new reporting guidance that reflects advances in methods to identify, select, appraise, and synthesize studies”. Notwithstanding that this update concerned systematic reviews and meta-analyses [30], The JBI Manual for Evidence Synthesis, which remains a pivotal reference in scoping review protocols, proposed many changes (; accessed on 10 April 2023) to PRISMA-ScR that we will also consider in our current review.
As agreed by the JBI manual, changes that were recommended in PRISMA 2020 standards and that are relevant to scoping reviews were considered in items 2, 5, 8–10, 14, and 22 of our PRISMA checklist (see Table 1) when applicable. Our research protocol is summarized in Figure 1 and detailed in Table 1. Moreover, owing to two main considerations, we have focused mainly on publications that were issued during the last four years. Firstly, our preliminary literature research showed repetition in the bioactivity-related parameters that were studied for BP. After analyzing available publications, we have seen that all previously published articles (older than 4 years) reported similar data to that which was available in publications in the last 4 years, evidently relating to our research topic in the current paper. Secondly, two general reviews on BP, dating back to 2020 and before, were published by other colleagues [31,32]. Although no major standardized methodological protocol for literature reviews was claimed or clearly followed by the authors, we have also outlined the main contributions of these two reviews in our current work.
The scientific data for analysis were collected from the main international databases dealing with the medical and pharmaceutical fields, viz. PubMed, ScienceDirect, Scopus, Web of Science, Cochrane Library, and Google Scholar. A preliminary search used the keyword “bee pollen” to screen potentially relevant publications. More affined terms were subsequently used including “bee AND pollen AND nutr*” when the retrieved number of publications was more than 1000 (this was the case with Google Scholar, ScienceDirect, Scopus, and Web of Science). The search term “bee AND pollen AND nutrition” was used in Science Direct because this database does not support searches with wildcard characters (“*” in our case) and have yielded 1271 results. Two filters were then applied: the “article type” filter was limited to “review articles” and “research articles”, and the “subject area” filter was limited to biochemistry, genetics and molecular biology, chemistry, medicine and dentistry, veterinary science and veterinary medicine, pharmacology, toxicology and pharmaceutical science, and immunology and microbiology areas were selected. A total of 305, 417, 547, 715, 2, and 2600 publications were retrieved from PubMed, ScienceDirect, Scopus, Web of Science, Cochrane Library, and Google Scholar, respectively. The search term ““bee pollen” AND nutr* AND doi”, with a 2020–2023 date interval, and just English, French, and Spanish language filters, was used in Google Scholar to refine the search. This refinement resulted in 373 publications after selecting only “review articles”. From the initial 2359 articles that were initially assessed by overviewing the titles and abstracts (when available), we have eliminated the following types from consideration: duplication across databases, books and conference proceedings, irrelevance for our research topic (they were mainly focusing on bee life or, to a much lesser extent, on other bee products, pollen allergy, and BP studies for pharmacological activities that were not considered in this study), and publication language other than the three chosen.
During the time in which we conducted our work, other searches were undertaken to validate the provided data about complementary scientific areas such as human pathophysiology. We have mainly conducted searches for up-to-date reviews of disease mechanisms and the implications for oxidative stress, inflammation, nutrient deficiency, and imbalances in disease onset and outcomes. These pursuits were conducted in PubMed and ScienceDirect. In PubMed, the “review” filter was applied. In both databases, only the last three years were selected as publication dates. We also conducted a search for literature reviews that investigated antioxidant and anti-inflammatory study methods in both databases to guide the structuring of our review of BP activities on these two biological processes.
Finally, 783 full-text articles, including mainly those related to BP, but also some related to honeybee life, human pathophysiology, and research methodology, were fully analyzed and 291 were included in this review. Only those articles published in indexed peer-reviewed journals, having a digital object identifier, and published in English, Spanish, or French, were considered.

3. Results and Discussion

3.1. Nutritional Value of BP

BP’s richness in nutrients, such as proteins, vitamins, minerals, oligo-elements, and unsaturated fatty acids, is certain, along with the fact that it provides a moderate calorie intake as well as a good level of tolerance and safety, except for in the case of allergic reactions or external pollution, which remain manageable and predictable. BP hazards can arise mainly from external contamination factors, as pollen is very sensitive to these factors [2], or from inconvenient storage and processing conditions [1]. Special requirements are being established in the ISO-TC34-SC19-WG3 norm to avoid such tampering in the quality assurance and control of the crude material. Allergic reactions to the product can be largely prevented if we document pollen composition and preliminarily consider patient sensitivity; BP remains safe for most physiological situations including in childhood, in the elderly and in recovering patients [3,4]. BP can also be a source of many essential elements for breastfeeding and pregnant women. A recent study of 27 different brand commercial BP samples showed that a daily consumption of 40 g of this product by a breastfeeding woman could bring 23.9%, 22.6%, 23.8%, and 26.3% of daily needs of copper, iron, manganese, and selenium, respectively [33]. Similarly, the same study showed that the same schedule consumption by a pregnant woman can supply 31.1%, 30.9%, and 30.7% of copper, manganese, and selenium daily needs, respectively. Moreover, some experimental studies reported that BP had protective effects against prenatal exposure to neurotoxic contaminants in animals [34,35]. Therefore, it appears a priori to be a very good food in basic nutrition, as a complementary functional food, or also as an adjuvant in different pathophysiological contexts. An abridged diagram of BP composition is presented in Figure 2.
According to a recent review of more than 100 published studies, the main components of BP are, in order of weight/weight importance: carbohydrates (percentages from 18.5 to 84% were reported), proteins (4.5–61%), lipids (0.4–20%), fibers, ash, and other components [31,36,37]. Carbohydrates exist here as two types of structurally and functionally distinct pools, namely structural carbohydrates, which contribute to pollen grain structure and protection, and non-structural carbohydrates, which are easily digestible and are generally studied and measured in experimental studies [38]. The high carbohydrate content is mainly due to the blending of plant pollen with nectar by honeybees during pellet formation, but is also modulated by plant species, growth level, and harvesting conditions [31]. BP carbohydrates consist mainly of monosaccharides with fructose and glucose as the main ingredients, and disaccharides such as sucrose, maltose, maltulose, and trehalose [31,39,40]. Polysaccharides are encountered in pellet-covering layers (e.g., sporopollenin in the exine and cellulose and pectin in the intine) where they play an encapsulating and protective role against physical, biological, and chemical degradation, and do not generally have any known nutritional value [31,39,40].
It Is important, moreover, to note that the abundance of polyols (e.g., mannitol, inositol, xylitol, ribitol), as included components of carbohydrates in this matrix, contribute to its lower caloric value while ensuring the equilibrated import of energy sources and other nutritional needs [5].
The second key components of BP are proteins. Some studies reported that protein content may reach 61% in some pollen types [37]. Further to the main botanical origin, the great variation of protein composition may also originate from the fact that BP is mono- or multi-floral [2]. Some comparative analyses reported that pollen was richer in amino acids than eggs, cow meat, and milk [41]. The protein content in this product is frequently regarded as a quality index of its nutritional value [7,42]. Indeed, BP is a natural protein source for honeybees, and thus constitutes a key nutritional supply to ensure the development and growth needs of colony members are met, as well as to serve, via the resulting bee bread [43], as a raw material for royal jelly secretion to feed the larvae and queen [44]. Protein supplementation from pollen may even have some advantages over other widely used protein supplements such as whey proteins. A study in Wistar rats has reported that this supplementation was more efficient as a hepatoprotective compared to whey protein, both in running and non-running animals. This was manifested particularly by enhanced hepatocyte activity and reduced glycogen deposition [45]. Moreover, BP is different from pollen, which is native on the plant. A recent comparative proteomic analysis of bee- and manually-collected pollen of dandelion showed that the bee-collected one contained more metabolism-specific proteins and honeybee proteins which are not found in manually-collected pollen [46]. This study, however, reported that total protein content differed only slightly between the two samples.
Despite its composition variability BP contains all the essential amino acids (AAs) needed by the human body, as well as others used to build proteins in humans [47]. However, this does not mean that all types of pollen contain all these AAs. Some floral sources may lack important AAs that are even essential for bee growth and life. Taraxacum officinale pollen, for example, was found to lack tryptophan, phenylalanine, and arginine [46]. A sample of Helianthus annuus BP was found to contain phenylalanine at levels that are lower than those needed by honeybees in their normal nutritional requirements [48]. Methionine and valine, which are also essential to honeybees, were found to be absent in BP samples from Cyanus segetum and Cytisus scoparius, while present in notable amounts in other BP samples from these same species [49]. These differences must be verified by further studies on BP from other species, and those emanating from the natural presence of AAs have to be well distinguished from those originating from experimental procedures. Moreover, in the same geographic location and environmental conditions, BP composition in amino acid could be variable and specific to the individual bee colony [50]. Of course, some of them are more widely present than others. A recent study of BP samples from 32 botanical species showed that arginine, asparagine, glutamine, leucine, lysine, and proline constitute about 60% of the total protein content of BP [49]. We should also underline that the recommended ratios of essential/total AAs are not met in all BP types and that, frequently, some of these molecules are found at limiting levels (qualified, then, as limiting AAs) [7,49]. These levels subsequently limit the total amount of proteins that can be synthesized in the human body following a pollen supplementation, even if total protein intake appears to be sufficient or even high. Therefore, an index called an “Amino Acid Score”, defined as the proportion of the limiting essential AAs in pollen divided by the standard accepted proportions of essential AAs that are considered optimal for protein utilization, was established by some authors. This allows a better assessment of BP protein richness and gives a more accurate estimation of its nutritional value [49].
We should then underline that these data could evidently be of great pharmacological and clinical relevance. The main proteins found in BP are albumins, globulins, glutelins, prolamines, and enzymes [51], but, considering the amino acid-related parameters that we have already discussed, it is the amino acid composition rather than the protein composition that really determines the biological and nutritional value of BP [14]. In fact, hundreds of proteins have been isolated in this crude material. One study of four pollen samples, for example, identified 207 proteins in them [3]. To further enhance BP proteinic value, the enzymatic disruption of pollen walls (by an enzymatic mixture of cellulase: pectinase: xylanase: papain, at 4:2:1:3 ratios) was reported to not only enhance protein liberation and availability from inside pollen grains, but also to permit, unlike physical methods (e.g., ultrasound-assisted and/or freeze-thawing wall breaking), the release of the proteins that form these walls [6].
The third main component of BP are lipids [49,52]. In addition to proteins, lipids appear to play decisive roles in the pollen assembly by honeybees. In fact, it has been shown from different plants and bees species that protein-to-lipid ratios of pollen can drive bee foraging behavior and health [53]. This consideration would be crucial if beekeepers want to “guide” bee foraging and naturally adapt the composition of collected BP for human or animal use. Studies in bumblebees have shown that lipid intake is strongly regulated (more than carbohydrates), and that these insects may overeat proteins to reach a sufficient lipid intake or adequate protein–lipid ratio [54]. Such behavior is not yet studied in honeybees and may, if verified in social honeybees, give important insights about naturally adapting the composition of BP. Bumblebees and honeybees have been shown to possess several similarities in foraging behaviors, and a similarity in lipid and protein foraging is consequently not impossible. Among behavioral similarities, some floral volatiles were shown to attract both insects [55]. A comparative study of honeybee and bumblebee honeys from different geographical and botanical origins reported a similar qualitative composition of free AAs between the two types of honeys, although the quantitative composition was different [56]. Another comparative study reported recently that honeybees and bumblebees both avoid foraging nutritionally poor (e.g., having low protein and high lipid content) and highly toxic pollen, compared to other insects [57].
BP lipids are mainly composed of phospholipids (mostly glycerophospholipids such as phosphatidylcholines, lysophosphatidylcholines, phosphatidylethanolamines, phosphatidylglycerols, and phosphatidylserines), and polyunsaturated fatty acids, but numerous sphingolipids (mainly ceramides), and glycolipids are also present in BP in smaller quantities [58,59,60]. Sterols are also widely present [54], since BP is the only source of these vital molecules for honey bees [61]. Phytosterols, viz. sterols, have also been found to drive phylogenetic signals in bee foraging behaviors [49] and have been linked to bee colony health and performance [53,54]. To our current knowledge, stanols in BP, although frequent in plant pollen [62] and known for their beneficial effects on human health [63], have unfortunately not yet been studied for pharmacological and nutritional purposes.
Long chain fatty acids such as linoleic (Omega-3), α-linolenic (Ω-6), oleic (Ω-9), and α-palmitic acid (saturated) are among the major fatty acids in BP [5,64]. Unsaturated fatty acids may reach 60% of pollen lipids, while palmitic acid is the most abundant saturated fatty acid [65]. Other fatty acids such as oleic acid and myristic acid have also been reported as the main lipidic components [43]. The storage conditions [66], manipulation and processing of BP may alter its lipidic profile. Drying with different techniques, for example, which is the most common operation in pollen use by humans, was shown to reduce its lipid content and alter the structure of its fatty acids, with freeze-drying having the least impact [59]. The lipid profile of BP has also been shown to vary with geographic location and environmental conditions, even for those that are derived from the same plant species [42]. Furthermore, harvesting season was also reported to significantly influence lipid profile. An analysis of pollen loads harvested around one year in the same geographic location showed that, not only did the percentage of different fatty acids in the total lipids vary according to the period of collection, but also that the ratio of unsaturated to total fatty acids was variable during the year with a maximum registered in the summer period [66].
Pollen lipids are not only important for bee life and in assessing BP nutritional profiles. Recent studies showed that these lipids determine the lipidic content and profile of other derivatives produced by honeybees, namely royal jelly [67]. In contrast to proteins, the great impact of the lipidic profile on pollen importance has only just begun to draw attention [68].
BP is also rich in many other nutrients in terms of vitamins and minerals, with a content of up to 0.7% of the total weight being constituted by vitamins, and with being a potential source of considerable amounts of fat soluble vitamins (e.g., pro-vitamin A, vitamins D, and E, which is present in many tocopherol derivatives). It could also contain water soluble vitamins (e.g., vitamins of the B group including B1, B2, B3, B5, B6, B7, B9, and B12, and vitamin C) [5,32,40]. BP is, for example, the richest known source of riboflavin in all plant-based materials [69]. Interestingly, according to numerous comparative studies from different regions of the world [5], the vitamin content of bee bread appears to be richer than BP (including the presence of vitamin K, which is rarely found in pollen). This may likely result from pollen fermentation by lactic acid bacteria from honeybee stomachs and by the bee bread microbiome [40].
Mineral elements are found in BP at an abundant ratio of about 1.6% [33]. They include, at largely variable levels between individual taxonomic types, macro-elements such as calcium, magnesium, phosphorus, potassium, and sodium, and microelements such as copper, iron, manganese, selenium, and zinc [5,32,33].
A large number of other micronutrients includes carotenoids [70], anthocyanins, glucosinolates, and coenzyme Q10, which are well known for their potential nutritional and health-related effects [5]. Numerous enzymes and coenzymes, as well as nucleic acids, particularly ribonucleic acids, are also universally found in considerable amounts [16,32,71]. Betaines were also recently discovered to be widely present in variable quantities depending on the pollen origin, and have been therefore proposed as additional potential markers for origin identification [72]. An analysis was conducted on Spanish BP samples from different botanical origins (e.g., Brassica napus, Vicia sativa, Quercus sp., Retama sp., Papaver sp., Rosa sp., Teucrium sp., Reseda sp., Cytisus sp., Rubus sp.,) and the authors verified the presence of betaines in all of them. Some are pharmacologically well-known molecules, such as betaine, betonicine, trigonelline, and choline, being consistently present at concentration ranges of 7–4910, 264–52,834, 12–3628, and 13–723 mg/kg BP dry weight, respectively [72]. These natural and safe molecules, widely known for their protective role against osmotic and oxidative stresses, especially at hepatic and renal levels [73], are still very scarcely studied in BP. Their wide presence, if verified by sufficient studies, may give additional support to the bioactivity of BP in human metabolic organs and related physiological functions and pathological processes.
BP also contains an interesting microbiome comprising mainly Lactobacillus strains and other microorganisms such as the Pseudomonas genus and yeasts from Saccharomyces genus [74,75]. This microbiome evidently originates, at least partly, from the digestive microbiota of the honey bee (bee saliva), and participates in the fermentation of pollen to manufacture bee bread [75]. The exploitation of these strains will contribute to increase the value of BP for further nutritional applications, as we will discuss bellow.
A significant observation to underline is that BP pellets in their natural form are hardly digestible and therefore do not allow the full release of their nutrients due to the high protection of the encapsulation walls of the pollen grains. These shells may decrease the bioavailability of micronutrients by as much as 50% or more [4]. Some studies reported that the grinding of pollen grains and their dissolution in warm water may increase nutrient bioavailability from 10–15% (values for raw grains) to 60–80% [76]. Studies showed that a preliminary disruption of pollen walls might increase nutrient release and bioavailability [6] and thus enhance the nutritional value and benefits for humans. However, be a “double-edged sword” alter pollen composition, and needs further studies and formulation enhancements.
Fermentation is among the most known processes that may enhance pollen’s nutrient availability. It was reported by many studies that it increases composition richness, either considering nutrients such as vitamins, AAs, peptides, and unsaturated fatty acids, or phytochemicals such as phenolic acids, flavonoids, phenolamides, etc. [69,70,77,78,79,80,81]. BP fermentation was found to potentiate bioactivities, such as those that are antioxidant, anti-inflammatory, antibacterial, and antifungal, and to amplify the lowering effects on many metabolic disorder biomarkers, including body mass index, glycemia, cholesterol, and triglyceride levels [70,79,80,81,82]. These kinds of results were obtained by many well-known and widely used fermenting strains, including bacteria such as Lactococcus lactis, Lactobacillus rhamnosus [82], Lactobacillus bulgaricus, and Lactobacillus kunkeei, and yeasts such as Saccharomyces cerevisiae [77] and Hanseniaspora uvarum [80]. Some studies reported that yeast fermentation resulted in a more pronounced enhancement of nutrient composition than lactic bacteria or mixed (bacteria and yeast strains together) fermentations [83]. It has even been reported that fermentation permitted the reduction in allergenicity of BP by significantly reducing its allergen contents and the immunoglobulin-E-binding affinity of these allergens (this was obtained by fermenting Brassica napus BP with Saccharomyces cerevisiae) [84]. Indeed, bee bread, which is the natural product of the honeybee-ensured lactic fermentation of BP over the course of approximately one week in the honeycomb, is characterized by a partial alteration of the resistant pollen grain wall and a richer and more balanced nutrient composition, as well as an enhanced digestibility, bio-accessibility, and compound bioavailability in the human body [69,79,82]. The results may evidently vary according to the assessed parameters, but the general tendencies that we have enumerated here are generally reported by almost all studies.

3.2. BP as a Functional Nutrient Source

3.2.1. Nutritional Deficiencies

It is estimated that more than two billion people suffer from micronutrient deficiency worldwide [33]. Such deficiencies are perceived by the World Health Organization (WHO) and scientists as a global health concern [85,86]. Evidently, the rich composition of BP fosters primarily its use in human nutrition for rebalancing or preventing miscellaneous nutritional deficiencies and pathophysiological conditions. However, the interpretation of experimental analyses warrants a great awareness before drawing any clinically relevant conclusions. Clinical trials that are continuously undertaken worldwide are broadly known to return conflicting results in a large number of dietary supplements. Evidently, miscellaneous bias and/or experimental drifts or shortcomings may lie behind such controversies; however, the lack of translational awareness may be the major “fausse-route” in such conditions, especially among the scientific community. BP may be an interesting option due to its balanced composition and its high safety but more preclinical and clinical investigations are still needed to fully support such claims.
Deficiencies in vital nutrients are widespread in all regions of the world regardless of the socioeconomic conditions. For example, multi-country surveys reported that more than 40% of the European population, 23% of the American population, and 38% of the Canadian population had vitamin D levels below 50nmol/l, which is the minimal normal value agreed upon globally [87]. Many other studies in European countries reported significant deficiencies in many vital nutrients and microelements such as selenium [88,89], and miscellaneous other trace elements and vitamins [90,91,92].
Nutritional deficiencies can be a modifiable risk to prevent subsequent pathological implications, and BP may therefore be a possible solution in most cases of nutritional deficiencies to prevent the outcome of the worsening of many pathophysiological processes. Among the different compounds, the mineral bio-elements, especially trace elements that are drastically lacking in modern lifestyle dietary habits, can be an added value in this product. Other recently highlighted issues, such as fermentation and prior-to-drying measures, may also be harnessed to ameliorate the profit of this matrix either by preventing its quality loss or by enhancing its nutritional qualities.

3.2.2. Antioxidant Potential

Redox regulation is among the most ubiquitously known mechanisms in the human body. Oxidative stress, as concept that reflects the disturbance of redox regulation, is often roughly and unclearly appraised. The translational research experience has shown in countless examples that experimentally and preclinically shown qualities of phytochemicals are not expressed by relevant outcomes in clinical trials [93,94]. However, oxidative stress is well known to contribute to the genesis and development of a wide range of human diseases, including metabolic [95,96] and cardiovascular [97,98] ones.
BP antioxidant activity is one of its most studied properties [99]. This bioeffect, which usually results from a combination of diverse mechanisms [79], is almost universally present in BP as it was always reported by published studies that searched for it, disregarding when and where they were undertaken [9,32,60,74,79,100,101,102,103,104,105]. Moreover, it has marked significance for its anti-inflammatory potential [65,101]. However, this activity, as is the case for overall BP composition, varies widely depending on bee and plant species, geographical location, soil type, timing, processing, and environmental conditions [79,101,106,107] which can make approaching it difficult. Despite that, it is noteworthy that comparative studies have generally reported that multi-floral pollens exhibit more pronounced antioxidant activity than mono-floral pollens [108]. In addition, it has been frequently reported that BP antioxidant activity correlates, sometimes linearly, with its total phenolic compounds [109], with phenolic acids and flavonoids being reportedly the most active [79]. Polyphenols are very well-known antioxidants and thousands of scientific works have verified this activity for these ubiquitous natural compounds. A countless number of them, including many of those encountered in BP, have been conducted either at experimental or clinical levels, and have concerned many types of human diseases [110,111,112,113,114,115,116,117,118,119,120,121,122,123]. The development of these studies being beyond the scope of our current paper, we will not develop these results here. Nevertheless, recent studies that investigated BP’s antioxidant effects are summarized in Table 2. Vitamins, for example, such as C [124,125], D [126,127], and E [128,129], are also well-documented antioxidants that are found in BP. As another example, polysaccharides from Carthamus tinctorius BP were repeatedly reported as having important antioxidant activities, such as upregulating antioxidant enzymes activities and lowering circulating levels of oxidative elements in many locations including the serum, liver and brain [130]. Another important observation to underline is that many studies, excluding some rare exceptions [44,109], have reported that bee bread and fermented BP both present more pronounced antioxidant activities than bee pollen alone [69,78,79,82].
Figure 3 explanation:
(*1): Miscellaneous exogenous factors may trigger free radical production in the body
(*2): Human body normally produces free radicals to ensure physiological functions.
(*3): In normal conditions, a balanced state is achieved between reactive species production and antioxidant mechanisms.
(*4): If the reactive species amount is excessive, or antioxidant mechanisms are insufficient, there is an abnormal accumulation of circulating reactive species and thus an impaired redox balance that is known as oxidative stress.
(*5): Bee pollen can act either by reducing reactive species levels by diverse mechanisms, or by enhancing endogenous antioxidant defense mechanisms.
(*6): BP action results in palliating deleterious oxidative stress consequences that are schematized from (*7) to (*10)
(*7): Oxidative stress results in genetic and epigenetic alterations.
(*8): Reactive species induce and oxidation of biological macromolecules, mainly of lipids and proteins. Lipid peroxidation may dangerously result in altering the structure and functions of plasma membranes.
(*9): Free radicals are also produced by mitochondria for physiological purposes, or as a response to diverse pathophysiological situations or other stressors.
(*10): The cumulation of diverse oxidative mechanisms and byproducts may result in altering cell functions and structure(s), and ultimately lead to cell death and generalized degenerative processes.
Figure 3. Oxidative Stress Mechanisms and Bee Pollen Action.
Figure 3. Oxidative Stress Mechanisms and Bee Pollen Action.
Nutrients 15 02413 g003
Available evidence, which comes mainly from experimental studies, supports potential multitarget activities for BP that have been shown to encompass at least the aspects illustrated in (*1)–(*10) in this figure (information reported in Table 2).
Oxidative stress can emanate either from an overproduction of reactive species or from an impairment or insufficiency of inner antioxidant mechanisms. A wide array of methods have been used to assess the antioxidant potential of natural compounds by measuring diverse molecular markers such as free radicals, antioxidant enzymes and oxidation byproducts [176,177,178]. In BP studies, all these types of analytical methods have been used but we will give only some illustrative examples from most recent studies. The known mechanisms of BP antioxidant activities are illustrated in Figure 3.
A hydroethanolic extract of a commercial multifloral BP was recently reported to manifest, in a dose-dependent manner, a radical scavenging activity on diverse test-generated radicals (2,2-diphenyl-1-picrylhydrazyl (DPPH) which is classically used in experimental studies, and nitric oxide, and superoxide which were used for the first time in pollen studies) [154]. Water and hydroethanolic extracts of Cannabis sativa were also reported to show an in vitro radical scavenging and peroxidase inhibitory activities with hydroethanolic extract being more active [179]. A study of hydroethanolic extracts of many BP samples, including monofloral (Quercus palustris, Actinidia arguta, Robinia pseudoacacia, and Amygdalus persica) and multifloral ones, reported that sixteen of the eighteen samples presented a potent DPPH scavenging activity [105]. Another recent study analyzed the antioxidant activity of twenty BP samples by assessing the 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid (ABTS)) cation elimination, the cupric ion reducing antioxidant capacity (CUPRAC), and the DPPH free radical scavenging, and reported that all studied samples presented a marked antioxidant potential which evidently varied according to the botanical origin of the BP [180]. Interestingly, this study unveiled two important observations. Firstly, hydrolyzed fractions (the treatment of extractable fraction by methanol–sulfuric acid, 10:1 mixture) of BP were more potent as antioxidants than extractable fractions (hydrochloric acid/methanol/water at 1:80:10, v/v mixture) in all used assays and samples. This is in accordance with other studies that have shown that enzymatic hydrolysis improved the antioxidant activities of BP [133,181]. Secondly, the measurements showed that the DDPH assay revealed a largely lower antioxidant activity compared to the other two methods (ABTS and CUPRAC). The authors then concluded that the DPPH assay was not suitable to study BP’s antioxidant potential. Since the DPPH assay is among the most used tests to assess the antioxidant potential of natural products and other chemicals [101,182], this intriguing observation should be validated by other BP studies.
The cellular antioxidant activity (CAA) assay is a recently developed method to assess antioxidant activity and is regarded as a better alternative to traditional chemical methods, as it considers the cellular uptake, distribution, and metabolism of the antioxidant compounds [183]. A topical study using this technique in a human hepatic cell line reported that the hydroethanolic extract of rape BP showed significant dose-dependent antioxidant activity that was largely more pronounced with fermented BP compared to unfermented BP [70]. Another study of the ethanolic extracts of different BP samples, including mono-species, -genus and -family botanical origin pollens, and using the CAA assay for the first time in an ex vivo system based on human erythrocytes, reported that all tested extracts induced a significant antioxidant activity in studied cells, with the Eucalyptus BP being the most potent and Erica BP being the least potent. Other BP samples in this study were Trifolium pratense for monofloral BP, Prunus, Rubus, Viburnum, and Rosa for BP composed mainly of one botanical genus, and Brassicaceae and Asteraceae for BP composed mainly of one botanical family.
The antioxidant potential of BP was also assessed by investigating the cellular and biochemical effects of oxidative stress and measuring their variation as a whole product or as an extract. The ethanolic extract of chestnut was also reported to reduce DNA oxidative damage products by 33% [152]. Ethanolic extract of Schisandra chinensis BP was shown to significantly upregulate superoxide dismutase activity and glutathione levels, reduce lipid peroxidation product malondialdehyde, and to markedly improve cell morphology and survival rate in a cardiomyocyte model culture [168]. This study also reported that the extract protects remarkably against H2O2-induced apoptosis by an intricate combination of mechanisms including a significant downregulation of Bax, cytochrome C, and caspase-3 mRNA expression, and an upregulation of Bcl-2 mRNA expression. Accordingly, a comparative study of the ethanolic extracts of Castanea, Cistus, and Rubus BP showed that they significantly reduced diverse molecular markers of oxidation and prevented erythrocytic hemolysis [156].
The antioxidant activity of BP is generally reported either when the study protocol relies on administering raw BP as whole product, or when diverse types of extracts are used. Numerous studies have reported that the feeding of BP to animals resulted in a marked activation of diverse antioxidant mechanisms and an improvement in antioxidant defense against different experimentally-induced oxidative damages [132,137,142,172,184,185]. In addition, studies of BP extracts obtained by diverse solvents, including ethanolic [148,156,167,168], hydroethanolic [15,154,171,179], and diverse organic solvent-mediated extracts [150,151,153,175], have noted important antioxidant activities regardless of the extraction media. These bioeffects were also widely reported in animal models by studies that focused on different anatomical organs and physiological systems including renal [174], nervous [139,174], digestive [144,151], and reproductive [172,185] systems, as well as on different biochemical, hematological, and toxicological markers at systemic levels [137,165,184].
Therefore, BP’s antioxidant potential appears to be very intricate and, surprisingly, encompasses many complementary pathways, ranging from reactive species’ scavenging and antioxidant defense activation to the abolition of the deleterious effects of oxidation byproducts and the resulting protection of cells against lethal injuries such as apoptosis and hemolysis. At the current level of knowledge, these mechanisms remain to be fully elucidate and their clinical relevance remains to be explored. Moreover, it is very important to underline that, during our reviews, we observed that BP samples are frequently supplied by commercial sources rather than by traceable and standardized sampling channels. This is perfectly understandable due to the costly and time-consuming nature of such channels, but, unfortunately, this is very likely to cause avoidable experimental result irregularities and alter the relevance and quality of research works. This observation evidently applies to the study of all BP aspects, either concerning composition, bioactivities, or safety.

3.2.3. Anti-Inflammatory Potential

Chronic low-grade inflammation has been widely recognized as a pathogenesis factor in a wide array of highly detrimental pathophysiological conditions such as auto-immune, cancerous, cardiovascular, metabolic, musculoskeletal, neurodegenerative, psychosomatic, reproductive, dermatological, and other disorders [186,187,188,189,190,191,192,193,194,195]. BP encompasses marked inhibitory activities on inflammations including systemic and localized forms such as neuroinflammation and digestive wall inflammations [65]. The anti-inflammatory potential of BP was amply studied and diverse mechanisms were spotlighted, especially at experimental level [11]. The most recent studies are summarized in Table 3. These activities have been evidently linked to the classically known anti-inflammatory phytochemicals such as polyphenols, but also to other phytonutrients of BP such as lipids, peptides, polysaccharides, and other compounds [11,171,181,196,197]. In addition to the obvious differences according to the botanical origin of BP, differences in anti-inflammatory activity were reported according to bee species. A comparison between the stingless bee, Melipona fasciculata, and the European bee, Apis mellifera, showed that BP collected by the former showed higher anti-inflammatory and antinociceptive activities [198]. Such observations may be of potential importance in adapting BP as a raw material for variable subsequent uses and indications.
On the common systemic inflammation markers, BP was shown to exert anti-inflammatory effects via diverse mechanisms. Rape BP hydroethanolic extract was reported to exert a potent inhibitory effect on nitric oxide and some proinflammatory cytokine production, and on Cyclooxygenase-2 expression in a macrophage culture [70]. This effect was significantly potentiated after fermenting BP with Saccharomyces cerevisiae. A potent and dose-dependent inhibitory activity on both Cyclooxygenase isoforms (COX-1 and COX-2) was also shown for an hydroethanolic extract of pollen (the authors did not mention botanical origin) from a stingless bee (Scaptotrigona affinis postica) [171].
Regarding neuroinflammation, a commercial BP feeding was reported to significantly downregulate pro-inflammatory cytokines such as Interleukins 1A and 6 (Il-1A and IL-6) and Interferon gamma (IFN-γ) in autistic animal models [65]. A multifloral pollen was also reported to significantly suppress neuroinflammation by lowering hippocampal levels of the proinflammatory cytokines TNF-α and IL-1β [139].
In the digestive system, a multistep hexane–ethanol extract of Camellia sinensis BP was reported to significantly upregulate transforming growth factor beta 1 (TGF-β1) gene expression, downregulate TNF-α and IL-6 gene expressions, and inhibit the mitogen-activated protein kinase (MAPK) signaling pathway in an in vitro inflammatory bowel disease (IBD) mimic [162]. In addition, this study noted that the studied extract reduced gut membrane permeability, reestablished the metabolic profile of tight junction cells, and exhibited other metabolic and antioxidative effects that alleviated the IBD condition and ameliorated the overall intestinal barrier function. In another study, the ethanolic extract of a multifloral pollen composed mainly by Castanea sativa (88.8%) and other plants, showed a cell protective effect against TNF-α-induced inflammation in a human colorectal adenocarcinoma cell line. The available mechanisms included the downregulation, in a dose-dependent manner, of many inflammation mediators such as Il-8, COX-2, and the cell surface inflammatory glycoprotein intercellular adhesion molecule 1 (ICAM-1) [11].
The anti-inflammatory potential of BP does not only rely on polyphenols. Protein hydrolysates have been widely researched for their prospects as prominent anti-inflammatory alternatives and are ubiquitous in natural resources [207,208]. BP protein hydrolysates, produced with Alcalase, Flavourzyme, and Neutrase enzymes from commercial BP samples, manifested potent nitric oxide scavenging activity, with IC50 (the concentration of BP hydrolysate that scavenges 50% of the nitric oxide radicals) being largely lower than that of the curcumin used as a positive control [181]. As another example, a water-soluble polysaccharide fraction from Fagopyrum esculentum BP manifested a pronounced anti-inflammatory activity by lowering pro-inflammatory cytokines and secretory immunoglobulins A, and acted through gut microbiota modulation to result in many inflammation-countering mechanisms in mice [196].
Many other nutrients which are known to be present in BP, such as vitamins (e.g., A, B group, C, D, E, and K [209,210]) and unsaturated fatty acids [211], are also widely known for their anti-inflammatory effects. In addition to all of those compounds, tannins [171] and glucosinolates [197] have also been shown to exert important anti-inflammatory activities through diverse mechanisms.
A brief illustration of the mechanisms that have been identified so far in experimental studies for BP anti-inflammatory effects is presented in Figure 4. It is important to underline that the studies of these parameters are still in their very early phases. Numerous interactions may influence unveiled parameters and outcomes. Striking contradictory results are generally rare in studying the anti-inflammatory potential of BP since this potential has been well established by experimental research. However, many differences in effect extents and mechanism specificities are certainly due to the great variability in BP composition, and numerous studies, as we have seen in Table 3, do not even give precise information about the botanical and geographical origin of the BP samples used. Most studies focus on the total content of phenolic compounds. In the best cases, mostly in total flavonoid compounds and seldom, if ever, contain characterizations of molecular compounds and, extremely rarely, a consideration of BP compounds other than phenolics in studying anti-inflammatory effects. In silico methods which may be of great benefit, especially with emerging omics and computational technologies, have also only recently been used in some studies. Moreover, studied mediators in experimental studies may not always be reliable in correctly assessing anti-inflammatory effects. The role of some examples that we have seen in this section may give a clear insight about this problem. IFN-γ, for example, is a pleiotropic mediator that may present anti- and pro-inflammatory roles depending on the pathophysiological contexts and triggering mechanisms, and its role is still not well understood [212,213]. The mechanism of pleiotropy is a frequent trait in cytokines that still hinders the understanding of their mechanisms and makes it difficult to clearly and firmly establish their roles in different pathophysiological situations [214]. The distinctive roles of the two macrophage subtypes on inflammation has been also shown by some studies [215] to not be as simple as they are classically appraised (M1 are classically considered as pro-inflammatory and M2 as anti-inflammatory). Future studies must therefore consider the knowledge gaps in pathophysiological mechanisms, and adopt a more all-inclusive approach in choosing the parameters to study and those to consider in preparing the raw material to use in experiments.
Another extremely important consideration that is still omitted in most studies lies in the fact that numerous pathologies that are among the most burdensome in our current world come from chronic inflammation, and most studies that have been undertaken so far evaluated the anti-inflammatory effect of BP in rapidly-produced experimental conditions which may not reflect the real pathogenesis evolution and the real BP effect in simulated disease models. Most of the diseases in which inflammatory processes are involved progress over many years or decades and, thus, any evaluation of possible corrective means must consider such a fact.
Furthermore, since the anti-inflammatory effect of BP may emanate also from a large array of its constituents, it is crucial to consider that the effect of them on the treated patients or the at-risk persons that may take BP for preventive purposes will not be the same as in healthy persons. It has been recently shown through many examples that the effects, including the anti-inflammatory ones, of nutrients are altered in inflammatory terrains [216]. A person with an inflamed internal milieu will not benefit in the same way from an anti-inflammatory diet as another person would. These kind of inferences being still recent and not completely understood, further investigations are necessary, especially when considering the differences between the preventive and curative potential of BP as an anti-inflammatory arsenal.
This biopotential is, however, an acknowledged characteristic of this product. Since inflammation is a major mechanism in numerous devastating diseases, especially those linked to modern lifestyle including digestive, metabolic, cardiovascular, and neurodegenerative ones, BP may boast a relevant interest in preventing and managing these conditions. The fact that it exerts its anti-inflammatory effects through a rich mechanism diversity, potentiated by diversified antioxidant mechanisms, remains, however, to be supported by more preclinical and clinical studies.
BP, with a controlled and standardized quality, would be an affordable and safe part of an integrative and balanced dietary intervention to prevent and scale down many pathophysiological conditions, which are weighing heavily on public health in our current societies, without efficient solutions. Innovative means must be ascertained in order to standardize reproducible BP compositions, and give sufficient data, as well as translational research, should be gathered and made available to the scientific community and healthcare practitioners.

3.2.4. Digestive Health

Numerous studies showed that BP may improve gastrointestinal functions in many ways including digestion, absorption, secretions, and microbiota modulation. It encompasses marked gut-protective potential, as was reported by a series of in vitro and in vivo studies. In a human intestinal cell line, a lipidic extract of Camellia sinensis BP was found to inhibit dextran-sulfate-sodium-induced cell viability loss, oxidative damage, and epithelial barrier permeability, and to significantly enhance transepithelial and cellular absorption and metabolism of lipids [58]. Using a lipidomic approach, the authors of this study unveiled the contribution to such effects by numerous lipids including those classically known to enhance cellular structure and intestinal barrier components such as monolayer and tight junctions.
The enhancing effects of BP on digestion-related functions in the digestive tract have also been reported by in vivo studies. A very recent meta-analysis reported that BP supplementation to rabbits resulted in an increased activity of digestive enzymes (protease, amylase, and lipase) in the intestinal content, and in an enhanced digestibility of crude proteins, crude fibers, and other organic matter [217].
Intestinal absorption and secretory function may also be enhanced by this matrix. The supplementation of Brassica napus BP to rats was reported to significantly increase intestinal crypts depth at 0.2% and 0.5% w/w feed ratios, and to decrease it at 0.75% w/w, but all ratios led to a significant increase in intestinal villi length [32]. Similar findings were reported in broilers where 1.5% supplementation resulted in an increased density and depth of intestinal crypts, as well as longer and thickener duodenum, jejunum, and ileum villi [32]. Such effects may therefore suggest the potential of BP to improve intestinal mucosa through enhancing absorption and secretory functions.
Many in vivo studies reported that BP modulated digestive tract microbiota in a favorable way. Many examples of digestive function ameliorations and microbiota enhancements or dysbiosis corrections were already given in Table 3, as microbiota are currently very widely known to modulate the inflammatory response in the digestive tract, but also in many distant localizations of the body. Some recent examples are given below.
In the oral cavity, BP fed at a ratio of 5% to rats for one month resulted in a marked increase in the genus Lactococcus (Lactococcus lactis is known to prevent oral pathogen spread such as Streptococcus mutans and Porphyromonas gingivalis) in oral and intestinal flora [218]. This effect in the oral cavity may not be totally due to the antimicrobial activity of BP, because the authors demonstrated that the latter did not have significant effect on Streptococcus mutans although a potent inhibitory effect was observed on Porphyromonas gingivalis, while an upregulated antimicrobial peptide production by oral epithelium was also noted.
An in vitro study of the hydroethanolic extracts of nineteen diverse pollen samples (Actinidia arguta, Amygdalus persica, Quercus palustris, and Robinia pseudoacacia being mono-floral and the others, multifloral) reported that all these extracts did not inhibit human intestinal beneficial bacteria [105]. The tested strains were some of those most widely utilized as probiotics in dietary supplements, viz., Bifidobacterium bifidum, B. breve, B. infantis, B. longum, Lactobacillus acidophilus, and L. casei, and an acidulating bacterium (Clostridium butyricum). Meanwhile, the extracts showed weak inhibitory activity on two nonpathogenic bacteria (Bacteroides fragilis and Escherichia coli) and on many tested pathogen bacteria (Clostridium difficile, C. paraputrificum, C. perfringens, and Staphylococcus aureus).
Accordingly, another study in rodents with high-fat-induced metabolic syndrome reported that supplementation of Brassica campestris BP sharply reduced proteobacteria abundance, restored the firmicutes–bacteroidetes ratio (which was altered by the high-fat diet), and increased Lactobacillus and Lactococcus abundance in the gut microbiota [81]. The study also showed that pollen submitted to a wall breaking by yeast fermentation was more effective than normal BP. Likewise, in hyperuricemic rats, Camellia japonica BP extract resulted in a normalization of the firmicutes–bacteroidetes ratio, and bacteroidetes, proteobacteria, and Clostridium levels [151]. This study also reported a significant increase in Lactobacillus and Clostridiaceae abundance, and in short chain fatty acids.
It can be inferred that numerous aspects of preventive and corrective bioactivities, in the digestive system structure and function, are verified with BP supplementation or extract administration. This, interestingly, covers nearly all major steps in the course of food digestion. We have seen some intriguing and valuable qualities on gut microbiota such as concomitantly enhancing the beneficial strains amount and microbiota diversity while inhibiting pathogen strains. Unfortunately, studies in humans are still lacking in all of the aspects discussed above.

3.2.5. Metabolic Disorders

BP has proven to improve many metabolic imbalances through different and combined mechanisms, some of them connected to disorders such as obesity, diabetes, and dyslipidemia.
Many studies showed that BP reduces liver fat deposition and lipid levels. In a murine hepatic cell line, the ethanolic extracts of many multifloral pollens manifested significant hepatoprotective effects against experimentally induced free radicals, and efficiently reduced lipid accumulation in liver cells [159]. This steatosis reduction showed a low correlation with total phenolic and flavonoid content, but correlated moderately with quercetin levels in pollen samples. In rodent hepatocytes it increased nucleus size, reduced total and low-density lipoprotein cholesterol (LDL-C), TG, and glycogen deposition, concomitantly with lowering the blood pressure of the portal vein [45]. In rodents, BP reduced the steatosis and liver cell degeneration resulting from a high-fat diet, and prevented nonalcoholic fatty liver disease establishment in obese mice [32,159]. In rats intoxicated by propionic acid, the ethanolic extract of a commercial BP sample was also reported to restore hepatocyte function through normalizing numerous hepatic enzymes and molecular markers of liver injury, mitigating oxidative stress [144]. In rodents suffering Fluvastatin-induced hepatitis, a supplementation of a multifloral BP was reported to reduce many biochemical and histological markers of hepatic injury including circulating enzymes marking hepatic injuries, albumin, bilirubin, liver oxidative stress markers, portal vein congestion, abundance of inflammatory cells, and hepatocyte necroptosis [158].


Although obesity is classically perceived as a disease resulting from an imbalance between calorie intake and expenditure, this disease has been recently acknowledged as evolving upon a complex interplay of biological and psychosocial factors, and the body has been found to encompass an ambiguous defense mechanism against weight loss even with hypocaloric diets [219]. However, it is at least well known that some biological aspects which are largely discussed in this review are tightly involved in the biological processes of obesity pathophysiology. Gut microbiota have been shown, for example, to be closely related to diverse macronutrient metabolisms and fat depositions, as well as to a large plethora of hormonal and other signaling pathways, making the dysbiosis of the micro-organism community involved in obesity inducement and worsening [220,221]. For instance, intestinal permeability, inflammatory processes, oxidative stress, epigenetic regulation, genetic predisposition, and, of course, imbalanced diet are certainly linked to obesity pathogenesis [220,222,223]. Notwithstanding genetic and lifestyle habits, we have seen, during the previous sections, that BP presented important modulatory effects in most of these pathophysiological factors.
Some in vivo studies reported that BP extracts may result in a marked reduction in body weight (18.23% and 19.37% reduction by 7.86 and 15.72 g/kg body weight of pollen extract Schisandra chinensis, respectively) [32], in addition to many effects related to other obesity traits, such as reducing liver fat deposition and its oxidative damage, improving lipidic profile, and enhancing hepatic metabolism and autophagy.
Many of the active phytochemicals in BP are widely studied or known for their obesity-mitigating effects. Flavonoids may be the most illustrative example, among them being flavonols (e.g., kaempferol, myricetin, quercetin), flavones (e.g., luteolin, vitexin), and flavanones (e.g., hesperidin, naringenin). These compounds entail numerous effects on pathophysiological markers of obesity such as lipid peroxidation and deposit inhibition, blood-glucose-lowering, anti-inflammatory, and antioxidant effects, hepatocytes and other protections, insulin resistance suppression, energetic catabolism activation, etc. The same observation may be carried out for other components such as phenolic acids too. These effects differ from one molecule to another, but numerous good reviews have been carried out on this topic and present promising prospects that we could not detail here [111,116,224,225,226,227,228,229,230].
As we have already highlighted, for some disorders, BP appears to have a very profitable potential in at-risk persons as a prophylactic product where it may act more profitably in inhibiting etiological pathophysiological events. It preserves, however, all these benefits in confirmed obesity stages since numerous management protocols of this disorder rely on dietary and lifestyle-changing measures such as meal replacements and low-calorie-based micronutrient supply, and it could perfectly fill these needs at least partly. A substantial amount of studies, especially at experimental and preclinical levels, have been published so far. However, these studies do not generally deal with the complete parameters that are gathered by a clinical picture of the obesity disease situation. Regrettably, studies in humans are still absent. Even in experimental studies, it is evidently noted that experimental protocols frequently lack an integrative approach in their study design, especially regarding variability considerations, investigated parameters, raw material standardization, etc.

Diabetes Mellitus

The beneficiary effects of BP on liver function and structure invoke a possible role in improving insulin resistance. This was, for example, recently verified with a polysaccharide fraction isolated from Rosa rugosa BP, which lowered glycemia levels in type 2 diabetic mice by reducing hepatic steatosis and insulin resistance [231]. To explore a possible effect in type 1 diabetes, this fraction, tested in vitro, resulted in increased pancreatic β-cell proliferation and insulin secretion, while, in mice, it reduced alloxan-induced fasting hyperglycemia, as well as water consumption, urinary volume, and ketone bodies levels, and markedly prevented β-cell loss, restored β-cell/total pancreas volume ratio, and increased insulin levels [231].
In a human colon cell line, Camellia sinensis BP extract significantly reduced glucose transport in the epithelium monolayer at different concentrations and time intervals, and drastically reduced glucose absorption by suppressing the expression of glucose transporter 2 and sodium-dependent glucose transporter 1 proteins [232]. Using molecular docking, this effect seemed to be largely due to phenolic compounds.
The possible antidiabetic action of BP in the intestinal tract was also shown by an in vitro study of a multifloral sample composed mainly of Echium plantagineum, Cistus ladanifer, and Quercus sp. A hydroethanolic extract of this BP resulted in a significant dose-dependent inhibition of α-glucosidase activity which was, however, much weaker than acarbose in all tested doses [154].
In mice models where type 2 diabetes was induced by a high-fat diet and streptozotocin administration, the ethanolic extract of Fagopyrum esculentum BP produced a marked decrease in fasting blood glucose and “homeostatic model assessment for insulin resistance index”, and an increase in insulin levels, “homeostasis model assessment-β index” (effect extents were more than metformin at certain doses) [201]. Moreover, this study noted that mice treated with this extract had a significant decrease in triglyceride, LDL-C, alanine transaminase, aspartate transaminase, and the lipid peroxidation byproduct malondialdehyde, an increase in high-density lipoprotein cholesterol (HDL-C), and a marked and dose-dependent restoration of adipocyte enlargement which is induced in diabetic mice.
However, this study reported some intriguing observations. Using two doses of BP extracts (1 and 6 g/kg bodyweight) and metformin in all assays, the authors reported that only the high dose of BP extract effectively reduced the total cholesterol, and a significant increase in hepatic glycogen level was only noticed with the low dose of extract. As pro-inflammatory cytokines are known to be upregulated in diabetic patients, and some of them such as IL-6 and TNF-α may be involved in inducing pancreatic β-cells apoptosis, this study curiously reported that mRNA expression of TNF-α and TGF-β were downregulated only by the low dose of pollen extract while the high dose only downregulated TGF-β mRNA expression but not TNF-α. Moreover, a down-regulated mRNA expression of IL-6 was observed in low-dose-treated mice but not in high-dose- and metformin-treated mice. This study being very recent, more work is needed to elucidate the reproducibility and the underlying mechanisms of these observations. Both BP extract dosages activated the phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) signaling pathway which, albeit involved in a multitude of physiological and pathological processes, promotes insulin secretion from pancreatic β cells and is impaired in type 2 diabetes. As another important effect, both BP extract dosages induced an enhancement in gut microbiota diversity and restored strains that were tested in this study to a profile that is close to normal diet mice.
It is worth underlining that the examples of BP that we enumerated in this section are all derived from well-known plants that have evidence-based antidiabetic effects. Indeed, Camellia sinensis [233,234] and Fagopyrum esculentum [235,236] were largely reported to exert antidiabetic, anti-dyslipidemia, and protective cardiovascular effects in animals and humans. Echium plantagineum oil [237] and Quercus sp. fruits [238] have been shown to possess diverse antidiabetic and metabolic-syndrome-lowering activities by human clinical studies. Rosa rugosa [239,240] has also been reported, experimentally and ethnopharmacologically, to have such effects. Such observations may be of great interest in guiding bioprospection research, although studies comparing the phytocompound contents of BP, plant pollen, and other plant parts remain very sparse and insufficient. Likewise, clinical trials on BP usefulness in diabetic patients and in early insulin resistance stages are unfortunately still lacking despite the substantial amount of preclinical evidence that is available and the affordability and known high safety of the product.
Studies that have investigated BP bioactivities on pathophysiological processes that may be related to diabetes are too manifold to all be cited here. Indeed, as we are focusing just on recent findings and inferences in this paper, we have exposed only some relevant examples. This allows us to draw evidence-based insights about the promising and multitargeting potential of BP in this pandemic disorder which is, for the most part, settled through a long course of imbalances and is complexly implicated in some of the greatest morbidities of human beings. BP has direct effects on key diabetes biomarkers such as glycemia levels, insulin secretion and resistance, hepatic glycogen levels, enzyme activities and steatosis, β-cells function, fitness and apoptosis, glucose transport, carbohydrate digesting enzymes, and ketone production. A summary of BP antidiabetic potential is illustrated in Figure 5.
A countless number of studies unveiling the antidiabetic properties, including early preventive, disease course modifying, and complication limiting effects, of individual nutrients and phytochemicals that are ubiquitously present in BP from different botanical and geographical origins have been published so far. This includes, for example, nutrients including vitamins such as groups B [241,242,243], C [244,245,246], D [247,248,249], and E [128,250,251], oligo-elements and other minerals [252,253,254], and lipids such as unsaturated fatty acids [255,256,257] and phytosterols [63,258,259], as well as other phytochemicals including polyphenols such as phenolic acids, flavonoids, and stilbenes (very recent and comprehensive reviews of preclinical and clinical evidence can be found in [260,261,262,263,264,265,266]). Despite the substantial amount of experimental and clinical evidence of all these BP compounds in the complex pathophysiology of diabetes and in its interaction with other comorbidities, the possible synergistic potential and real clinical outcome of these compounds, which are always combined in BP, have generally been omitted in research and must be further studied by in vivo experiments, and subsequently verified and objectively assessed by clinical studies. Notwithstanding the biological and chemical diversity of BP, these kind of studies in humans may be more easily reachable than individual phytochemicals and other drugs due to the affordability, wide human use, and potential safety of BP.


In this text, it was already seen through many examples that numerous mono- and multifloral BP samples produced marked improvements in lipid profiles in vivo.
As we have already cited, Brassica campestris BP supplementation to high-fat-fed mice resulted in a significant decrease in total cholesterol, triglycerides, and LDL-C, but unexpectedly did not result in a significant variation in HDL-C [81]. Another example that we have already given involves a polysaccharide from Fagopyrum esculentum BP which induced a significant decrease in triglyceride levels [196]. This fraction also did not significantly affect the HDL-C levels. The ethyl acetate and n-butanol extracts of a commercial BP showed an important decrease in the total LDL-C and triglycerides, and a significant increase in HDL-C in rodents, but such effects disappeared when animals were intoxicated with propionic acid [144]. Lipid lowering effects and lipid peroxidation prevention were reported for many monofloral, multifloral, and commercial BP extracts [16,32,45]. In contrast, supplementation in aged horses did not result in such significant changes after 30 days of 60 g/day of pollen supplementation [137].
A daily supplementation of 40 g of pollen in patients with heart failure reduced their total cholesterol levels [60]. In patients with atherogenic dyslipidemia, a mixture of BP, bee bread, and honey induced a marked decrease in total cholesterol (−18.3%), but it is worth noting that bee bread alone reduced total cholesterol by 15.7% [267]. BP alone resulted, in patients with a body mass index above 25, in an improved blood lipid profile after weight loss [267].
Despite seemingly controversial results in animals, which may obviously emanate from different extraction medias and pollen contents, in vitro, in vivo, and human experiments show very encouraging results to pursue research investigations about BP use in dyslipidemia. However, more studies linking BP composition to its lipid lowering effects are needed to have robust data that could provide the evidence for a rebalancing of the diet plans made with this product.
Evidently, lipid profile improvement by BP will be coupled with many other benefits that we have seen previously, such as antioxidative and anti-inflammatory effects, insulin resistance and hyperglycemia alleviation, unsaturated fatty acid, phytosterols, and other nutrient supplies, gut microbiota improvement, and atherosclerosis-risk-lowering potential. This may therefore give BP a general potential in managing dyslipidemias and particularly in preventing their long-term detriments, but such claims must always be verified by well-designed interventional clinical studies.


Hyperuricemia is no longer a “disease of kings”, but a widespread disorder which is frequently seen in patients with metabolic syndrome, is tightly linked to some pathophysiological processes such as oxidative stress, inflammation, and apoptosis, and is a confirmed risk factor of disorders such as non-alcoholic fatty liver disease, chronic kidney disease, and cardiovascular diseases [268]. Due to its anti-inflammatory, antioxidant, and apoptosis inhibitory effects, BP may be presumed as a useful product in hyperuricemia.
Studies regarding BP in hyperuricemia models are practically absent. One study that was very recently published reported that the phenolic-concentrated extract of Camellia japonica BP markedly decreased uric acid levels in rodents with a potassium-oxonate-induced hyperuricemia [151]. Animals receiving 4 g/kg body weight of the extract manifested restored uric acid levels that were close to those reached by allopurinol (uric acid levels decreased by 72.83% and 75.38% in animals receiving 4 g/kg of BP extract and 5 mg/kg of allopurinol, respectively).
This study invites more detailed investigations of BP in metabolic troubles. It gives an example of how BP, in addition to its nutritional value, may bear other active compounds that may correct, or at least alleviate, nutritional and metabolic troubles.

3.2.6. Cardiovascular Diseases

Cardiovascular diseases, as we highlighted before, can be caused by few or many of the unbalanced situations described above, such as nutrient shortages or imbalances, oxidative stress, inflammation, digestive troubles, and especially metabolic disorders. The main reason why we decided to include this point here is to discuss the possibilities that involve some of the renowned potential benefits of BP to prevent and/or manage cardiovascular disorders.
BP has been shown to exert many bioactivities related to the functions and diseases of the cardiovascular system. In addition to its high anti-inflammatory and antioxidant potential, BP has been experimentally reported to reduce blood pressure [100,269] and circulating cholesterol and triglyceride levels in some animals [137]. Elevated blood pressure and hyperlipidemia are known among the major risk factors for fatal outcomes of cardiovascular diseases, and their reductions are very widely confirmed as cardiovascular risk-lowering measures [270]. Inflammation [193] and oxidation [271] are also among the most marked secondary and aggravating processes in the pathophysiology of cardiovascular diseases. Other troubles such as diabetes, obesity, and other metabolic disorders are also among major risk factors of cardiovascular defects [272,273,274]. Moreover, BP manifested a potential to reduce the secondary cardiovascular complications associated with these metabolic disorders [16].
BP extracts have been shown to reduce hypertension by different ways, emanating mainly from its antioxidant and anti-inflammatory mechanisms, that lead to a marked inhibition of the angiotensin-converting enzyme and general promotion of endothelial functions by modulating the renin–angiotensin system. Such mechanisms were shown to be driven, at least, by polyphenolic compounds [100].
Polysaccharides from Carthamus tinctorius BP were also shown to exert a marked anticoagulant effect which was, interestingly, for certain extract fractions, more pronounced than heparin in prolonging prothrombin time in vitro and in human plasma [130]. Cardiac glycosides have also been isolated in hydroethanolic extracts from pollens of Micromeria fruticose, Achillea fragrantissima, and Phoenix dactylifera, but the corresponding BP of these botanical species was unfortunately not included in the study [275]. To our current knowledge, no study has until now focused on the presence and variability of such compounds in this product and this may constitute an interesting research pathway.
Among its possible mechanisms, it induces hepatic lipid metabolism [276], but other systemic effects related to rich pollen composition, such as the elevated ratio of unsaturated/saturated fatty acids [5], and the abundance of phenolic compounds, phospholipids, and phytosterols [277], are also involved. It is worth noting that it was, curiously, supposed that foraging honeybees prefer pollens that contain high levels of unsaturated fatty acids [31].
The anti-atherosclerotic effect was reported by studies in animals and humans for BP and for numerous individual phytochemicals that are mostly present in it, such as some polyphenols. This effect was frequently reported concomitantly with other cardioprotective effects such as stimulating microcirculation, blood clotting reduction, endothelial function and renin-angiotensin-aldosterone system enhancement, and lipid lowering, in addition to the classically reported antioxidant and anti-inflammatory effects [16,32,267,276]. In animal models, the anti-atherosclerotic effect of BP ethanolic extracts was verified through diverse markers, including a marked decrease in atherosclerosis biochemical markers, such as total cholesterol, oxidized low-density lipoprotein, asymmetric di-methylarginine, angiotensin-converting factor, and angiotensin-converting enzyme, as well as an overall reduction in atherosclerotic plaques [16,32,100]. Accordingly, whole BP supplementation in rabbits resulted in a significant decrease in cholesterol and total lipids, as well as in other biochemical parameters that are closely related to atherosclerotic and myocardial infarction risk, such as lipid peroxidation byproduct malondialdehyde, and the infarct marker aspartate aminotransferases [217].
The use of Castanea sativa BP was found to efficiently reduce endoplasmic reticulum stress (ER) in human microvascular endothelial cells, an effect which manifested in many ways such as enhancing cell viability, reducing reactive species genesis, and modulating the expression of the diverse factors involved in ER stress [156]. This stress is known to interfere very intricately with an extensive plethora of metabolic and pathophysiological processes, especially in metabolic, cardiovascular, and degenerative diseases [278,279,280,281]. The anti-inflammatory and antioxidative potential of BP may obviously endorse its action on ER stress, but further mechanisms should be investigated as studies that focus on the topic are still very scarce. In the same context, carbonized Typhae spp. pollen was found to inhibit endoplasmic-reticulum-stress-induced apoptosis in human aortic-vascular smooth muscle cells, and to additionally exert a significant antithrombotic effect [282]. These results also invoke the importance of the prospect of the different modifications of BP in ameliorating its bioactivities and making pollen production and clinical use more profitable.
In a pouch-induced inflammation model, BP methanolic extract exerted an anti-angiogenic effect in addition to an anti-inflammatory effect, manifested mainly by markedly reducing pro-inflammatory cytokine production [203]. This potent anti-angiogenic effect, although proposed by the authors to be due to TNF-α and vascular endothelial growth factor inhibition, needs further investigation for other possible mechanisms and interferences, as may possibly be the case in cardiovascular and neoplastic diseases.
BP from many plants such as Brassica napus, Nelumbo nucifera, and Schisandra chinensis were found to mitigate induced cardiomyocyte hypertrophy in animal models via antioxidant, anti-inflammatory, and anti-apoptotic mechanisms [15]. Nelumbo nucifera pollen was found to significantly reduce cellular damage, prevent cell surface area increase, and suppress pathological protein synthesis [15]. It is worth noting that highly different concentrations of BP extract in this study did not show parallel variability in all three effects (100, 250, and 500 µg/mL were used). In the same context, it was found that BP could reduce the production of the aging promoter lipofuscin in many tissues including cardiac muscle [283]. Schisandra chinensis BP showed also a potent and dose-dependent inhibitory effect on the apoptosis of cultured rat cardiomyocytes [168].
The cardioprotective effects of BP, especially toward myocardial infarction, were verified via diverse mechanisms in rodents. In isoprenaline-treated animals, Schisandra chinensis BP extract exerted some vital cardioprotective actions in the heart through upregulating, in a dose-dependent manner, nuclear factor-erythroid 2-related factor 2 (Nrf2), heme oxygenase-1, and B-cell lymphoma 2 (Bcl-2) protein expressions, and decreasing Bcl2-associated X protein expression [267].
In experimentally induced hypertensive rats, the administration of BP was found to reduce many tissular injuries in reproductive organs and to prevent the loss of spermatogenic cells. The highlighted mechanisms in this study were mainly the local amelioration of antioxidative defense in testis and epididymis through significantly upregulating important enzymes such as nitric oxide synthase, catalase, and paraoxonase, and through the suppression of inflammatory events by inhibiting the nuclear factor kappa-light-chain-enhancer of the activated B cells signaling pathway [152]. BP could pave the way for drug discovery in cardiovascular medicine, especially in the search for the preventative treatments widely desired by scientific and medical specialists.
A few interesting clinical studies evaluated the effects of BP combinations on the parameters related to metabolic and cardiovascular diseases in humans and generally reported encouraging results including disease-modifying effects in patients with atherogenic dyslipidemia (reviewed in [16,284]), but the pharmacological and clinical relevance of these reports remains to be investigated, since comparative studies or clinical studies of BP alone are still practically absent.
Preventive measures are among the most prominent policies that are widely coveted worldwide to reduce the burden of various illness such as, for instance, cardiovascular diseases that are still unfortunately the leading cause of deaths globally. Sex-specific differences are widely recognized in cardiovascular risk due to numerous physiological differences between men and women [285]. As BP is a promising preventive product, such consideration must be investigated by scientific research, and a possible role and adaptation of BP may be important in this context. To our knowledge, there is no published study on such a topic.

3.3. BP as a Food Adjuvant

Many assays are being performed to develop BP’s use as a functional food as well as an adjuvant in food preparations for different purposes. In its natural form, BP is reputed to be a barely digestible product due to the well-sheltered structure of its grains, which hinders the bioavailability of its nutrients and phenolic compounds at high extents that can exceed 90%, and also for some nutrients and other compounds, with a very important variation depending on the floral origin and assessed molecules [99,286,287]. Many safe processing schemes, including fermentation [70,78,80,81], wall-breaking biotechnological, physical and chemical techniques [288], and some guided extraction protocols [2,101], were reported to significantly enhance bio-accessibility to its compounds.
In addition, this product is already widely used as an adjuvant in numerous food recipes to enhance their nutritional values, benefiting from its diverse additive (e.g., antioxidant and preservative) qualities. It is used or studied in many fermented products such as bakery and dairy products, confectionary, meats (e.g., livestock and broiler feeding) and meat derivatives (e.g., frankfurter sausages), and fruit juices [4,8,31,44,140,289], or to change the nutritional and bioactive values of other bee products such as honey [51].
BP also possesses many functional properties that may serve to enhance textural and other formulation aspects in foods. It has, for example, a high emulsifying potential, oil retention capacity, and carbohydrate solubility, but may also have a significant water holding capacity and foaming properties. All these properties are very closely related to pollen composition, except some that are still not fully understood (e.g., water and oil holding capacity was found to not correlate with protein, carbohydrate, or lipid contents, nor with other functional properties) [31]. This kind of observation provides another argument that BP composition and properties are just beginning to be understood.

4. Conclusions

This is the first comprehensive review on the nutritional aspects of BP that has followed a structured and standardized approach. The scoping review, which analyzed all works that have been published in the last four years, summarized and unveiled the evidence for human nutrition, especially in at-risk and other vulnerable persons. The antioxidant and anti-inflammatory potential of BP is well documented and repeatedly reported by almost all experimental studies. A large number of studies have also confirmed, although on an experimental level, that BP has a very important potential to tackle the most important metabolic disorders that are currently known, including diabetes, obesity, and dyslipidemia. Recent research also pointed to its potential in lowering their major complications, viz. cardiovascular diseases. For the different nutritional proposes, it was emphasized that there is a major shortfall in all scientific research concerning BP. The quasi-absence of translational research on BP’s nutritional and pharmacological potential and, therefore, the quasi-absence of clinical studies, providing more robust data.
We identified numerous gaps in the available evidence due to the scoping methodology utilized. Briefly, only dozens of botanical species have been studied so far among more than one hundred thousand species that are known around the globe; providing numbers about percentages or about chemical identities is therefore very challenging and hard to admit from a scientific evidence-based point of view, especially considering the poorly representative sample that is studied from the whole earth flora. The variability will markedly hinder translational efforts and any other conclusion drawing from experimental studies. Standardization and universally consented protocols in experimental studies will be crucial as extraction methods. A great number of studies do not report the geographical and botanical origin of the used BP samples, which may deeply affect preclinical and translational significance, and therefore the clinical relevance, of reported results. There is insufficient data available about BP pharmacokinetics and pharmacodynamics. Although substantial knowledge about numerous nutrients and phytochemicals has already been acquired, understanding of how these compounds interact and act in the human body is still very poor.
Regarding the issue of safety, despite BP enjoying a long history and a wide extent of uses by humans and despite already being the main nutrient resource for honeybees, large-scale and long-period controlled clinical studies of its use, and evaluating in the “real world” context are still missing. Questions associated with the bioaccessibility and bioavailability of BP compounds in the human body still need further research.
In addition to these observations, there is a general knowledge shortfall concerning plant phyllo-spheric microbiomes which may deeply affect BP composition either in plants before pollen foraging or during the crafting of BP pellets by honeybees. These determinants of phytochemical diversity, although widely known and studied in many other natural products and phenomena, have very rarely been studied for BP.
To simplify, the essence of recommendations, from our modest point of view, is to try to resolve the gaps that we have listed above, and we recommend that future research on BP adopt the emerging high-throughput technologies such as omics sciences and computational-based simulation technics to screen the large and very heterogenous data. Stepping forward from the experimental stage to translational research will unavoidably rely on the presence of a substantial body of data, which must not only be sufficiently representative, but also sufficiently reliable, reproducible, clinically translatable, and able to greatly facilitate its clinical assessment and larger-scale adoption.

Author Contributions

Conceptualization, M.G.C. and R.K.; methodology, R.K.; validation, M.G.C. and R.K.; writing—original draft preparation, R.K.; writing—review and editing, M.G.C.; funding acquisition, M.G.C. All authors have read and agreed to the published version of the manuscript.


This research was funded by the Center of Chemistry from Faculty of Sciences and Technology of University of Coimbra, Portugal by Fundação para a Ciência e a Tecnologia I.P. (FCT), Portugal (UI0204): UIDB/00313/2020.

Conflicts of Interest

The authors declare no conflict of interest.


  1. Campos, M.G.; Frigerio, C.; Bobiş, O.; Urcan, A.C.; Gomes, N.G.M. Infrared irradiation drying impact on bee pollen: Case study on the phenolic composition of Eucalyptus globulus labill and Salix atrocinerea Brot. pollens. Processes 2021, 9, 890. [Google Scholar] [CrossRef]
  2. Campos, M.G.; Anjos, O.; Chica, M.; Campoy, P.; Nozkova, J.; Almaraz-Abarca, N.; Barreto, L.M.R.C.; Nordi, J.C.; Estevinho, L.M.; Pascoal, A.; et al. Standard methods for pollen research. J. Apic. Res. 2021, 60, 1–109. [Google Scholar] [CrossRef]
  3. Matuszewska, E.; Plewa, S.; Pietkiewicz, D.; Kossakowski, K.; Matysiak, J.; Rosiński, G.; Matysiak, J. Mass Spectrometry-Based Identification of Bioactive Bee Pollen Proteins: Evaluation of Allergy Risk after Bee Pollen Supplementation. Molecules 2022, 27, 7733. [Google Scholar] [CrossRef] [PubMed]
  4. Kostić, A.Ž.; Milinčić, D.D.; Barać, M.B.; Shariati, M.A.; Tešić, L.; Pešić, M.B. The Application of Pollen as a Functional Food and Feed Ingredient—The Present and Perspectives. Biomolecules 2020, 10, 84. [Google Scholar] [CrossRef]
  5. Baky, M.H.; Abouelela, M.B.; Wang, K.; Farag, M.A. Bee Pollen and Bread as a Super-Food: A Comparative Review of Their Metabolome Composition and Quality Assessment in the Context of Best Recovery Conditions. Molecules 2023, 28, 715. [Google Scholar] [CrossRef]
  6. Xue, F.; Li, C. Effects of ultrasound assisted cell wall disruption on physicochemical properties of camellia bee pollen protein isolates. Ultrason. Sonochem. 2023, 92, 106249. [Google Scholar] [CrossRef]
  7. Alshallash, K.S.; Abolaban, G.; Elhamamsy, S.M.; Zaghlool, A.; Nasr, A.; Nagib, A.; El-Hakim, A.F.A.; Zahra, A.A.; Hamdy, A.E.; Taha, I. Bee Pollen as a Functional Product–Chemical Constituents and Nutritional Properties. J. Ecol. Eng. 2023, 24, 173–183. [Google Scholar] [CrossRef]
  8. Végh, R.; Csóka, M.; Stefanovits-Bányai, É.; Juhász, R.; Sipos, L. Biscuits Enriched with Monofloral Bee Pollens: Nutritional Properties, Techno-Functional Parameters, Sensory Profile, and Consumer Preference. Foods 2022, 12, 18. [Google Scholar] [CrossRef]
  9. Rojo, S.; Escuredo, O.; Rodríguez-Flores, M.S.; Seijo, M.C. Botanical Origin of Galician Bee Pollen (Northwest Spain) for the Characterization of Phenolic Content and Antioxidant Activity. Foods 2023, 12, 294. [Google Scholar] [CrossRef]
  10. Hanafy, N.A.N.; Salim, E.I.; Mahfouz, M.E.; Eltonouby, E.A.; Hamed, I.H. Fabrication and characterization of bee pollen extract nanoparticles: Their potential in combination therapy against human A549 lung cancer cells. Food Hydrocoll. Heal. 2023, 3, 100110. [Google Scholar] [CrossRef]
  11. Chelucci, E.; Chiellini, C.; Cavallero, A.; Gabriele, M. Bio-Functional Activities of Tuscan Bee Pollen. Antioxidants 2023, 12, 115. [Google Scholar] [CrossRef] [PubMed]
  12. Zhou, E.; Xue, X.; Xu, H.; Zhao, L.; Wu, L.; Li, Q. Effects of covalent conjugation with quercetin and its glycosides on the structure and allergenicity of Bra c p from bee pollen. Food Chem. 2023, 406, 135075. [Google Scholar] [CrossRef] [PubMed]
  13. Qiao, J.; Feng, Z.; Zhang, Y.; Xiao, X.; Dong, J.; Haubruge, E.; Zhang, H. Phenolamide and flavonoid glycoside profiles of 20 types of monofloral bee pollen. Food Chem. 2023, 405, 134800. [Google Scholar] [CrossRef] [PubMed]
  14. Oroian, M.; Dranca, F.; Ursachi, F. Characterization of Romanian Bee Pollen—An Important Nutritional Source. Foods 2022, 11, 2633. [Google Scholar] [CrossRef] [PubMed]
  15. Han, S.; Chen, L.; Zhang, Y.; Xie, S.; Yang, J.; Su, S.; Yao, H.; Shi, P. Lotus Bee Pollen Extract Inhibits Isoproterenol-Induced Hypertrophy via JAK2/STAT3 Signaling Pathway in Rat H9c2 Cells. Antioxidants 2022, 12, 88. [Google Scholar] [CrossRef] [PubMed]
  16. Algethami, J.S.; El-Wahed, A.A.A.; Elashal, M.H.; Ahmed, H.R.; Elshafiey, E.H.; Omar, E.M.; Al Naggar, Y.; Algethami, A.F.; Shou, Q.; Alsharif, S.M.; et al. Bee Pollen: Clinical Trials and Patent Applications. Nutrients 2022, 14, 2858. [Google Scholar] [CrossRef]
  17. El-Seedi, H.R.; Khalifa, S.A.M.; El-Wahed, A.A.; Gao, R.; Guo, Z.; Tahir, H.E.; Zhao, C.; Du, M.; Farag, M.A.; Musharraf, S.G.; et al. Honeybee products: An updated review of neurological actions. Trends Food Sci. Technol. 2020, 101, 17–27. [Google Scholar] [CrossRef]
  18. Camacho-Bernal, G.I.; Cruz-Cansino, N.d.S.; Ramírez-Moreno, E.; Delgado-Olivares, L.; Zafra-Rojas, Q.Y.; Castañeda-Ovando, A.; Suárez-Jacobo, Á. Addition of Bee Products in Diverse Food Sources: Functional and Physicochemical Properties. Appl. Sci. 2021, 11, 8156. [Google Scholar] [CrossRef]
  19. Xi, X.; Li, J.; Guo, S.; Li, Y.; Xu, F.; Zheng, M.; Cao, H.; Cui, X.; Guo, H.; Han, C. The Potential of Using Bee Pollen in Cosmetics: A Review. J. Oleo Sci. 2018, 67, 1071–1082. [Google Scholar] [CrossRef]
  20. Lu, P.; Takiguchi, S.; Honda, Y.; Lu, Y.; Mitsui, T.; Kato, S.; Kodera, R.; Furihata, K.; Zhang, M.; Okamoto, K.; et al. NMR and HPLC profiling of bee pollen products from different countries. Food Chem. Mol. Sci. 2022, 5, 100119. [Google Scholar] [CrossRef]
  21. Tao, Y.; Zhou, E.; Li, F.; Meng, L.; Li, Q.; Wu, L. Allergenicity Alleviation of Bee Pollen by Enzymatic Hydrolysis: Regulation in Mice Allergic Mediators, Metabolism, and Gut Microbiota. Foods 2022, 11, 3454. [Google Scholar] [CrossRef] [PubMed]
  22. Munn, Z.; Pollock, D.; Khalil, H.; Alexander, L.; Mclnerney, P.; Godfrey, C.M.; Peters, M.; Tricco, A.C. What are scoping reviews? Providing a formal definition of scoping reviews as a type of evidence synthesis. JBI Évid. Synth. 2022, 20, 950–952. [Google Scholar] [CrossRef] [PubMed]
  23. Bradbury-Jones, C.; Aveyard, H.; Herber, O.R.; Isham, L.; Taylor, J.; O’malley, L. Scoping reviews: The PAGER framework for improving the quality of reporting. Int. J. Soc. Res. Methodol. 2022, 25, 457–470. [Google Scholar] [CrossRef]
  24. Maggio, L.A.; Larsen, K.; Thomas, A.; Costello, J.A.; Artino, A.R. Scoping reviews in medical education: A scoping review. Med. Educ. 2021, 55, 689–700. [Google Scholar] [CrossRef] [PubMed]
  25. Peters, M.D.; Marnie, C.; Tricco, A.C.; Pollock, D.; Munn, Z.; Alexander, L.; McInerney, P.; Godfrey, C.M.; Khalil, H. Updated methodological guidance for the conduct of scoping reviews. JBI Évid. Synth. 2020, 18, 2119–2126. [Google Scholar] [CrossRef]
  26. Khalil, H.; Tricco, A.C. Differentiating between mapping reviews and scoping reviews in the evidence synthesis ecosystem. J. Clin. Epidemiol. 2022, 149, 175–182. [Google Scholar] [CrossRef]
  27. Pollock, D.; Tricco, A.C.; Peters, M.D.; Mclnerney, P.A.; Khalil, H.; Godfrey, C.M.; Alexander, L.A.; Munn, Z. Methodological quality, guidance, and tools in scoping reviews: A scoping review protocol. JBI Évid. Synth. 2022, 20, 1098–1105. [Google Scholar] [CrossRef]
  28. Buus, N.; Nygaard, L.; Berring, L.L.; Hybholt, L.; Kamionka, S.L.; Rossen, C.B.; Søndergaard, R.; Juel, A. Arksey and O′Malley’s consultation exercise in scoping reviews: A critical review. J. Adv. Nurs. 2022, 78, 2304–2312. [Google Scholar] [CrossRef]
  29. Tricco, A.C.; Lillie, E.; Zarin, W.; O’Brien, K.K.; Colquhoun, H.; Levac, D.; Moher, D.; Peters, M.D.J.; Horsley, T.; Weeks, L.; et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann. Intern. Med. 2018, 169, 467–473. [Google Scholar] [CrossRef]
  30. Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews. BMJ 2021, 372, n71. [Google Scholar] [CrossRef]
  31. Thakur, M.; Nanda, V. Composition and functionality of bee pollen: A review. Trends Food Sci. Technol. 2020, 98, 82–106. [Google Scholar] [CrossRef]
  32. Khalifa, S.A.M.; Elashal, M.H.; Yosri, N.; Du, M.; Musharraf, S.G.; Nahar, L.; Sarker, S.D.; Guo, Z.; Cao, W.; Zou, X.; et al. Bee Pollen: Current Status and Therapeutic Potential. Nutrients 2021, 13, 1876. [Google Scholar] [CrossRef] [PubMed]
  33. Sevin, S.; Tutun, H.; Yipel, M.; Aluç, Y.; Ekici, H. Concentration of essential and non-essential elements and carcinogenic/non-carcinogenic health risk assessment of commercial bee pollens from Turkey. J. Trace Elem. Med. Biol. 2023, 75, 127104. [Google Scholar] [CrossRef] [PubMed]
  34. Ben Bacha, A.; Norah, A.-O.; Al-Osaimi, M.; Harrath, A.H.; Mansour, L.; El-Ansary, A. The therapeutic and protective effects of bee pollen against prenatal methylmercury induced neurotoxicity in rat pups. Metab. Brain Dis. 2020, 35, 215–224. [Google Scholar] [CrossRef]
  35. Al-Osaimi, M.; El-Ansary, A.; Al-Daihan, S.; Bhat, R.S.; Ben Bacha, A. Therapeutic and Protective Potency of Bee Pollen Against Neurotoxic Effects Induced by Prenatal Exposure of Rats to Methyl Mercury. J. Mol. Neurosci. 2018, 65, 327–335. [Google Scholar] [CrossRef]
  36. Crone, M.K.; Grozinger, C.M. Pollen protein and lipid content influence resilience to insecticides in honey bees (Apis mellifera). J. Exp. Biol. 2021, 224, jeb242040. [Google Scholar] [CrossRef] [PubMed]
  37. Prđun, S.; Svečnjak, L.; Valentić, M.; Marijanović, Z.; Jerković, I. Characterization of Bee Pollen: Physico-Chemical Properties, Headspace Composition and FTIR Spectral Profiles. Foods 2021, 10, 2103. [Google Scholar] [CrossRef]
  38. Lau, P.; Lesne, P.; Grebenok, R.J.; Rangel, J.; Behmer, T.S. Assessing pollen nutrient content: A unifying approach for the study of bee nutritional ecology. Philos. Trans. R. Soc. B Biol. Sci. 2022, 377, 20210510. [Google Scholar] [CrossRef]
  39. Aylanc, V.; Falcão, S.I.; Vilas-Boas, M. Bee pollen and bee bread nutritional potential: Chemical composition and macronutrient digestibility under in vitro gastrointestinal system. Food Chem. 2023, 413, 135597. [Google Scholar] [CrossRef]
  40. Didaras, N.A.; Karatasou, K.; Dimitriou, T.G.; Amoutzias, G.D.; Mossialos, D. Antimicrobial Activity of Bee-Collected Pollen and Beebread: State of the Art and Future Perspectives. Antibiotics 2020, 9, 811. [Google Scholar] [CrossRef]
  41. dos Santos, T.R.; Melo, J.d.S.; dos Santos, A.V.; Severino, P.; Lima, S.; Souto, E.B.; Zielińska, A.; Cardoso, J.C. Development of a Protein-Rich By-Product by 23 Factorial Design: Characterization of Its Nutritional Value and Sensory Analysis. Molecules 2022, 27, 8918. [Google Scholar] [CrossRef] [PubMed]
  42. Hsu, P.-S.; Wu, T.-H.; Huang, M.-Y.; Wang, D.-Y.; Wu, M.-C. Nutritive Value of 11 Bee Pollen Samples from Major Floral Sources in Taiwan. Foods 2021, 10, 2229. [Google Scholar] [CrossRef] [PubMed]
  43. Ahmad, S.; Campos, M.G.; Fratini, F.; Altaye, S.Z.; Li, J. New Insights into the Biological and Pharmaceutical Properties of Royal Jelly. Int. J. Mol. Sci. 2020, 21, 382. [Google Scholar] [CrossRef] [PubMed]
  44. Darwish, A.M.G.; El-Wahed, A.A.A.; Shehata, M.G.; El-Seedi, H.R.; Masry, S.H.D.; Khalifa, S.A.M.; Mahfouz, H.M.; El-Sohaimy, S.A. Chemical Profiling and Nutritional Evaluation of Bee Pollen, Bee Bread, and Royal Jelly and Their Role in Functional Fermented Dairy Products. Molecules 2022, 28, 227. [Google Scholar] [CrossRef] [PubMed]
  45. Jarosz, P.M.; Jasielski, P.P.; Zarobkiewicz, M.K.; Sławiński, M.A.; Wawryk-Gawda, E.; Jodłowska-Jędrych, B. Changes in Histological Structure, Interleukin 12, Smooth Muscle Actin and Nitric Oxide Synthase 1. and 3. Expression in the Liver of Running and Non-Running Wistar Rats Supplemented with Bee Pollen or Whey Protein. Foods 2022, 11, 1131. [Google Scholar] [CrossRef]
  46. Čeksterytė, V.; Treigytė, G.; Matuzevičius, D.; Jaškūnė, K.; Navakauskas, D.; Kurtinaitienė, B.; Navakauskienė, R. Comparative proteomic profile in bee- and manually-collected Taraxacum officinale pollen. J. Apic. Res. 2022, 61, 543–556. [Google Scholar] [CrossRef]
  47. Ares, A.M.; Martín, M.T.; Toribio, L.; Bernal, J. Determination of Free Amino Acids in Bee Pollen by Liquid Chromatography with Fluorescence Detection. Food Anal. Methods 2022, 15, 2172–2180. [Google Scholar] [CrossRef]
  48. Taha, E.-K.A.; Al-Kahtani, S.; Taha, R. Protein content and amino acids composition of bee-pollens from major floral sources in Al-Ahsa, eastern Saudi Arabia. Saudi J. Biol. Sci. 2019, 26, 232–237. [Google Scholar] [CrossRef]
  49. Jeannerod, L.; Carlier, A.; Schatz, B.; Daise, C.; Richel, A.; Agnan, Y.; Baude, M.; Jacquemart, A.-L. Some bee-pollinated plants provide nutritionally incomplete pollen amino acid resources to their pollinators. PLoS ONE 2022, 17, e0269992. [Google Scholar] [CrossRef] [PubMed]
  50. Sommano, S.R.; Bhat, F.M.; Wongkeaw, M.; Sriwichai, T.; Sunanta, P.; Chuttong, B.; Burgett, M. Amino Acid Profiling and Chemometric Relations of Black Dwarf Honey and Bee Pollen. Front. Nutr. 2020, 7, 558579. [Google Scholar] [CrossRef]
  51. Habryka, C.; Socha, R.; Juszczak, L. Effect of Bee Pollen Addition on the Polyphenol Content, Antioxidant Activity, and Quality Parameters of Honey. Antioxidants 2021, 10, 810. [Google Scholar] [CrossRef] [PubMed]
  52. Chakrabarti, P.; Lucas, H.M.; Sagili, R.R. Evaluating Effects of a Critical Micronutrient (24-Methylenecholesterol) on Honey Bee Physiology. Ann. EÈntomol. Soc. Am. 2020, 113, 176–182. [Google Scholar] [CrossRef]
  53. Vaudo, A.D.; Tooker, J.F.; Patch, H.M.; Biddinger, D.J.; Coccia, M.; Crone, M.K.; Fiely, M.; Francis, J.S.; Hines, H.M.; Hodges, M.; et al. Pollen Protein: Lipid Macronutrient Ratios May Guide Broad Patterns of Bee Species Floral Preferences. Insects 2020, 11, 132. [Google Scholar] [CrossRef] [PubMed]
  54. Grund-Mueller, N.; Ruedenauer, F.A.; Spaethe, J.; Leonhardt, S.D. Adding Amino Acids to a Sucrose Diet Is Not Sufficient to Support Longevity of Adult Bumble Bees. Insects 2020, 11, 247. [Google Scholar] [CrossRef] [PubMed]
  55. Zhang, J.; Liu, J.; Gao, F.; Chen, M.; Jiang, Y.; Zhao, H.; Ma, W. Electrophysiological and Behavioral Responses of Apis mellifera and Bombusterrestris to Melon Flower Volatiles. Insects 2022, 13, 973. [Google Scholar] [CrossRef]
  56. Dimins, F.; Cinkmanis, I.; Radenkovs, V.; Augspole, I.; Valdovska, A. Analysis of 18 Free Amino Acids in Honeybee and Bumblebee Honey from Eastern and Northern Europe and Central Asia Using HPLC-ESI-TQ-MS/MS Approach Bypassing Derivatization Step. Foods 2022, 11, 2744. [Google Scholar] [CrossRef]
  57. Hao, K.; Xu, Q.; Huang, S. Pollen-feeding behavior of diverse insects on Geranium delavayi, a flower with large, accessible pollen grains. Am. J. Bot. 2023, 110, e16113. [Google Scholar] [CrossRef]
  58. Li, Q.; Liang, X.; Xue, X.; Wang, K.; Wu, L. Lipidomics Provides Novel Insights into Understanding the Bee Pollen Lipids Transepithelial Transport and Metabolism in Human Intestinal Cells. J. Agric. Food Chem. 2020, 68, 907–917. [Google Scholar] [CrossRef]
  59. Wang, J.; Chen, Y.; Zhao, L.; Zhang, Y.; Fang, X. Lipidomics reveals the molecular mechanisms underlying the changes in lipid profiles and lipid oxidation in rape bee pollen dried by different methods. Food Res. Int. 2022, 162, 112104. [Google Scholar] [CrossRef]
  60. Giampieri, F.; Quiles, J.L.; Cianciosi, D.; Forbes-Hernández, T.Y.; Orantes-Bermejo, F.J.; Alvarez-Suarez, J.M.; Battino, M. Bee Products: An Emblematic Example of Underutilized Sources of Bioactive Compounds. J. Agric. Food Chem. 2022, 70, 6833–6848. [Google Scholar] [CrossRef]
  61. Chakrabarti, P.; Lucas, H.M.; Sagili, R.R. Novel Insights into Dietary Phytosterol Utilization and Its Fate in Honey Bees (Apis mellifera L.). Molecules 2020, 25, 571. [Google Scholar] [CrossRef] [PubMed]
  62. Zu, P.; Koch, H.; Schwery, O.; Pironon, S.; Phillips, C.; Ondo, I.; Farrell, I.W.; Nes, W.D.; Moore, E.; Wright, G.A.; et al. Pollen sterols are associated with phylogeny and environment but not with pollinator guilds. New Phytol. 2021, 230, 1169–1184. [Google Scholar] [CrossRef] [PubMed]
  63. Nattagh-Eshtivani, E.; Barghchi, H.; Pahlavani, N.; Barati, M.; Amiri, Y.; Fadel, A.; Khosravi, M.; Talebi, S.; Arzhang, P.; Ziaei, R.; et al. Biological and pharmacological effects and nutritional impact of phytosterols: A comprehensive review. Phytother. Res. 2022, 36, 299–322. [Google Scholar] [CrossRef] [PubMed]
  64. Nainu, F.; Masyita, A.; Bahar, M.A.; Raihan, M.; Prova, S.R.; Mitra, S.; Bin Emran, T.; Simal-Gandara, J. Pharmaceutical Prospects of Bee Products: Special Focus on Anticancer, Antibacterial, Antiviral, and Antiparasitic Properties. Antibiotics 2021, 10, 822. [Google Scholar] [CrossRef] [PubMed]
  65. Alfawaz, H.A.; El-Ansary, A.; Al-Ayadhi, L.; Bhat, R.S.; Hassan, W.M. Protective Effects of Bee Pollen on Multiple Propionic Acid-Induced Biochemical Autistic Features in a Rat Model. Metabolites 2022, 12, 571. [Google Scholar] [CrossRef] [PubMed]
  66. Al-Kahtani, S.N.; Taha, E.-K.A.; Farag, S.A.; Taha, R.A.; Abdou, E.A.; Mahfouz, H.M. Harvest Season Significantly Influences the Fatty Acid Composition of Bee Pollen. Biology 2021, 10, 495. [Google Scholar] [CrossRef]
  67. Zhou, E.; Wang, Q.; Li, X.; Zhu, D.; Niu, Q.; Li, Q.; Wu, L. Effects of Bee Pollen Derived from Acer mono Maxim. or Phellodendron amurense Rupr. on the Lipid Composition of Royal Jelly Secreted by Honeybees. Foods 2023, 12, 625. [Google Scholar] [CrossRef]
  68. Bennett, M.M.; Welchert, A.C.; Carroll, M.; Shafir, S.; Smith, B.H.; Corby-Harris, V. Unbalanced fatty acid diets impair discrimination ability of honey bee workers to damaged and healthy brood odors. J. Exp. Biol. 2022, 225, jeb244103. [Google Scholar] [CrossRef]
  69. Barta, D.G.; Cornea-Cipcigan, M.; Margaoan, R.; Vodnar, D.C. Biotechnological Processes Simulating the Natural Fermentation Process of Bee Bread and Therapeutic Properties—An Overview. Front. Nutr. 2022, 9, 871896. [Google Scholar] [CrossRef]
  70. Zhang, H.; Zhu, X.; Huang, Q.; Zhang, L.; Liu, X.; Liu, R.; Lu, Q. Antioxidant and anti-inflammatory activities of rape bee pollen after fermentation and their correlation with chemical components by ultra-performance liquid chromatography-quadrupole time of flight mass spectrometry-based untargeted metabolomics. Food Chem. 2023, 409, 135342. [Google Scholar] [CrossRef]
  71. Miyata, R.; Hoshino, S.; Ahn, M.-R.; Kumazawa, S. Chemical Profiles of Korean Bee Pollens and Their Catechol-O-methyltransferase Inhibitory Activities. J. Agric. Food Chem. 2022, 70, 1174–1181. [Google Scholar] [CrossRef] [PubMed]
  72. Ares, A.M.; Martín, M.T.; Tapia, J.A.; González-Porto, A.V.; Higes, M.; Martín-Hernández, R.; Bernal, J. Differentiation of bee pollen samples according to the betaines and other quaternary ammonium related compounds content by using a canonical discriminant analysis. Food Res. Int. 2022, 160, 111698. [Google Scholar] [CrossRef] [PubMed]
  73. Arumugam, M.K.; Paal, M.C.; Donohue, T.M.; Ganesan, M.; Osna, N.A.; Kharbanda, K.K. Beneficial Effects of Betaine: A Comprehensive Review. Biology 2021, 10, 456. [Google Scholar] [CrossRef] [PubMed]
  74. Ilie, C.-I.; Oprea, E.; Geana, E.-I.; Spoiala, A.; Buleandra, M.; Pircalabioru, G.G.; Badea, I.A.; Ficai, D.; Andronescu, E.; Ficai, A.; et al. Bee Pollen Extracts: Chemical Composition, Antioxidant Properties, and Effect on the Growth of Selected Probiotic and Pathogenic Bacteria. Antioxidants 2022, 11, 959. [Google Scholar] [CrossRef]
  75. Pełka, K.; Otłowska, O.; Worobo, R.W.; Szweda, P. Bee Bread Exhibits Higher Antimicrobial Potential Compared to Bee Pollen. Antibiotics 2021, 10, 125. [Google Scholar] [CrossRef]
  76. Kieliszek, M.; Piwowarek, K.; Kot, A.M.; Błażejak, S.; Chlebowska-Śmigiel, A.; Wolska, I. Pollen and bee bread as new health-oriented products: A review. Trends Food Sci. Technol. 2018, 71, 170–180. [Google Scholar] [CrossRef]
  77. Zhang, H.; Lu, Q.; Liu, R. Widely targeted metabolomics analysis reveals the effect of fermentation on the chemical composition of bee pollen. Food Chem. 2021, 375, 131908. [Google Scholar] [CrossRef]
  78. Adaškevičiūtė, V.; Kaškonienė, V.; Barčauskaitė, K.; Kaškonas, P.; Maruška, A. The Impact of Fermentation on Bee Pollen Polyphenolic Compounds Composition. Antioxidants 2022, 11, 645. [Google Scholar] [CrossRef]
  79. Martinello, M.; Mutinelli, F. Antioxidant activity in bee products: A review. Antioxidants 2021, 10, 71. [Google Scholar] [CrossRef]
  80. Filannino, P.; Di Cagno, R.; Vincentini, O.; Pinto, D.; Polo, A.; Maialetti, F.; Porrelli, A.; Gobbetti, M. Nutrients Bioaccessibility and Anti-inflammatory Features of Fermented Bee Pollen: A Comprehensive Investigation. Front. Microbiol. 2021, 12, 622091. [Google Scholar] [CrossRef]
  81. Yan, S.; Wang, K.; Wang, X.; Ou, A.; Wang, F.; Wu, L.; Xue, X. Effect of fermented bee pollen on metabolic syndrome in high-fat diet-induced mice. Food Sci. Hum. Wellness 2021, 10, 345–355. [Google Scholar] [CrossRef]
  82. Kaškonienė, V.; Adaškevičiūtė, V.; Kaškonas, P.; Mickienė, R.; Maruška, A. Antimicrobial and antioxidant activities of natural and fermented bee pollen. Food Biosci. 2020, 34, 100532. [Google Scholar] [CrossRef]
  83. Yan, S.; Li, Q.; Xue, X.; Wang, K.; Zhao, L.; Wu, L. Analysis of improved nutritional composition of bee pollen (Brassica campestris L.) after different fermentation treatments. Int. J. Food Sci. Technol. 2019, 54, 2169–2181. [Google Scholar] [CrossRef]
  84. Yin, S.; Tao, Y.; Jiang, Y.; Meng, L.; Zhao, L.; Xue, X.; Li, Q.; Wu, L. A Combined Proteomic and Metabolomic Strategy for Allergens Characterization in Natural and Fermented Brassica napus Bee Pollen. Front. Nutr. 2022, 9, 822033. [Google Scholar] [CrossRef] [PubMed]
  85. Barkhidarian, B.; Roldos, L.; Iskandar, M.M.; Saedisomeolia, A.; Kubow, S. Probiotic Supplementation and Micronutrient Status in Healthy Subjects: A Systematic Review of Clinical Trials. Nutrients 2021, 13, 3001. [Google Scholar] [CrossRef]
  86. Kobylińska, M.; Antosik, K.; Decyk, A.; Kurowska, K. Malnutrition in Obesity: Is It Possible? Obes. Facts 2021, 15, 19–25. [Google Scholar] [CrossRef]
  87. Cashman, K.D. 100 Years of Vitamin D: Global differences in vitamin D status and dietary intake: A review of the data. Endocr. Connect. 2022, 11, e210282. [Google Scholar] [CrossRef]
  88. Mehl, S.; Sun, Q.; Görlich, C.L.; Hackler, J.; Kopp, J.F.; Renko, K.; Mittag, J.; Schwerdtle, T.; Schomburg, L. Cross-sectional analysis of trace element status in thyroid disease. J. Trace Elem. Med. Biol. 2020, 58, 126430. [Google Scholar] [CrossRef]
  89. Giacconi, R.; Chiodi, L.; Boccoli, G.; Costarelli, L.; Piacenza, F.; Provinciali, M.; Malavolta, M. Reduced levels of plasma selenium are associated with increased inflammation and cardiovascular disease in an Italian elderly population. Exp. Gerontol. 2021, 145, 111219. [Google Scholar] [CrossRef]
  90. Vural, Z.; Avery, A.; Kalogiros, D.I.; Coneyworth, L.J.; Welham, S.J.M. Trace Mineral Intake and Deficiencies in Older Adults Living in the Community and Institutions: A Systematic Review. Nutrients 2020, 12, 1072. [Google Scholar] [CrossRef]
  91. Richardson, D.P.; Lovegrove, J.A. Nutritional status of micronutrients as a possible and modifiable risk factor for COVID-19: A UK perspective. Br. J. Nutr. 2021, 125, 678–684. [Google Scholar] [CrossRef] [PubMed]
  92. Marley, A.; Smith, S.C.; Ahmed, R.; Nightingale, P.; Cooper, S.C. Vitamin A deficiency: Experience from a tertiary referral UK hospital; not just a low- and middle-income country issue. Public Health Nutr. 2021, 24, 6466–6471. [Google Scholar] [CrossRef] [PubMed]
  93. Forman, H.J.; Zhang, H. Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy. Nat. Rev. Drug Discov. 2021, 20, 689–709. [Google Scholar] [CrossRef] [PubMed]
  94. Feelisch, M.; Cortese-Krott, M.M.; Santolini, J.; Wootton, S.A.; Jackson, A.A. Systems Redox Biology in Health and Disease. EXCLI J. 2022, 21, 623–646. [Google Scholar] [CrossRef] [PubMed]
  95. Manzoor, M.F.; Arif, Z.; Kabir, A.; Mehmood, I.; Munir, D.; Razzaq, A.; Ali, A.; Goksen, G.; Coşier, V.; Ahmad, N.; et al. Oxidative stress and metabolic diseases: Relevance and therapeutic strategies. Front. Nutr. 2022, 9, 994309. [Google Scholar] [CrossRef] [PubMed]
  96. Raut, S.K.; Khullar, M. Oxidative stress in metabolic diseases: Current scenario and therapeutic relevance. Mol. Cell. Biochem. 2023, 478, 185–196. [Google Scholar] [CrossRef]
  97. Panda, P.; Verma, H.K.; Lakkakula, S.; Merchant, N.; Kadir, F.; Rahman, S.; Jeffree, M.S.; Lakkakula, B.V.K.S.; Rao, P.V. Biomarkers of Oxidative Stress Tethered to Cardiovascular Diseases. Oxidative Med. Cell. Longev. 2022, 2022, 9154295. [Google Scholar] [CrossRef]
  98. Batty, M.; Bennett, M.R.; Yu, E. The Role of Oxidative Stress in Atherosclerosis. Cells 2022, 11, 3843. [Google Scholar] [CrossRef]
  99. Aylanc, V.; Tomás, A.; Russo-Almeida, P.; Falcão, S.I.; Vilas-Boas, M. Assessment of bioactive compounds under simulated gastrointestinal digestion of bee pollen and bee bread: Bioaccessibility and antioxidant activity. Antioxidants 2021, 10, 651. [Google Scholar] [CrossRef]
  100. El-Seedi, H.R.; Eid, N.; Abd El-Wahed, A.A.; Rateb, M.E.; Afifi, H.S.; Algethami, A.F.; Zhao, C.; Al Naggar, Y.; Alsharif, S.M.; Tahir, H.E. Honey Bee Products: Preclinical and Clinical Studies of Their Anti-inflammatory and Immunomodulatory Properties. Front. Nutr. 2022, 8, 1109. [Google Scholar] [CrossRef]
  101. Lawag, I.L.; Yoo, O.; Lim, L.Y.; Hammer, K.; Locher, C. Optimisation of Bee Pollen Extraction to Maximise Extractable Antioxidant Constituents. Antioxidants 2021, 10, 1113. [Google Scholar] [CrossRef] [PubMed]
  102. Thakur, M.; Nanda, V. Screening of Indian bee pollen based on antioxidant properties and polyphenolic composition using UHPLC-DAD-MS/MS: A multivariate analysis and ANN based approach. Food Res. Int. 2021, 140, 110041. [Google Scholar] [CrossRef] [PubMed]
  103. Barbieri, D.; Gabriele, M.; Summa, M.; Colosimo, R.; Leonardi, D.; Domenici, V.; Pucci, L. Antioxidant, Nutraceutical Properties, and Fluorescence Spectral Profiles of Bee Pollen Samples from Different Botanical Origins. Antioxidants 2020, 9, 1001. [Google Scholar] [CrossRef] [PubMed]
  104. Mazurek, S.; Szostak, R.; Kondratowicz, M.; Węglińska, M.; Kita, A.; Nemś, A. Modeling of Antioxidant Activity, Polyphenols and Macronutrients Content of Bee Pollen Applying Solid-State 13C NMR Spectra. Antioxidants 2021, 10, 1123. [Google Scholar] [CrossRef] [PubMed]
  105. Zou, Y.; Hu, J.; Huang, W.; Zhu, L.; Shao, M.; Dordoe, C.; Ahn, Y.-J.; Wang, D.; Zhao, Y.; Xiong, Y.; et al. The botanical origin and antioxidant, anti-BACE1 and antiproliferative properties of bee pollen from different regions of South Korea. BMC Complement. Med. Ther. 2020, 20, 236. [Google Scholar] [CrossRef]
  106. Węglińska, M.; Szostak, R.; Kita, A.; Nemś, A.; Mazurek, S. Determination of nutritional parameters of bee pollen by Raman and infrared spectroscopy. Talanta 2020, 212, 120790. [Google Scholar] [CrossRef]
  107. Castiglioni, S.; Stefano, M.; Astolfi, P.; Pisani, M.; Carloni, P. Characterisation of Bee Pollen from the Marche Region (Italy) According to the Botanical and Geographical Origin with Analysis of Antioxidant Activity and Colour, Using a Chemometric Approach. Molecules 2022, 27, 7996. [Google Scholar] [CrossRef]
  108. Alimoglu, G.; Guzelmeric, E.; Yuksel, P.I.; Celik, C.; Deniz, I.; Yesilada, E. Monofloral and polyfloral bee pollens: Comparative evaluation of their phenolics and bioactivity profiles. LWT 2021, 142, 110973. [Google Scholar] [CrossRef]
  109. Sawicki, T.; Starowicz, M.; Kłębukowska, L.; Hanus, P. The Profile of Polyphenolic Compounds, Contents of Total Phenolics and Flavonoids, and Antioxidant and Antimicrobial Properties of Bee Products. Molecules 2022, 27, 1301. [Google Scholar] [CrossRef]
  110. Rana, A.; Samtiya, M.; Dhewa, T.; Mishra, V.; Aluko, R.E. Health benefits of polyphenols: A concise review. J. Food Biochem. 2022, 46, e14264. [Google Scholar] [CrossRef]
  111. Wang, S.; Du, Q.; Meng, X.; Zhang, Y. Natural polyphenols: A potential prevention and treatment strategy for metabolic syndrome. Food Funct. 2022, 13, 9734–9753. [Google Scholar] [CrossRef] [PubMed]
  112. Gasmi, A.; Mujawdiya, P.K.; Noor, S.; Lysiuk, R.; Darmohray, R.; Piscopo, S.; Lenchyk, L.; Antonyak, H.; Dehtiarova, K.; Shanaida, M.; et al. Polyphenols in Metabolic Diseases. Molecules 2022, 27, 6280. [Google Scholar] [CrossRef] [PubMed]
  113. Aravind, S.M.; Wichienchot, S.; Tsao, R.; Ramakrishnan, S.; Chakkaravarthi, S. Role of dietary polyphenols on gut microbiota, their metabolites and health benefits. Food Res. Int. 2021, 142, 110189. [Google Scholar] [CrossRef]
  114. Zhang, Y.; Yu, W.; Zhang, L.; Wang, M.; Chang, W. The Interaction of Polyphenols and the Gut Microbiota in Neurodegenerative Diseases. Nutrients 2022, 14, 5373. [Google Scholar] [CrossRef]
  115. Cherubim, D.J.D.L.; Martins, C.V.B.; Fariña, L.O.; Lucca, R.A.D.S.D. Polyphenols as natural antioxidants in cosmetics applications. J. Cosmet. Dermatol. 2020, 19, 33–37. [Google Scholar] [CrossRef]
  116. de Araújo, F.F.; de Paulo Farias, D.; Neri-Numa, I.A.; Pastore, G.M. Polyphenols and their applications: An approach in food chemistry and innovation potential. Food Chem. 2021, 338, 127535. [Google Scholar] [CrossRef]
  117. Winiarska-Mieczan, A.; Kwiecień, M.; Jachimowicz-Rogowska, K.; Donaldson, J.; Tomaszewska, E.; Baranowska-Wójcik, E. Anti-Inflammatory, Antioxidant, and Neuroprotective Effects of Polyphenols—Polyphenols as an Element of Diet Therapy in Depressive Disorders. Int. J. Mol. Sci. 2023, 24, 2258. [Google Scholar] [CrossRef]
  118. Morén, C.; Desouza, R.M.; Giraldo, D.M.; Uff, C. Antioxidant Therapeutic Strategies in Neurodegenerative Diseases. Int. J. Mol. Sci. 2022, 23, 9328. [Google Scholar] [CrossRef]
  119. Bjørklund, G.; Shanaida, M.; Lysiuk, R.; Butnariu, M.; Peana, M.; Sarac, I.; Strus, O.; Smetanina, K.; Chirumbolo, S. Natural Compounds and Products from an Anti-Aging Perspective. Molecules 2022, 27, 7084. [Google Scholar] [CrossRef]
  120. Maiuolo, J.; Gliozzi, M.; Carresi, C.; Musolino, V.; Oppedisano, F.; Scarano, F.; Nucera, S.; Scicchitano, M.; Bosco, F.; Macri, R.; et al. Nutraceuticals and cancer: Potential for natural polyphenols. Nutrients 2021, 13, 3834. [Google Scholar] [CrossRef]
  121. Di Lorenzo, C.; Colombo, F.; Biella, S.; Stockley, C.; Restani, P. Polyphenols and human health: The role of bioavailability. Nutrients 2021, 13, 273. [Google Scholar] [CrossRef]
  122. Shen, N.; Wang, T.; Gan, Q.; Liu, S.; Wang, L.; Jin, B. Plant flavonoids: Classification, distribution, biosynthesis, and antioxidant activity. Food Chem. 2022, 383, 132531. [Google Scholar] [CrossRef]
  123. Rajendran, P.; Abdelsalam, S.A.; Renu, K.; Veeraraghavan, V.; Ben Ammar, R.; Ahmed, E.A. Polyphenols as Potent Epigenetics Agents for Cancer. Int. J. Mol. Sci. 2022, 23, 11712. [Google Scholar] [CrossRef]
  124. Doseděl, M.; Jirkovský, E.; Macáková, K.; Krčmová, L.K.; Javorská, L.; Pourová, J.; Mercolini, L.; Remião, F.; Nováková, L.; Mladěnka, P.; et al. Vitamin C-sources, physiological role, kinetics, deficiency, use, toxicity, and determination. Nutrients 2021, 13, 615. [Google Scholar] [CrossRef]
  125. Caritá, A.C.; Fonseca-Santos, B.; Shultz, J.D.; Michniak-Kohn, B.; Chorilli, M.; Leonardi, G.R. Vitamin C: One compound, several uses. Advances for delivery, efficiency and stability. Nanomed. Nanotechnol. Biol. Med. 2020, 24, 102117. [Google Scholar] [CrossRef]
  126. Moslemi, E.; Musazadeh, V.; Kavyani, Z.; Naghsh, N.; Shoura, S.M.S.; Dehghan, P. Efficacy of vitamin D supplementation as an adjunct therapy for improving inflammatory and oxidative stress biomarkers: An umbrella meta-analysis. Pharmacol. Res. 2022, 186, 106484. [Google Scholar] [CrossRef]
  127. Albergamo, A.; Apprato, G.; Silvagno, F. The Role of Vitamin D in Supporting Health in the COVID-19 Era. Int. J. Mol. Sci. 2022, 23, 3621. [Google Scholar] [CrossRef]
  128. Ciarcià, G.; Bianchi, S.; Tomasello, B.; Acquaviva, R.; Malfa, G.A.; Naletova, I.; La Mantia, A.; Di Giacomo, C. Vitamin E and Non-Communicable Diseases: A Review. Biomedicines 2022, 10, 2473. [Google Scholar] [CrossRef]
  129. Liao, S.; Omage, S.O.; Börmel, L.; Kluge, S.; Schubert, M.; Wallert, M.; Lorkowski, S. Vitamin E and Metabolic Health: Relevance of Interactions with Other Micronutrients. Antioxidants 2022, 11, 1785. [Google Scholar] [CrossRef]
  130. Wu, X.; Cai, X.; Ai, J.; Zhang, C.; Liu, N.; Gao, W. Extraction, Structures, Bioactivities and Structure-Function Analysis of the Polysaccharides From Safflower (Carthamus tinctorius L.). Front. Pharmacol. 2021, 12, 767947. [Google Scholar] [CrossRef]
  131. Adaškevičiūtė, V.; Kaškonienė, V.; Kaškonas, P.; Barčauskaitė, K.; Maruška, A. Comparison of Physicochemical Properties of Bee Pollen with Other Bee Products. Biomolecules 2019, 9, 819. [Google Scholar] [CrossRef] [PubMed]
  132. Naseri, L.; Khazaei, M.R.; Khazaei, M. Potential Therapeutic Effect of Bee Pollen and Metformin Combination on Testosterone and Estradiol Levels, Apoptotic Markers and Total Antioxidant Capacity in A Rat Model of Polycystic Ovary Syndrome. Int. J. Fertil. Steril. 2021, 15, 101–107. [Google Scholar] [CrossRef] [PubMed]
  133. Saisavoey, T.; Sangtanoo, P.; Srimongkol, P.; Reamtong, O.; Karnchanatat, A. Hydrolysates from bee pollen could induced apoptosis in human bronchogenic carcinoma cells (ChaGo-K-1). J. Food Sci. Technol. 2021, 58, 752–763. [Google Scholar] [CrossRef] [PubMed]
  134. Bakour, M.; Laaroussi, H.; Ferreira-Santos, P.; Genisheva, Z.; Ousaaid, D.; Teixeira, J.A.; Lyoussi, B. Exploring the Palynological, Chemical, and Bioactive Properties of Non-Studied Bee Pollen and Honey from Morocco. Molecules 2022, 27, 5777. [Google Scholar] [CrossRef] [PubMed]
  135. Bridi, R.; Atala, E.; Pizarro, P.N.; Montenegro, G. Honeybee Pollen Load: Phenolic Composition and Antimicrobial Activity and Antioxidant Capacity. J. Nat. Prod. 2019, 82, 559–565. [Google Scholar] [CrossRef]
  136. Aylanc, V.; Larbi, S.; Calhelha, R.; Barros, L.; Rezouga, F.; Rodríguez-Flores, M.S.; Seijo, M.C.; El Ghouizi, A.; Lyoussi, B.; Falcão, S.I.; et al. Evaluation of Antioxidant and Anticancer Activity of Mono- and Polyfloral Moroccan Bee Pollen by Characterizing Phenolic and Volatile Compounds. Molecules 2023, 28, 835. [Google Scholar] [CrossRef]
  137. Kędzierski, W.; Janczarek, I.; Kowalik, S.; Jamioł, M.; Wawak, T.; Borsuk, G.; Przetacznik, M. Bee Pollen Supplementation to Aged Horses Influences Several Blood Parameters. J. Equine Vet. Sci. 2020, 90, 103024. [Google Scholar] [CrossRef] [PubMed]
  138. Zhou, W.; Zhao, Y.; Yan, Y.; Mi, J.; Lu, L.; Luo, Q.; Li, X.; Zeng, X.; Cao, Y. Antioxidant and immunomodulatory activities in vitro of polysaccharides from bee collected pollen of Chinese wolfberry. Int. J. Biol. Macromol. 2020, 163, 190–199. [Google Scholar] [CrossRef] [PubMed]
  139. Saral, Ö.; Şahin, H.; Saral, S.; Alkanat, M.; Akyıldız, K.; Topçu, A.; Yılmaz, A. Bee pollen increases hippocampal brain-derived neurotrophic factor and suppresses neuroinflammation in adult rats with chronic immobilization stress. Neurosci. Lett. 2021, 766, 136342. [Google Scholar] [CrossRef]
  140. Novaković, S.; Djekic, I.; Pešić, M.; Kostić, A.; Milinčić, D.; Stanisavljević, N.; Radojević, A.; Tomasevic, I. Bee pollen powder as a functional ingredient in frankfurters. Meat Sci. 2021, 182, 108621. [Google Scholar] [CrossRef]
  141. Di Chiacchio, I.M.; Gómez-Abenza, E.; Paiva, I.M.; de Abreu, D.J.M.; Rodríguez-Vidal, J.F.; Carvalho, E.E.N.; Carvalho, S.M.; Solis-Murgas, L.D.; Mulero, V. Bee pollen in zebrafish diet affects intestinal microbiota composition and skin cutaneous melanoma development. Sci. Rep. 2022, 12, 9998. [Google Scholar] [CrossRef]
  142. Al-Kahtani, S.N.; Alaqil, A.A.; Abbas, A.O. Modulation of Antioxidant Defense, Immune Response, and Growth Performance by Inclusion of Propolis and Bee Pollen into Broiler Diets. Animals 2022, 12, 1658. [Google Scholar] [CrossRef]
  143. Yang, Y.; Zhang, J.; Zhou, Q.; Wang, L.; Huang, W.; Wang, R. Effect of ultrasonic and ball-milling treatment on cell wall, nutrients, and antioxidant capacity of rose (Rosa rugosa) bee pollen, and identification of bioactive components. J. Sci. Food Agric. 2019, 99, 5350–5357. [Google Scholar] [CrossRef]
  144. Al-Salem, H.S.; Al-Yousef, H.M.; Ashour, A.E.; Ahmed, A.F.; Amina, M.; Issa, I.S.; Bhat, R.S. Antioxidant and hepatorenal protective effects of bee pollen fractions against propionic acid-induced autistic feature in rats. Food Sci. Nutr. 2020, 8, 5114–5127. [Google Scholar] [CrossRef]
  145. El Ghouizi, A.; El Menyiy, N.; Falcão, S.I.; Vilas-Boas, M.; Lyoussi, B. Chemical composition, antioxidant activity, and diuretic effect of Moroccan fresh bee pollen in rats. Vet. World 2020, 13, 1251–1261. [Google Scholar] [CrossRef]
  146. Zhang, H.; Liu, R.; Lu, Q. Separation and Characterization of Phenolamines and Flavonoids from Rape Bee Pollen, and Comparison of Their Antioxidant Activities and Protective Effects Against Oxidative Stress. Molecules 2020, 25, 1264. [Google Scholar] [CrossRef]
  147. Gercek, Y.C.; Celik, S.; Bayram, S. Screening of Plant Pollen Sources, Polyphenolic Compounds, Fatty Acids and Antioxidant/Antimicrobial Activity from Bee Pollen. Molecules 2021, 27, 117. [Google Scholar] [CrossRef]
  148. Şahin, S.; Karkar, B. The antioxidant properties of the chestnut bee pollen extract and its preventive action against oxidatively induced damage in DNA bases. J. Food Biochem. 2019, 43, e12888. [Google Scholar] [CrossRef]
  149. Laaroussi, H.; Bakour, M.; Ousaaid, D.; Aboulghazi, A.; Ferreira-Santos, P.; Genisheva, Z.; Teixeira, J.A.; Lyoussi, B. Effect of antioxidant-rich propolis and bee pollen extracts against D-glucose induced type 2 diabetes in rats. Food Res. Int. 2020, 138, 109802. [Google Scholar] [CrossRef]
  150. Kostić, A.; Milinčić, D.D.; Nedić, N.; Gašić, U.M.; Trifunović, B.; Vojt, D.; Tešić, L.; Pešić, M.B. Phytochemical Profile and Antioxidant Properties of Bee-Collected Artichoke (Cynara scolymus) Pollen. Antioxidants 2021, 10, 1091. [Google Scholar] [CrossRef]
  151. Xu, Y.; Cao, X.; Zhao, H.; Yang, E.; Wang, Y.; Cheng, N.; Cao, W. Impact of Camellia japonica Bee Pollen Polyphenols on Hyperuricemia and Gut Microbiota in Potassium Oxonate-Induced Mice. Nutrients 2021, 13, 2665. [Google Scholar] [CrossRef]
  152. Gulhan, M.F. Therapeutic potentials of propolis and pollen on biochemical changes in reproductive function of L-NAME induced hypertensive male rats. Clin. Exp. Hypertens. 2019, 41, 292–298. [Google Scholar] [CrossRef]
  153. Belina-Aldemita, M.D.; Schreiner, M.; D’Amico, S. Characterization of phenolic compounds and antioxidative potential of pot-pollen produced by stingless bees (Tetragonula biroi Friese) from the Philippines. J. Food Biochem. 2020, 44, e13102. [Google Scholar] [CrossRef]
  154. Gonçalves, A.C.; Lahlou, R.A.; Alves, G.; Garcia-Viguera, C.; Moreno, D.A.; Silva, L.R. Potential activity of abrantes pollen extract: Biochemical and cellular model studies. Foods 2021, 10, 2804. [Google Scholar] [CrossRef]
  155. Bujang, J.S.; Zakaria, M.H.; Ramaiya, S.D. Chemical constituents and phytochemical properties of floral maize pollen. PLoS ONE 2021, 16, e0247327. [Google Scholar] [CrossRef]
  156. Gabriele, M.; Frassinetti, S.; Pucci, L. Antimicrobial activity and protective effect of Tuscan bee pollens on oxidative and endoplasmic reticulum stress in different cell-based models. Foods 2021, 10, 1422. [Google Scholar] [CrossRef]
  157. Shen, Z.; Geng, Q.; Huang, H.; Yao, H.; Du, T.; Chen, L.; Wu, Z.; Miao, X.; Shi, P. Antioxidative and cardioprotective effects of Schisandra chinensis bee pollen extract on isoprenaline-induced myocardial infarction in rats. Molecules 2019, 24, 1090. [Google Scholar] [CrossRef] [PubMed]
  158. Mohamed, A.E.; El-Magd, M.A.; El-Said, K.S.; El-Sharnouby, M.; Tousson, E.M.; Salama, A.F. Potential therapeutic effect of thymoquinone and/or bee pollen on fluvastatin-induced hepatitis in rats. Sci. Rep. 2021, 11, 15688. [Google Scholar] [CrossRef]
  159. Oyarzún, J.E.; Andia, M.E.; Uribe, S.; Núñez Pizarro, P.; Núñez, G.; Montenegro, G.; Bridi, R. Honeybee Pollen Extracts Reduce Oxidative Stress and Steatosis in Hepatic Cells. Molecules 2021, 26, 6. [Google Scholar] [CrossRef]
  160. Prado, A.; Brunet, J.-L.; Peruzzi, M.; Bonnet, M.; Bordier, C.; Crauser, D.; Le Conte, Y.; Alaux, C. Warmer winters are associated with lower levels of the cryoprotectant glycerol, a slower decrease in vitellogenin expression and reduced virus infections in winter honeybees. J. Insect Physiol. 2022, 136, 104348. [Google Scholar] [CrossRef]
  161. Ricigliano, V.A.; Cank, K.B.; Todd, D.A.; Knowles, S.L.; Oberlies, N.H. Metabolomics-Guided Comparison of Pollen and Microalgae-Based Artificial Diets in Honey Bees. J. Agric. Food Chem. 2022, 70, 9790–9801. [Google Scholar] [CrossRef] [PubMed]
  162. Li, Q.; Liang, X.; Guo, N.; Hu, L.; Maruthi, P.E.; Wu, Y.; Xue, X.; Wu, L.; Wang, K. Protective effects of Bee pollen extract on the Caco-2 intestinal barrier dysfunctions induced by dextran sulfate sodium. Biomed. Pharmacother. 2019, 117, 109200. [Google Scholar] [CrossRef] [PubMed]
  163. Laaroussi, H.; Ferreira-Santos, P.; Genisheva, Z.; Bakour, M.; Ousaaid, D.; El Ghouizi, A.; Teixeira, J.A.; Lyoussi, B. Unveiling the techno-functional and bioactive properties of bee pollen as an added-value food ingredient. Food Chem. 2023, 405, 134958. [Google Scholar] [CrossRef] [PubMed]
  164. Khongkarat, P.; Ramadhan, R.; Phuwapraisirisan, P.; Chanchao, C. Safflospermidines from the bee pollen of Helianthus annuus L. exhibit a higher in vitro antityrosinase activity than kojic acid. Heliyon 2020, 6, e03638. [Google Scholar] [CrossRef]
  165. Lopes, A.J.O.; Vasconcelos, C.C.; Pereira, F.A.N.; Silva, R.H.M.; Queiroz, P.F.d.S.; Fernandes, C.V.; Garcia, J.B.S.; Ramos, R.M.; da Rocha, C.Q.; Lima, S.T.d.J.R.M.; et al. Anti-Inflammatory and Antinociceptive Activity of Pollen Extract Collected by Stingless Bee Melipona fasciculata. Int. J. Mol. Sci. 2019, 20, 4512. [Google Scholar] [CrossRef]
  166. Chen, S.; Zhao, H.; Cheng, N.; Cao, W. Rape bee pollen alleviates dextran sulfate sodium (DSS)-induced colitis by neutralizing IL-1β and regulating the gut microbiota in mice. Food Res. Int. 2019, 122, 241–251. [Google Scholar] [CrossRef]
  167. Chen, S.; Wang, X.; Cheng, N. Ultrasound-assisted ethanol extraction of Actinidia arguta pollen possesses antioxidant activity and protects DNA from oxidative damage. J. Food Biochem. 2021, 45, e13603. [Google Scholar] [CrossRef]
  168. Shi, P.; Geng, Q.; Chen, L.; Du, T.; Lin, Y.; Lai, R.; Meng, F.; Wu, Z.; Miao, X.; Yao, H. Schisandra chinensis bee pollen’s chemical profiles and protective effect against H2O2-induced apoptosis in H9c2 cardiomyocytes. BMC Complement. Med. Ther. 2020, 20, 274. [Google Scholar] [CrossRef]
  169. Messina, C.M.; Panettieri, V.; Arena, R.; Renda, G.; Ruiz, C.E.; Morghese, M.; Piccolo, G.; Santulli, A.; Bovera, F. The Inclusion of a Supercritical Fluid Extract, Obtained From Honey Bee Pollen, in the Diet of Gilthead Sea Bream (Sparus aurata), Improves Fish Immune Response by Enhancing Anti-oxidant, and Anti-bacterial Activities. Front. Vet. Sci. 2020, 7, 95. [Google Scholar] [CrossRef]
  170. Kostić, A.; Milinčić, D.D.; Stanisavljević, N.S.; Gašić, U.M.; Lević, S.; Kojić, M.O.; Tešić, L.; Nedović, V.; Barać, M.B.; Pešić, M.B. Polyphenol bioaccessibility and antioxidant properties of in vitro digested spray-dried thermally-treated skimmed goat milk enriched with pollen. Food Chem. 2021, 351, 129310. [Google Scholar] [CrossRef]
  171. Lopes, A.J.O.; Vasconcelos, C.C.; Garcia, J.B.S.; Pinheiro, M.S.D.; Pereira, F.A.N.; Camelo, D.d.S.; de Morais, S.V.; Freitas, J.R.B.; da Rocha, C.Q.; Ribeiro, M.N.d.S.; et al. Anti-Inflammatory and Antioxidant Activity of Pollen Extract Collected by Scaptotrigona affinis postica: In silico, in vitro, and in vivo Studies. Antioxidants 2020, 9, 103. [Google Scholar] [CrossRef]
  172. Saral, O.; Dokumacioglu, E.; Saral, S.; Sumer, A.; Bulmus, O.; Kaya, S.O.; Canpolat, S. The effect of bee pollen on reproductive and biochemical parameters in methotrexate-induced testicular damage in adult rats. J. Basic Clin. Physiol. Pharmacol. 2020, 32, 1001–1006. [Google Scholar] [CrossRef] [PubMed]
  173. Amalia, E.; Diantini, A.; Subarnas, A. Water-soluble propolis and bee pollen of Trigona spp. from South Sulawesi Indonesia induce apoptosis in the human breast cancer MCF-7 cell line. Oncol. Lett. 2020, 20, 274. [Google Scholar] [CrossRef]
  174. Elghouizi, A.; Al-Waili, N.; Elmenyiy, N.; Elfetri, S.; Aboulghazi, A.; Al-Waili, A.; Lyoussi, B. Protective effect of bee pollen in acute kidney injury, proteinuria, and crystalluria induced by ethylene glycol ingestion in rats. Sci. Rep. 2022, 12, 8351. [Google Scholar] [CrossRef] [PubMed]
  175. Khongkarat, P.; Phuwapraisirisan, P.; Chanchao, C. Phytochemical content, especially spermidine derivatives, presenting antioxidant and antilipoxygenase activities in Thai bee pollens. PeerJ 2022, 10, e13506. [Google Scholar] [CrossRef] [PubMed]
  176. Gulcin, İ. Antioxidants and antioxidant methods: An updated overview. Arch. Toxicol. 2020, 94, 651–715. [Google Scholar] [CrossRef]
  177. Ivanova, A.; Gerasimova, E.; Gazizullina, E. Study of Antioxidant Properties of Agents from the Perspective of Their Action Mechanisms. Molecules 2020, 25, 4251. [Google Scholar] [CrossRef]
  178. Munteanu, I.G.; Apetrei, C. Analytical Methods Used in Determining Antioxidant Activity: A Review. Int. J. Mol. Sci. 2021, 22, 3380. [Google Scholar] [CrossRef]
  179. Acquaviva, A.; Di Simone, S.C.; Canini, A.; Braglia, R.; Di Marco, G.; Campana, C.; Angelini, P.; Flores, G.A.; Venanzoni, R.; Libero, M.L.; et al. Phytochemical and biological investigations on the pollen from industrial hemp male inflorescences. Food Res. Int. 2022, 161, 111883. [Google Scholar] [CrossRef]
  180. Altiner, D.D.; Altunatmaz, S.S.; Sabuncu, M.; Aksu, F.; Sahan, Y. In-vitro bioaccessibility of antioxidant properties of bee pollen in Turkey. Food Sci. Technol. 2021, 41 (Suppl. S1), 133–141. [Google Scholar] [CrossRef]
  181. Saisavoey, T.; Sangtanoo, P.; Chanchao, C.; Reamtong, O.; Karnchanatat, A. Identification of novel anti-inflammatory peptides from bee pollen (Apis mellifera) hydrolysate in lipopolysaccharide-stimulated RAW264.7 macrophages. J. Apic. Res. 2021, 60, 280–289. [Google Scholar] [CrossRef]
  182. Nwachukwu, I.D.; Sarteshnizi, R.A.; Udenigwe, C.C.; Aluko, R.E. A Concise Review of Current In Vitro Chemical and Cell-Based Antioxidant Assay Methods. Molecules 2021, 26, 4865. [Google Scholar] [CrossRef] [PubMed]
  183. Gong, E.S.; Liu, C.; Li, B.; Zhou, W.; Chen, H.; Li, T.; Wu, J.; Zeng, Z.; Wang, Y.; Si, X.; et al. Phytochemical profiles of rice and their cellular antioxidant activity against ABAP induced oxidative stress in human hepatocellular carcinoma HepG2 cells. Food Chem. 2020, 318, 126484. [Google Scholar] [CrossRef] [PubMed]
  184. Nassar, A.M.K.; Salim, Y.M.; Eid, K.S.; Shaheen, H.M.; Saati, A.A.; Hetta, H.F.; Elmistekawy, A.; Batiha, G.E.-S. Ameliorative Effects of Honey, Propolis, Pollen, and Royal Jelly Mixture against Chronic Toxicity of Sumithion Insecticide in White Albino Rats. Molecules 2020, 25, 2633. [Google Scholar] [CrossRef] [PubMed]
  185. Suleiman, J.B.; Abu Bakar, A.B.; Mohamed, M. Review on Bee Products as Potential Protective and Therapeutic Agents in Male Reproductive Impairment. Molecules 2021, 26, 3421. [Google Scholar] [CrossRef]
  186. Khanna, D.; Khanna, S.; Khanna, P.; Kahar, P.; Patel, B.M. Obesity: A Chronic Low-Grade Inflammation and Its Markers. Cureus 2022, 14, e22711. [Google Scholar] [CrossRef]
  187. Fabozzi, G.; Verdone, G.; Allori, M.; Cimadomo, D.; Tatone, C.; Stuppia, L.; Franzago, M.; Ubaldi, N.; Vaiarelli, A.; Ubaldi, F.M.; et al. Personalized Nutrition in the Management of Female Infertility: New Insights on Chronic Low-Grade Inflammation. Nutrients 2022, 14, 1918. [Google Scholar] [CrossRef]
  188. Herrero-Cervera, A.; Soehnlein, O.; Kenne, E. Neutrophils in chronic inflammatory diseases. Cell. Mol. Immunol. 2022, 19, 177–191. [Google Scholar] [CrossRef]
  189. Livshits, G.; Kalinkovich, A. A cross-talk between sestrins, chronic inflammation and cellular senescence governs the development of age-associated sarcopenia and obesity. Ageing Res. Rev. 2023, 86, 101852. [Google Scholar] [CrossRef]
  190. Wang, X.-L.; Feng, S.-T.; Wang, Y.-T.; Yuan, Y.-H.; Li, Z.-P.; Chen, N.-H.; Wang, Z.-Z.; Zhang, Y. Mitophagy, a Form of Selective Autophagy, Plays an Essential Role in Mitochondrial Dynamics of Parkinson’s Disease. Cell. Mol. Neurobiol. 2022, 42, 1321–1339. [Google Scholar] [CrossRef]
  191. Teissier, T.; Boulanger, E.; Cox, L.S. Interconnections between Inflammageing and Immunosenescence during Ageing. Cells 2022, 11, 359. [Google Scholar] [CrossRef] [PubMed]
  192. Di Giosia, P.; Stamerra, C.A.; Giorgini, P.; Jamialahamdi, T.; Butler, A.E.; Sahebkar, A. The role of nutrition in inflammaging. Ageing Res. Rev. 2022, 77, 101596. [Google Scholar] [CrossRef] [PubMed]
  193. Henein, M.Y.; Vancheri, S.; Longo, G.; Vancheri, F. The Role of Inflammation in Cardiovascular Disease. Int. J. Mol. Sci. 2022, 23, 12906. [Google Scholar] [CrossRef] [PubMed]
  194. Walker, K.A.; Basisty, N.; Wilson, D.M.; Ferrucci, L. Connecting aging biology and inflammation in the omics era. J. Clin. Investig. 2022, 132, e158448. [Google Scholar] [CrossRef]
  195. Kosyreva, A.M.; Sentyabreva, A.V.; Tsvetkov, I.S.; Makarova, O.V. Alzheimer’s Disease and Inflammaging. Brain Sci. 2022, 12, 1237. [Google Scholar] [CrossRef]
  196. Zhu, L.; Li, J.; Wei, C.; Luo, T.; Deng, Z.; Fan, Y.; Zheng, L. A polysaccharide from Fagopyrum esculentum Moench bee pollen alleviates microbiota dysbiosis to improve intestinal barrier function in antibiotic-treated mice. Food Funct. 2020, 11, 10519–10533. [Google Scholar] [CrossRef]
  197. Kotipalli, R.S.S.; Tirunavalli, S.K.; Pote, A.B.; Sahu, B.D.; Kuncha, M.; Jerald, M.K.; Sistla, R.; Andugulapati, S.B. Sinigrin Attenuates the Dextran Sulfate Sodium-induced Colitis in Mice by Modulating the MAPK Pathway. Inflammation 2023, 46, 787–807. [Google Scholar] [CrossRef]
  198. Khongkarat, P.; Traiyasut, P.; Phuwapraisirisan, P.; Chanchao, C. First report of fatty acids in Mimosadiplotricha bee pollen with in vitro lipase inhibitory activity. PeerJ 2022, 10, e12722. [Google Scholar] [CrossRef]
  199. Kosedag, M.; Gulaboglu, M. Pollen and bee bread expressed highest anti-inflammatory activities among bee products in chronic inflammation: An experimental study with cotton pellet granuloma in rats. Inflammopharmacology 2023, 1–9. [Google Scholar] [CrossRef]
  200. Chen, S.; Xu, Y.; Cheng, N.; Li, F.; Zhao, H.; Bai, N.; El-Seedi, H.R.; Cao, W. Mitigation of DSS-Induced Colitis Potentially via Th1/Th2 Cytokine and Immunological Function Balance Induced by Phenolic-Enriched Buckwheat (Fagopyrum esculentum Moench) Bee Pollen Extract. Foods 2022, 11, 1293. [Google Scholar] [CrossRef]
  201. Zhang, J.; Cao, W.; Zhao, H.; Guo, S.; Wang, Q.; Cheng, N.; Bai, N. Protective Mechanism of Fagopyrum esculentum Moench. Bee Pollen EtOH Extract Against Type II Diabetes in a High-Fat Diet/Streptozocin-Induced C57BL/6J Mice. Front. Nutr. 2022, 9, 925351. [Google Scholar] [CrossRef] [PubMed]
  202. Shaldoum, F.; El-Kott, A.F.; Ouda, M.M.A.; Abd-Ella, E.M. Immunomodulatory effects of bee pollen on doxorubicin-induced bone marrow/spleen immunosuppression in rat. J. Food Biochem. 2021, 45, e13747. [Google Scholar] [CrossRef] [PubMed]
  203. Eteraf-Oskouei, T.; Shafiee-Khamneh, A.; Heshmati-Afshar, F.; Delazar, A. Anti-inflammatory and anti-angiogenesis effect of bee pollen methanolic extract using air pouch model of inflammation. Res. Pharm. Sci. 2020, 15, 66–75. [Google Scholar] [CrossRef] [PubMed]
  204. Li, Q.; Sun, M.; Wan, Z.; Liang, J.; Betti, M.; Hrynets, Y.; Xue, X.; Wu, L.; Wang, K. Bee Pollen Extracts Modulate Serum Metabolism in Lipopolysaccharide-Induced Acute Lung Injury Mice with Anti-Inflammatory Effects. J. Agric. Food Chem. 2019, 67, 7855–7868. [Google Scholar] [CrossRef] [PubMed]
  205. Cheng, N.; Chen, S.; Liu, X.; Zhao, H.; Cao, W. Impact of SchisandraChinensis Bee Pollen on Nonalcoholic Fatty Liver Disease and Gut Microbiota in HighFat Diet Induced Obese Mice. Nutrients 2019, 11, 346. [Google Scholar] [CrossRef]
  206. Aabed, K.; Bhat, R.S.; Al-Dbass, A.; Moubayed, N.; Algahtani, N.; Merghani, N.M.; Alanazi, A.; Zayed, N.; El-Ansary, A. Bee pollen and propolis improve neuroinflammation and dysbiosis induced by propionic acid, a short chain fatty acid in a rodent model of autism. Lipids Health Dis. 2019, 18, 200. [Google Scholar] [CrossRef]
  207. Rivera-Jiménez, J.; Berraquero-García, C.; Gálvez, A.R.P.; García-Moreno, P.J.; Espejo-Carpio, F.J.; Guadix, A.; Guadix, E.M. Peptides and protein hydrolysates exhibiting anti-inflammatory activity: Sources, structural features and modulation mechanisms. Food Funct. 2022, 13, 12510–12540. [Google Scholar] [CrossRef]
  208. Mansinhbhai, C.H.; Sakure, A.; Maurya, R.; Bishnoi, M.; Kondepudi, K.K.; Das, S.; Hati, S. Significance of whey protein hydrolysate on anti-oxidative, ACE-inhibitory and anti-inflammatory activities and release of peptides with biofunctionality: An in vitro and in silico approach. J. Food Sci. Technol. 2021, 59, 2629–2642. [Google Scholar] [CrossRef]
  209. Pisoschi, A.M.; Pop, A.; Iordache, F.; Stanca, L.; Geicu, O.I.; Bilteanu, L.; Serban, A.I. Antioxidant, anti-inflammatory and immunomodulatory roles of vitamins in COVID-19 therapy. Eur. J. Med. Chem. 2022, 232, 114175. [Google Scholar] [CrossRef]
  210. Garbicz, J.; Całyniuk, B.; Górski, M.; Buczkowska, M.; Piecuch, M.; Kulik, A.; Rozentryt, P. Nutritional Therapy in Persons Suffering from Psoriasis. Nutrients 2021, 14, 119. [Google Scholar] [CrossRef]
  211. Coniglio, S.; Shumskaya, M.; Vassiliou, E. Unsaturated Fatty Acids and Their Immunomodulatory Properties. Biology 2023, 12, 279. [Google Scholar] [CrossRef] [PubMed]
  212. Gocher, A.M.; Workman, C.J.; Vignali, D.A.A. Interferon-γ: Teammate or opponent in the tumour microenvironment? Nat. Rev. Immunol. 2022, 22, 158–172. [Google Scholar] [CrossRef]
  213. Benci, J.L.; Johnson, L.R.; Choa, R.; Xu, Y.; Qiu, J.; Zhou, Z.; Xu, B.; Ye, D.; Nathanson, K.L.; June, C.H.; et al. Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade. Cell 2019, 178, 933–948.e14. [Google Scholar] [CrossRef] [PubMed]
  214. Mertowska, P.; Mertowski, S.; Smarz-Widelska, I.; Grywalska, E. Biological Role, Mechanism of Action and the Importance of Interleukins in Kidney Diseases. Int. J. Mol. Sci. 2022, 23, 647. [Google Scholar] [CrossRef] [PubMed]
  215. Djuric, N.; Lafeber, G.C.M.; Vleggeert-Lankamp, C.L.A. The contradictory effect of macrophage-related cytokine expression in lumbar disc herniations: A systematic review. Eur. Spine J. 2020, 29, 1649–1659. [Google Scholar] [CrossRef] [PubMed]
  216. Stumpf, F.; Keller, B.; Gressies, C.; Schuetz, P. Inflammation and Nutrition: Friend or Foe? Nutrients 2023, 15, 1159. [Google Scholar] [CrossRef]
  217. Sierra-Galicia, M.I.; Lara, R.R.-D.; Orzuna-Orzuna, J.F.; Lara-Bueno, A.; Ramírez-Valverde, R.; Fallas-López, M. Effects of Supplementation with Bee Pollen and Propolis on Growth Performance and Serum Metabolites of Rabbits: A Meta-Analysis. Animals 2023, 13, 439. [Google Scholar] [CrossRef]
  218. Khurelchuluun, A.; Uehara, O.; Paudel, D.; Morikawa, T.; Kawano, Y.; Sakata, M.; Shibata, H.; Yoshida, K.; Sato, J.; Miura, H.; et al. Bee Pollen Diet Alters the Bacterial Flora and Antimicrobial Peptides in the Oral Cavities of Mice. Foods 2021, 10, 1282. [Google Scholar] [CrossRef]
  219. Aaseth, J.; Ellefsen, S.; Alehagen, U.; Sundfør, T.M.; Alexander, J. Diets and drugs for weight loss and health in obesity—An update. Biomed. Pharmacother. 2021, 140, 111789. [Google Scholar] [CrossRef]
  220. Lin, X.; Li, H. Obesity: Epidemiology, Pathophysiology, and Therapeutics. Front. Endocrinol. 2021, 12, 706978. [Google Scholar] [CrossRef]
  221. Zhang, Q.; Bai, Y.; Wang, W.; Li, J.; Zhang, L.; Tang, Y.; Yue, S. Role of herbal medicine and gut microbiota in the prevention and treatment of obesity. J. Ethnopharmacol. 2023, 305, 116127. [Google Scholar] [CrossRef] [PubMed]
  222. Endalifer, M.L.; Diress, G. Epidemiology, Predisposing Factors, Biomarkers, and Prevention Mechanism of Obesity: A Systematic Review. J. Obes. 2020, 2020, 6134362. Available online: (accessed on 26 March 2023). [CrossRef] [PubMed]
  223. Savova, M.S.; Mihaylova, L.V.; Tews, D.; Wabitsch, M.; Georgiev, M.I. Targeting PI3K/AKT signaling pathway in obesity. Biomed. Pharmacother. 2023, 159, 114244. [Google Scholar] [CrossRef]
  224. Sandoval, V.; Sanz-Lamora, H.; Arias, G.; Marrero, P.F.; Haro, D.; Relat, J. Metabolic impact of flavonoids consumption in obesity: From central to peripheral. Nutrients 2020, 12, 2393. [Google Scholar] [CrossRef]
  225. Oliveira, A.K.D.S.; Silva, A.M.D.O.E.; Pereira, R.O.; Santos, A.S.; Junior, E.V.B.; Bezerra, M.T.; Barreto, R.S.S.; Quintans-Junior, L.J.; Quintans, J.S.S. Anti-obesity properties and mechanism of action of flavonoids: A review. Crit. Rev. Food Sci. Nutr. 2022, 62, 7827–7848. [Google Scholar] [CrossRef] [PubMed]
  226. Ngamsamer, C.; Sirivarasai, J.; Sutjarit, N. The Benefits of Anthocyanins against Obesity-Induced Inflammation. Biomolecules 2022, 12, 852. [Google Scholar] [CrossRef] [PubMed]
  227. Martín, M.Á.; Ramos, S. Dietary Flavonoids and Insulin Signaling in Diabetes and Obesity. Cells 2021, 10, 1474. [Google Scholar] [CrossRef]
  228. Rufino, A.T.; Costa, V.M.; Carvalho, F.; Fernandes, E. Flavonoids as antiobesity agents: A review. Med. Res. Rev. 2020, 41, 556–585. [Google Scholar] [CrossRef]
  229. Kadar, N.N.M.A.; Ahmad, F.; Teoh, S.L.; Yahaya, M.F. Caffeic Acid on Metabolic Syndrome: A Review. Molecules 2021, 26, 5490. [Google Scholar] [CrossRef]
  230. Pérez-Torres, I.; Castrejón-Téllez, V.; Soto, M.E.; Rubio-Ruiz, M.E.; Manzano-Pech, L.; Guarner-Lans, V. Oxidative Stress, Plant Natural Antioxidants, and Obesity. Int. J. Mol. Sci. 2021, 22, 1786. [Google Scholar] [CrossRef]
  231. Yang, S.; Qu, Y.; Chen, J.; Chen, S.; Sun, L.; Zhou, Y.; Fan, Y. Bee Pollen Polysaccharide From Rosa rugosa Thunb. (Rosaceae) Promotes Pancreatic β-Cell Proliferation and Insulin Secretion. Front. Pharmacol. 2021, 12, 688073. [Google Scholar] [CrossRef] [PubMed]
  232. Li, Q.; Ren, C.; Yan, S.; Wang, K.; Hrynets, Y.; Xiang, L.; Xue, X.; Betti, M.; Wu, L. Extract of Unifloral Camellia sinensis L. Pollen Collected by Apis mellifera L. Honeybees Exerted Inhibitory Effects on Glucose Uptake and Transport by Interacting with Glucose Transporters in Human Intestinal Cells. J. Agric. Food Chem. 2021, 69, 1877–1887. [Google Scholar] [CrossRef] [PubMed]
  233. Zhao, T.; Li, C.; Wang, S.; Song, X. Green Tea (Camellia sinensis): A Review of Its Phytochemistry, Pharmacology, and Toxicology. Molecules 2022, 27, 3909. [Google Scholar] [CrossRef]
  234. Brimson, J.M.; Prasanth, M.I.; Kumaree, K.K.; Thitilertdecha, P.; Malar, D.S.; Tencomnao, T.; Prasansuklab, A. Tea Plant (Camellia sinensis): A Current Update on Use in Diabetes, Obesity, and Cardiovascular Disease. Nutrients 2023, 15, 37. [Google Scholar] [CrossRef]
  235. Noreen, S.; Rizwan, B.; Khan, M.; Farooq, S. Health Benefits of Buckwheat (Fagopyrum Esculentum), Potential Remedy for Diseases, Rare to Cancer: A Mini Review. Infect. Disord. Drug Targets 2021, 21, e170721189478. [Google Scholar] [CrossRef] [PubMed]
  236. Llanaj, E.; Ahanchi, N.S.; Dizdari, H.; Taneri, P.E.; Niehot, C.D.; Wehrli, F.; Khatami, F.; Raeisi-Dehkordi, H.; Kastrati, L.; Bano, A.; et al. Buckwheat and Cardiometabolic Health: A Systematic Review and Meta-Analysis. J. Pers. Med. 2022, 12, 1940. [Google Scholar] [CrossRef] [PubMed]
  237. Rizzo, G.; Baroni, L.; Lombardo, M. Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review. Int. J. Environ. Res. Public Health 2023, 20, 1683. [Google Scholar] [CrossRef]
  238. Sasani, N.; Kazemi, A.; Babajafari, S.; Amiri-Ardekani, E.; Rezaiyan, M.; Barati-Boldaji, R.; Mazloomi, S.M.; Clark, C.C.T.; Ashrafi-Dehkordi, E. The effect of acorn muffin consumption on glycemic indices and lipid profile in type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trial. Food Sci. Nutr. 2023, 11, 883–891. [Google Scholar] [CrossRef]
  239. Choi, D.-H.; Han, J.-H.; Hong, M.; Lee, S.-Y.; Lee, S.-U.; Kwon, T.-H. Antioxidant and lipid-reducing effects of Rosa rugosa root extract in 3T3-L1 cell. Food Sci. Biotechnol. 2022, 31, 121–129. [Google Scholar] [CrossRef]
  240. Baiyisaiti, A.; Wang, Y.; Zhang, X.; Chen, W.; Qi, R. Rosa rugosa flavonoids exhibited PPARα agonist-like effects on genetic severe hypertriglyceridemia of mice. J. Ethnopharmacol. 2019, 240, 111952. [Google Scholar] [CrossRef]
  241. Farah, S.; Yammine, K. A systematic review on the efficacy of vitamin B supplementation on diabetic peripheral neuropathy. Nutr. Rev. 2022, 80, 1340–1355. [Google Scholar] [CrossRef] [PubMed]
  242. Mascolo, E.; Vernì, F. Vitamin B6 and Diabetes: Relationship and Molecular Mechanisms. Int. J. Mol. Sci. 2020, 21, 3669. [Google Scholar] [CrossRef] [PubMed]
  243. Prabhakar, B.; Kulkarni, Y.A. Water Soluble Vitamins and their Role in Diabetes and its Complications. Curr. Diabetes Rev. 2020, 16, 649–656. [Google Scholar] [CrossRef]
  244. Mason, S.A.; Parker, L.; van der Pligt, P.; Wadley, G.D. Vitamin C supplementation for diabetes management: A comprehensive narrative review. Free. Radic. Biol. Med. 2023, 194, 255–283. [Google Scholar] [CrossRef] [PubMed]
  245. Liu, M.; Park, S. A Causal Relationship between Vitamin C Intake with Hyperglycemia and Metabolic Syndrome Risk: A Two-Sample Mendelian Randomization Study. Antioxidants 2022, 11, 857. [Google Scholar] [CrossRef] [PubMed]
  246. Sun, H.; Karp, J.; Sun, K.M.; Weaver, C.M. Decreasing Vitamin C Intake, Low Serum Vitamin C Level and Risk for US Adults with Diabetes. Nutrients 2022, 14, 3902. [Google Scholar] [CrossRef]
  247. Pittas, A.G.; Kawahara, T.; Jorde, R.; Dawson-Hughes, B.; Vickery, E.M.; Angellotti, E.; Nelson, J.; Trikalinos, T.A.; Balk, E.M. Vitamin D and Risk for Type 2 Diabetes in People With Prediabetes: A Systematic Review and Meta-analysis of Individual Participant Data From 3 Randomized Clinical Trials. Ann. Intern. Med. 2023, 176, 355–363. [Google Scholar] [CrossRef]
  248. Abugoukh, T.M.; Al Sharaby, A.; Elshaikh, A.O.; Joda, M.; Madni, A.; Ahmed, I.; Abdalla, R.S.; Ahmed, K.; Elazrag, S.E.; Abdelrahman, N. Does Vitamin D Have a Role in Diabetes? Cureus 2022, 14, e30432. [Google Scholar] [CrossRef]
  249. Michael, W.; Couture, A.D.; Swedlund, M.; Hampton, A.; Eglash, A.; Schrager, S. An Evidence-Based Review of Vitamin D for Common and High-Mortality Conditions. J. Am. Board Fam. Med. 2022, 35, 1217–1229. [Google Scholar] [CrossRef]
  250. Asbaghi, O.; Nazarian, B.; Yousefi, M.; Anjom-Shoae, J.; Rasekhi, H.; Sadeghi, O. Effect of vitamin E intake on glycemic control and insulin resistance in diabetic patients: An updated systematic review and meta-analysis of randomized controlled trials. Nutr. J. 2023, 22, 10. [Google Scholar] [CrossRef]
  251. Ziegler, M.; Wallert, M.; Lorkowski, S.; Peter, K. Cardiovascular and metabolic protection by Vitamin E: A matter of treatment strategy? Antioxidants 2020, 9, 935. [Google Scholar] [CrossRef] [PubMed]
  252. Dubey, P.; Thakur, V.; Chattopadhyay, M. Role of minerals and trace elements in diabetes and insulin resistance. Nutrients 2020, 12, 1864. [Google Scholar] [CrossRef] [PubMed]
  253. Xia, J.; Yu, J.; Xu, H.; Zhou, Y.; Li, H.; Yin, S.; Xu, D.; Wang, Y.; Xia, H.; Liao, W.; et al. Comparative effects of vitamin and mineral supplements in the management of type 2 diabetes in primary care: A systematic review and network meta-analysis of randomized controlled trials. Pharmacol. Res. 2023, 188, 106647. [Google Scholar] [CrossRef] [PubMed]
  254. Adams, J.B.; Sorenson, J.C.; Pollard, E.L.; Kirby, J.K.; Audhya, T. Evidence-based recommendations for an optimal prenatal supplement for women in the U.S., part two: Minerals. Nutrients 2021, 13, 1849. [Google Scholar] [CrossRef]
  255. Le, Y.; Wang, B.; Xue, M. Nutraceuticals use and type 2 diabetes mellitus. Curr. Opin. Pharmacol. 2022, 62, 168–176. [Google Scholar] [CrossRef]
  256. Xiao, Y.; Zhang, Q.; Liao, X.; Elbelt, U.; Weylandt, K.H. The effects of omega-3 fatty acids in type 2 diabetes: A systematic review and meta-analysis. Prostaglandins Leukot. Essent. Fat. Acids 2022, 182, 102456. [Google Scholar] [CrossRef]
  257. Bhat, S.; Sarkar, S.; Zaffar, D.; Dandona, P.; Kalyani, R.R. Omega-3 Fatty Acids in Cardiovascular Disease and Diabetes: A Review of Recent Evidence. Curr. Cardiol. Rep. 2023, 25, 51–65. [Google Scholar] [CrossRef]
  258. Prasad, M.; Jayaraman, S.; Eladl, M.A.; El-Sherbiny, M.; Abdelrahman, M.A.E.; Veeraraghavan, V.P.; Vengadassalapathy, S.; Umapathy, V.R.; Hussain, S.F.J.; Krishnamoorthy, K.; et al. A Comprehensive Review on Therapeutic Perspectives of Phytosterols in Insulin Resistance: A Mechanistic Approach. Molecules 2022, 27, 1595. [Google Scholar] [CrossRef]
  259. Vezza, T.; Canet, F.; de Marañón, A.M.; Bañuls, C.; Rocha, M.; Víctor, V.M. Phytosterols: Nutritional health players in the management of obesity and its related disorders. Antioxidants 2020, 9, 1266. [Google Scholar] [CrossRef]
  260. Menezes, R.; Matafome, P.; Freitas, M.; García-Conesa, M.-T. Updated Information of the Effects of (Poly)phenols against Type-2 Diabetes Mellitus in Humans: Reinforcing the Recommendations for Future Research. Nutrients 2022, 14, 3563. [Google Scholar] [CrossRef]
  261. Shamsudin, N.F.; Ahmed, Q.U.; Mahmood, S.; Shah, S.A.A.; Sarian, M.N.; Khattak, M.M.A.K.; Khatib, A.; Sabere, A.S.M.; Yusoff, Y.M.; Latip, J. Flavonoids as Antidiabetic and Anti-Inflammatory Agents: A Review on Structural Activity Relationship-Based Studies and Meta-Analysis. Int. J. Mol. Sci. 2022, 23, 12605. [Google Scholar] [CrossRef] [PubMed]
  262. Akpoveso, O.-O.P.; Ubah, E.E.; Obasanmi, G. Antioxidant Phytochemicals as Potential Therapy for Diabetic Complications. Antioxidants 2023, 12, 123. [Google Scholar] [CrossRef] [PubMed]
  263. Mahboob, A.; Senevirathne, D.K.L.; Paul, P.; Nabi, F.; Khan, R.H.; Chaari, A. An investigation into the potential action of polyphenols against human Islet Amyloid Polypeptide aggregation in type 2 diabetes. Int. J. Biol. Macromol. 2023, 225, 318–350. [Google Scholar] [CrossRef] [PubMed]
  264. Jin, Y.; Arroo, R. The protective effects of flavonoids and carotenoids against diabetic complications—A review of in vivo evidence. Front. Nutr. 2023, 10, 1020950. [Google Scholar] [CrossRef]
  265. Islam, F.; Khadija, J.F.; Islam, R.; Shohag, S.; Mitra, S.; Alghamdi, S.; Babalghith, A.O.; Theyab, A.; Rahman, M.T.; Akter, A.; et al. Investigating Polyphenol Nanoformulations for Therapeutic Targets against Diabetes Mellitus. Evid.-Based Complement. Altern. Med. 2022, 2022, 5649156. [Google Scholar] [CrossRef]
  266. Chu, A.J. Quarter-Century Explorations of Bioactive Polyphenols: Diverse Health Benefits. Front. Biosci. 2022, 27, 134. [Google Scholar] [CrossRef]
  267. Olas, B. Bee Products as Interesting Natural Agents for the Prevention and Treatment of Common Cardiovascular Diseases. Nutrients 2022, 14, 2267. [Google Scholar] [CrossRef]
  268. Copur, S.; Demiray, A.; Kanbay, M. Uric acid in metabolic syndrome: Does uric acid have a definitive role? Eur. J. Intern. Med. 2022, 103, 4–12. [Google Scholar] [CrossRef]
  269. Ozdemir, B.; Gulhan, M.F.; Sahna, E.; Selamoglu, Z. The investigation of antioxidant and anti-inflammatory potentials of apitherapeutic agents on heart tissues in nitric oxide synthase inhibited rats via Nω-nitro-L-arginine methyl ester. Clin. Exp. Hypertens. 2021, 43, 69–76. [Google Scholar] [CrossRef]
  270. Brainin, M.; Grisold, W.; Hankey, G.J.; Norrving, B.; Feigin, V.L. Time to revise primary prevention guidelines for stroke and cardiovascular disease. Lancet Neurol. 2022, 21, 686–687. [Google Scholar] [CrossRef]
  271. Kong, A.S.-Y.; Lai, K.S.; Hee, C.-W.; Loh, J.Y.; Lim, S.H.E.; Sathiya, M. Oxidative Stress Parameters as Biomarkers of Cardiovascular Disease towards the Development and Progression. Antioxidants 2022, 11, 1175. [Google Scholar] [CrossRef] [PubMed]
  272. Adorni, M.P.; Ferri, N. Nutrition Intervention and Cardiovascular Disease. Nutrients 2022, 14, 1435. [Google Scholar] [CrossRef] [PubMed]
  273. Cainzos-Achirica, M.; Patel, K.V.; Nasir, K. The Evolving Landscape of Cardiovascular Disease Prevention. Methodist DeBakey Cardiovasc. J. 2021, 17, 1–7. [Google Scholar] [CrossRef] [PubMed]
  274. Hinnen, D.; Kruger, D.; Magwire, M. Type 2 diabetes and cardiovascular disease: Risk reduction and early intervention. Postgrad. Med. 2023, 135, 2–12. [Google Scholar] [CrossRef] [PubMed]
  275. Sadeq, O.; Mechchate, H.; Es-Safi, I.; Bouhrim, M.; Jawhari, F.Z.; Ouassou, H.; Kharchoufa, L.; AlZain, M.N.; Alzamel, N.M.; Al Kamaly, O.M.; et al. Phytochemical Screening, Antioxidant and Antibacterial Activities of Pollen Extracts from Micromeria fruticosa, Achillea fragrantissima, and Phoenix dactylifera. Plants 2021, 10, 676. [Google Scholar] [CrossRef] [PubMed]
  276. Weis, W.A.; Ripari, N.; Conte, F.L.; Honorio, M.D.S.; Sartori, A.A.; Matucci, R.H.; Sforcin, J.M. An overview about apitherapy and its clinical applications. Phytomedicine Plus 2022, 2, 100239. [Google Scholar] [CrossRef]
  277. Durazzo, A.; Lucarini, M.; Plutino, M.; Lucini, L.; Aromolo, R.; Martinelli, E.; Souto, E.B.; Santini, A.; Pignatti, G. Bee Products: A Representation of Biodiversity, Sustainability, and Health. Life 2021, 11, 970. [Google Scholar] [CrossRef]
  278. Koksal, A.R.; Verne, G.N.; Zhou, Q. Endoplasmic Reticulum Stress in Biological Processing and Disease. J. Investig. Med. 2021, 69, 309–315. [Google Scholar] [CrossRef]
  279. Ye, J.; Liu, X. Interactions between endoplasmic reticulum stress and extracellular vesicles in multiple diseases. Front. Immunol. 2022, 13, 955419. [Google Scholar] [CrossRef]
  280. Fernandes-Da-Silva, A.; Miranda, C.S.; Santana-Oliveira, D.A.; Oliveira-Cordeiro, B.; Rangel-Azevedo, C.; Silva-Veiga, F.M.; Martins, F.F.; Souza-Mello, V. Endoplasmic reticulum stress as the basis of obesity and metabolic diseases: Focus on adipose tissue, liver, and pancreas. Eur. J. Nutr. 2021, 60, 2949–2960. [Google Scholar] [CrossRef]
  281. Ajoolabady, A.; Liu, S.; Klionsky, D.J.; Lip, G.Y.; Tuomilehto, J.; Kavalakatt, S.; Pereira, D.M.; Samali, A.; Ren, J. ER stress in obesity pathogenesis and management. Trends Pharmacol. Sci. 2021, 43, 97–109. [Google Scholar] [CrossRef] [PubMed]
  282. Gao, M.; Lan, J.; Bao, B.; Yao, W.; Cao, Y.; Shan, M.; Cheng, F.; Chen, P.; Zhang, L. Effects of carbonized process on quality control, chemical composition and pharmacology of Typhae Pollen: A review. J. Ethnopharmacol. 2020, 270, 113774. [Google Scholar] [CrossRef] [PubMed]
  283. Ali, A.M.; Kunugi, H. Apitherapy for Age-Related Skeletal Muscle Dysfunction (Sarcopenia): A Review on the Effects of Royal Jelly, Propolis, and Bee Pollen. Foods 2020, 9, 1362. [Google Scholar] [CrossRef] [PubMed]
  284. El-Hakam, F.E.-Z.A.; Laban, G.A.; El-Din, S.B.; El-Hamid, H.A.; Farouk, M.H. Apitherapy combination improvement of blood pressure, cardiovascular protection, and antioxidant and anti-inflammatory responses in dexamethasone model hypertensive rats. Sci. Rep. 2022, 12, 20765. [Google Scholar] [CrossRef]
  285. Al Rifai, M.; Virani, S.S.; Nambi, V. Identifying Differences: A Key Step in Precision Cardiovascular Disease Prevention. J. Am. Hear. Assoc. 2022, 11, e026600. [Google Scholar] [CrossRef]
  286. Wu, W.; Qiao, J.; Xiao, X.; Kong, L.; Dong, J.; Zhang, H. In vitro and In vivo digestion comparison of bee pollen with or without wall-disruption. J. Sci. Food Agric. 2021, 101, 2744–2755. [Google Scholar] [CrossRef]
  287. Pohl, P.; Dzimitrowicz, A.; Lesniewicz, A.; Welna, M.; Szymczycha-Madeja, A.; Cyganowski, P.; Jamroz, P. Room temperature solvent extraction for simple and fast determination of total concentration of Ca, Cu, Fe, Mg, Mn, and Zn in bee pollen by FAAS along with assessment of the bioaccessible fraction of these elements using in vitro gastrointestinal digestion. J. Trace Elem. Med. Biol. 2020, 60, 126479. [Google Scholar] [CrossRef]
  288. Luo, X.; Dong, Y.; Gu, C.; Zhang, X.; Ma, H. Processing Technologies for Bee Products: An Overview of Recent Developments and Perspectives. Front. Nutr. 2021, 8, 727181. [Google Scholar] [CrossRef]
  289. Aylanc, V.; Falcão, S.I.; Ertosun, S.; Vilas-Boas, M. From the hive to the table: Nutrition value, digestibility and bioavailability of the dietary phytochemicals present in the bee pollen and bee bread. Trends Food Sci. Technol. 2021, 109, 464–481. [Google Scholar] [CrossRef]
Figure 1. Flow Diagram of Resource Identification and Screening. (The protocol conception relies on PRISMA-ScR and PRISMA 2020 Standards [29]).
Figure 1. Flow Diagram of Resource Identification and Screening. (The protocol conception relies on PRISMA-ScR and PRISMA 2020 Standards [29]).
Nutrients 15 02413 g001
Figure 2. General Composition of Bee Pollen According to the Currently Available Literature.
Figure 2. General Composition of Bee Pollen According to the Currently Available Literature.
Nutrients 15 02413 g002
Figure 4. Main Identified Mechanisms of BP Anti-inflammatory Effects.
Figure 4. Main Identified Mechanisms of BP Anti-inflammatory Effects.
Nutrients 15 02413 g004
Figure 5. General Mechanisms of BP Antidiabetic Potential.
Figure 5. General Mechanisms of BP Antidiabetic Potential.
Nutrients 15 02413 g005
Table 1. Research Protocol According to the Reporting Guidance of PARISMA-ScR Checklist for Scoping Reviews and Updated Recommendations from PRISMA 2020 Statement for Systematic Reviews.
Table 1. Research Protocol According to the Reporting Guidance of PARISMA-ScR Checklist for Scoping Reviews and Updated Recommendations from PRISMA 2020 Statement for Systematic Reviews.
SectionItemPrisma-ScR Checklist ItemReported on Page #
Title1Identify the report as a scoping review.1
Structured summary2Provide a structured summary that includes (as applicable): background, objectives, eligibility criteria, sources of evidence, charting methods, results, and conclusions that relate to the review questions and objectives.1
Rationale3Describe the rationale for the review in the context of what is already known. Explain why the review questions/objectives lend themselves to a scoping review approach.1, 2
Objectives4Provide an explicit statement of the questions and objectives being addressed with reference to their key elements (e.g., population or participants, concepts, and context) or other relevant key elements used to conceptualize the review questions and/or objectives.1, 2
Protocol and registration5Indicate whether a review protocol exists; state if and where it can be accessed (e.g., a web address); and if available, provide registration information, including the registration number.None
Eligibility criteria6Specify characteristics of the sources of evidence used as eligibility criteria (e.g., years considered, language, and publication status), and provide a rationale.4, 7
Information sources7Describe all information sources in the search (e.g., databases with dates of coverage and contact with authors to identify additional sources), as well as the date the most recent search was executed.7
Search8Present the full electronic search strategy for at least 1 database, including any limits used, such that it could be repeated.7
Selection of sources of evidence9State the process for selecting sources of evidence (i.e., screening and eligibility) included in the scoping review.4, 7
Data charting process10Describe the methods of charting data from the included sources of evidence (e.g., calibrated forms or forms that have been tested by the team before their use, and whether data charting was performed independently or in duplicate) and any processes for obtaining and confirming data from investigators.3, 4, 7
Data items11List and define all variables for which data were sought and any assumptions and simplifications made.2, 7–46
Critical appraisal of individual sources of evidence12If carried out, provide a rationale for conducting a critical appraisal of included sources of evidence; describe the methods used and how this information was used in any data synthesis (if appropriate).None
Synthesis of results13Describe the methods of handling and summarizing the data that were charted.4–7
Selection of sources of evidence14Give numbers of sources of evidence screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally using a flow diagram.4,7
Characteristics of sources of evidence15For each source of evidence, present characteristics for which data were charted and provide the citations.4, 7
Critical appraisal within sources of evidence16If carried out, present data on critical appraisal of included sources of evidence (see item 12).35, 39, 42, 47, 48
Results of individual sources of evidence17For each included source of evidence, present the relevant data that were charted that relate to the review questions and objectives.7–46
Synthesis of results18Summarize and/or present the charting results as they relate to the review questions and objectives.8, 14–25, 28–33, 36, 39, 41,
Summary of evidence19Summarize the main results (including an overview of concepts, themes, and types of evidence available), link to the review questions and objectives, and consider the relevance to key groups.28, 35, 38, 42, 45–48
Limitations20Discuss the limitations of the scoping review process.48
Conclusions21Provide a general interpretation of the results with respect to the review questions and objectives, as well as potential implications and/or next steps.46–48
Funding22Describe sources of funding for the included sources of evidence, as well as sources of funding for the scoping review. Describe the role of the funders of the scoping review.49
Table template from [29] Updated recommendations from PRISMA 2020 statement were retrieved from the JBI Manual for Evidence Synthesis as updated on 26 July 2022 (; accessed on 1 December 2022).
Table 2. BP antioxidant bioactivities: Studies published during the last four years (2019–2023).
Table 2. BP antioxidant bioactivities: Studies published during the last four years (2019–2023).
Form of BP UseBotanical OriginGeographical OriginExperiment ProtocolReported ResultsUnveiled MechanismsRef.Correlation with TPC (*)
80% MENA (*)PolandABTS (*), DPPH (*), FRAP (*), CUPRAC (*), PCL (*)Marked AO (*) activity (much higher than bee bread, wax and honey).Radical scavenging, ion reduction.[109]Strong
Whole dried BP in waterNAEuropean countriesOxidation-reduction potential (ORP)The first study of ORP in BP. Marked improvement in AO status.Radical scavenging. Overall decrease in oxidant abundance.[131]Moderate
BP fed to animal models of POS (*)NANATAC (*) of serum measured by FRAPTAC increased.Radical scavenging. Apoptosis increase in ovarian cysts.[132]NA
BP protein hydrolysates (enzymatic)NAThailandABTS and DPPHAO activity, and apoptosis activation in a human lung cancer cell line.Radical scavenging. Promoting cancer cells apoptosis.[133]NA
Ethanol 95% and water extractsMultifloral: Castanea sativa, Hedera helix, Rubus ulmifolius.ItalyIn vitro: ABTS, DPPH, ORAC (*), FRAP, Fe2+.
In erythrocytes: CAA (*), oxidative lysis
Good AO activities in all assays. Erythrocytes hemolysis prevention. BP microbiota yeasts also showed AO activity.Radical scavenging, ion reduction, inhibition of free radical production, cell lysis prevention, metal-chelating ability.[11]NA.
Water extractMultifloral: Citrus aurantium, ApiaceaeMoroccoDPPH, ABTS, and FRAP.AO activity of BP was much more pronounced than honey in all assays.Radical scavenging, ion reduction.[134]Strong
Absolute EEMainly Brassica rapa, Eschscholzia californica. Others.ChileFRAP, ORAC-fluorescein.The AO activity varied significantly between samples, independently of TPC.Radical scavenging, ion reduction.[135]No correlation
70% EEMany monoflorals, Other MultifloralsMoroccoDPPH, ABTS, Reducing Power Assay (ferric ion reduction).Authors curiously reported that an Ononis Monofloral BP had the lowest activity in DPPH and ABTS test, and another botanically similar BP had the highest activity in all assays. Radical scavenging, ion reduction.[136]High for DPPH and ABTS, but nil for FRAP.
BP feeding to aged horses during autumnNANAIn the blood: FRAP, GSH-Px (*), [SH] (*) as indicator of OS (*).FRAP declined significantly, and SH increase was prevented, while GSH-Px activity was not changedRadical scavenging, protein oxidation abolition, but AO defense (GSH-Px activity) not enhanced[137]NA
80% ME of fermented and non-fermented BPNADifferent European regionsIn vitro: DPPH (fermentation either spontaneous or by lactic bacteria)Increased radical scavenging activity and total phenolic and flavonoid contents in fermented BPRadical scavenging.[78]High
Polysaccharide fractions of BPLycium chinenseChinaIn vitro: DPPH, O2 radical scavenging, ABTS, Fe2+ chelating Fraction with lower molecular weight and higher uronic acid content had the highest AO activity.Radical scavenging, low ferrous ion chelating ability.[138]NA
EENATurkeyIn vitro: FRAPIn vivo: Rat hippocampusFRAP reduction in vitro and BDNF (*) increase in vivo.Radical scavenging, AO defense enhancement.[139]High
80% methanol for assays, BP powder to frankfurtersPredominantly Brassica napus and Fraxinus spp.SerbiaTAC, FRP, ABTS, DPPH, TBARS (*)Strong AO activity in all tests, good stabilization of sausages.Radical scavenging, ion reduction, prevention of free radial production, food stabilization[140]NA
Pollen feeding to zebrafishNABrazilABTSBP had radical scavenging activity but induced higher growth of melanoma without weight gain.Such results have never been reported in other studies. [141]NA
BP feeding to broilersNASaudi ArabiaDPPH, TAC, total SOD (*) (T-SOD), and CAT (*) in blood samples.In vitro: DPPH decrease,
In vivo: Increased TAC, T-SOD, and CAT activities.
Radical scavenging, AO defense enhancement.[142]NA
80% ethanol extractMiscellaneous multifloral BPsSpainDPPH, ABTSBotanical origin and climatic conditions determine AO activity of BPRadical scavenging.[9]High
In vitro: 70% EE of wall-broken BP
Animals: raw and wall-broken BP
Rosa rugosaChinaORAC, DPPH, ABTS In vitro: AO activity improved by BP wall-breaking.
In vivo: Elevated SOD and CAT. MDA (*) decrease. Protection of kidney, liver, spleen and thymus.
Radical scavenging, reduction in free radical production, enhancement of AO defense, cell and tissue protection.[143]NA
95% EE fractionated by organic solventsNASaudi ArabiaMDA levels and AO status (CAT, Vit. C, GSH), GST (*) in rat brains.Inhibition of lipid peroxidation and increase in AO defense biomarkers depending on BP fraction. Protective effects in other organs than the brain.Radical scavenging, AO defense enhancement, prevention of free radical generation.[144]Correlation present but extent not assessed
Water extractNAMoroccoDPPH, FRAP, Phosphomolybdate assay.Marked DPPH decrease and ferric ion reduction.Radical scavenging, ion reduction.[145]NA
70% MEDiverse botanical speciesItalyORAC, DPPH, ABTS AO capacity varied with botanical species and geographical area even for the same botanical species. It was higher for multi-floral pollens.Radical scavenging.[107]Significant with some exceptions
80% EE after petroleum treatment to remove lipidsRape (Brassica sp.)ChinaDPPH, ABTS, FRAPAO activity decreased as follows: phenolamines fraction > crude extract > flavonoid fraction.Radical scavenging, ion reduction.[146]NA
70% EE4 Mono-floral, One bi-floral, and 13 Multifloral BPs.South KoreaDPPH16/18 samples had potent AO activity depended on botanical and geographical origins and climate Radical scavenging[105]Absent for both TPC and TFC (*)
70% MENAPolandABTSAO activity varied largely between samples although always present.Radical scavenging.[104]High
95% EESpecies from diverse botanical familiesTurkeyTAC assessed by CERAC and CUPRAC (*).Strong AO activity in all samples with high TPC and unsaturated fatty acid contentsRadical scavenging, ion reduction.[147]NA
EEChestnut (Castanea sp.)TurkeyFRAP, CHROMAC (*), and ABTS. Fenton reaction for DNA (*) oxidative damageMarked AO activity, protection against DNA oxidative damages.Radical scavenging, ion reduction, Inhibition of free radical production, especially DNA oxidation byproducts [148]No correlation
80% EEMultifloral (17 pollen types present at >3%)Portugal
  • DPPH, Reducing Power Assay
  • Simulated gastrointestinal digestion
Marked decrease in radical scavenging and reducing power after digestion (only one BP has the highest AO capacity at the end of the digestion).Radical scavenging, ion reducing effect[99]Strong correlation
70% EERape (Brassica sp.) BP: fermented and unfermented ChinaIn vitro: DPPH, ABTS, FRAP. In human hepatocytes: CAABoth pollen types were active, but the fermented one was more potent in all assays.Radical scavenging and reducing effect. High increase in TPC and TFC after fermentation[70]NA
95% EEMono-floral BPs.ItalyFRAP in vitro, Cellular AO Activity in Red Blood Cells (ex vivo)BP composition and activity varied even for similar botanical origin. Marked AO activity in both assaysIon reduction, and cell protection against oxidative injuries.[103]Positive for TPC and TFC
70% EEBP from a region with limited botanical species MoroccoTAC evaluated by the phosphor-molybdenum method; DPPHHigh AO and radical scavenging activities. TPC, TFC and TAA of BP were markedly lower than propolisRadical scavenging and reducing effect.[149]NA
85% ME
  • Mono-floral and multifloral BPs
IndiaDPPH, FRAP, ABTS, Metal chelating activity (MCA) on Fe2+All samples were active with variations according to the sample and used testRadical scavenging, ion reduction and metal chelation.
Similar botanical origins resulted in equivalent AO activities.
[102]Very strong except for very few molecules
Multistep extraction by different organic solventsCynara scolymusSerbiaDPPH, ABTS, TAC, FRAP, and FCC.Extractable phenolic fraction largely more potent in ABTS, FRP and TAC. Lipid fraction had high TAC. Hydrolysable fraction: highest DPPH.Radical scavenging, ion reduction, metal chelating, and inhibition of free radical production.[150]NA
75% EE dissolved in methanol/water, then extracted in 2 fractions: ethyl acetate and n-hexaneCamellia japonicaChinaDPPH, FCC, FRAP, Effect on DNA Oxidation induced by Hydroxyl Radicals
  • In vitro: Ethyl acetate fraction had the highest TPC and AO activity,
  • In mice liver: Increase in SOD and GSH and decrease in MDA.
  • Microbiota modulation.
Radical scavenging, AO defense enhancement, prevention of free radical generation, Increase in the gut microbiota diversity and beneficial strain abundance.[151]Significant in the two studied fractions
70% EEMultifloral samplesRomaniaABTSStudied AO activity correlated fully with both TPC and TFC.Radical scavenging, ion reduction.[74]Strong correlation
Micronized BP added to multi-flower honeyNAPolandTAC, DPPH, ABTS, FRAP, CUPRACIncrease in TPC, TFC, phenolic acids, anthocyanin, and carotenoid contents of honey.Excellent augmentation of total AO, antiradical and reducing activity of honey.[51]NA
Ethanol, methanol, water, and 70% ethanol extractsEucalyptus marginata and Corymbia calophyllaAustraliaFRAP, DPPHAn extensive analysis of used extraction protocols in the literature and multiple fractions in this study.Non-pulverized BP extracted with 70% EE coupled with agitation is the best method to maximize phenolics and AOs.[101]NA
Ethanol extractNANAIn hypertensive rat testes: TAS (*), TOS (*), NF-κB (*), MDA, NO (*), PON1 (*) and CAT.BP markedly restored the activity of PON1 and CAT, enhanced TAS, reduced TOS, NF-κB, and MDA levels, and relatively restored NO levels.Reducing total oxidant status, increasing AO defense, and thus abolishing reproductive function damages.[152]NA
Hexane and then methanol or acidified methanol extractionNA. Stingless bee (Tetragonula biroi) pot pollen.PhilippinesFRAP, DPPH, and ABTS, and lipid peroxidation inhibition (BCB (*) activity).Significant differences between different extracts (all were active). DPPH and FRAP lower than those of A. mellifera BP in other studies.Radical scavenging, ion reduction, inhibiting of free radical production (from lipid peroxidation).[153]High for TPC and TFC, except on lipid peroxidation
Enrichment of biscuits with dried BP Mono-floral BP: Brassica napus, Phacelia tanacetifolia and Helianthus annuusHungaryDPPH, FRAP, TEAC (*) Marked increases in AO activities and TPC in all samples with a ratio of 10% BP/Biscuit (w/w). TPC and AO activity decreased as follows: phacelia > rapeseed > sunflowerRadical scavenging, ion reduction, food stabilization.[8]High
70% EEMulti-floral: Echium plantagineum, Cistus ladanifer and Quercus sp., etc.PortugalIn vitro: DPPH, NO and O2- radical assaysIn erythrocytes: HB, lipid and others; hemolysis Radical scavenging was much lower than that of ascorbic acid.Radical scavenging, inhibition of free radical production and intracellular reactions, cell protection against oxidation and lysis. [154]High, especially for selected compounds
70% EEZea maysMalaysiaDPPHStrong AO activities and high TPC.Radical scavenging.[155]strong
BP Lipid fraction evaluated by lipidomicsCamellia sinensisChinaAntioxidative gene expression after DSS(*) OS, and gut barrier function Activating the Nrf2-ARE-dependent pathway (*) and activating NF-κB, TOR (*), and Nrf2 signaling factors.Enhancing the AO defense and the general barrier function and structure in the gut epithelium[58]NA
95% EEMulti-floral: Castanea, Rubus, and Cistus.ItalyEx vivo (erythrocytes): CAA, hemolysis, cellular ROS (*) productionAll samples were similarly efficient in preventing AAPH (*)-induced hemolysis and OS.Boost of cellular AO status, prevention of membrane alteration and cell injuries and lysis.[156]Judged probable but not confirmed
70% EESchisandra chinensisChinaIn vitro: ABTS, FRAP
Infarcted rat myocardium: SOD, GSH-Px, CAT
AO activity in vitro and significant in vivo increase in AO enzyme activities at high doses of BP extract.Radical scavenging, ion reduction, AO defense activation and myocardial tissue protection.[157]NA
Water extractNAEgyptIn Fluvastatin-induced hepatitis rat liver: MDA, GSH, GSH-Px and CAT Lower MDA and higher GSH levels, and higher GSH-Px, and CAT activities. Synergism with thymoquinone.Inhibition of free radical production, activation of AO defense, and liver tissue protection.[158]NA
Absolute EEDiverse botanical originsChileIn vitro: FRAP, ORAC
In a hepatic cell line: Cytotoxicity and hepatoprotection AAPH
AO activity in all samples but varied largely. Hepatic cell death prevented. Significant reduction in lipid accumulation in steatosis.Radical scavenging, ion reduction. Cell protection against lipid loads and AAPH.[159]Present for TPC and TFC
BP diet feeding to Apis mellifera isolated in cagesPredominantly Solidago spp.United StatesIn bee abdomens: SOD, CAT, vitellogenin (VG), HSP70 and HSP90 (*). VG expression very high in BP-fed compared to sugar-fed bees. Other parameters did not differ. Improvement in a vital protein status. In honeybees, VG is a vital protein with AO activity [160].[161]NA
Hexane, 70% ethanol and ethyl acetate successivelyCamellia sinensisChinaNQO1 (*), Txnrd1 (*), and Nrf2 genes in colon adenocarcinoma cellsPotent increase in NQO1, Txnrd1 and Nrf2 gene expressions following the DSS-induced oxidative stress.Enhancing cellular AO defense.[162]NA
70% EEMono-floral and multi-floral BPsMoroccoDPPH, ABTS, FRAPPotential AO activity with great difference in all samples, and Thymus vulgaris BP being the most active.Radical scavenging, ion reduction.[163]No correlation
ME fractioned with hexane and dichloro-methaneHelianthus annuusThailandDPPHAO potential of different fractions varied from nil to low, while it was absent for crude extracts.No AO activity. Botanical origin and extraction method may determine the AO activity.[164]NA
70% EE of BP from Melipona fasciculataNABrazilDPPH, FRAP and ABTSAO activity present in all samples, varied largely and is higher than that of Apis mellifera BP in other studies.Radical scavenging, ion reduction.[165]No correlation
75% EERape (Brassica sp.)ChinaIn mice models of DSS-induced colitis: Oxidative and microbiota markersIncrease in SOD and GSH-Px activities decrease in NO and MPO (*) levels. Increase in microbiota diversity and beneficial strains abundance.Radical scavenging, AO defense enhancement, prevention of free radical generation, microbiota modulation.[166]NA
Water or 75% EE assisted with ultrasounds or heat refluxActinidia argutaChinaIn vitro: FRAP, FCC, and DPPH. In a plasmid DNA and in lymphocytes: OS-induced damages Strong AO activities. EEs were more potent (more with ultrasound in FRAP and FCC). Potent inhibition of DNA alterationsRadical scavenging, reduction
Abolishing oxidative damages to circulating DNA and cytoprotective effect on lymphocytes.
[167]Evident (but only few samples were studied)
70% EE from pulverized BP powderSchisandra chinensisChinaIn H2O2-injured cardiomyocyte: Cell survival, morphology, MDA, SOD, and GSH.Increase in cell viability, SOD and GSH, marked prevention of morphological alterations, and decrease in MDA levels.AO defense enhancement, prevention of free radical generation, cell protection against oxidative injuries and death.[168]NA
Water, 80% EE and supercritical fluid extracts (SFE)Chestnut (Castanea sp.)ItalyDPPH, ferrous ion reduction.EE by far the most active in both assays followed by SFE and water extracts. SFE was the richest in TPC.Radical scavenging, ion reduction.[169]No correlation
BP powder added to skimmed goat milk Helianthus annuusSerbiaPolyphenol bio-accessibility in a digestion model. TAC, ABTS, FCCBP reduced milk TAC and TPC, and reduced polyphenol bioaccessibility. Digestion increased RSA.Enhancing AO potential and functionality. The TAC decrease is probably due to polyphenol capture by casein micelles. [170]NA
Water extractsDifferent botanical originsEgyptDPPHBP was the most active compared to bee bread, royal jelly, and different mixes of bee products.Radical scavenging.[44]No correlation
70% EENA. BP of stingless bee Scaptotrigona affinis posticaBrazilDPPH, ABTS, FRAPDPPH AO activity and TPC much higher than Apis mellifera BP in other studies. FRAP and ABTS AO activity similar to other bee species.Radical scavenging, ion reduction.[171]NA
70% MEMultifloral BPsPolandABTSABTS AO activity varied with TPCRadical scavenging.[106]High
WaterNANA.MDA, CAT and SOD in rat testes damaged by methotrexate Decrease in MDA levels and SOD activity. No change in CAT activity. BP restored rat fertility parameters.Reducing lipid peroxidation, enhancing AO state, and reproductive organ structure and function[172]NA
WaterNA. BP of stingless bee Trigona spp.IndonesiaDPPH. Mild activity: the 1/4th of vitamin C, better than propolis and honey.Radical scavenging.[173]NA
70% EENAMoroccoDPPH, ABTS and FRAPAO activity in all assays. Remained however lower than vitamin C.Radical scavenging, ion reduction, protection against induced cell and tissue injury.[174]NA
ME partitioned by hexane, DCM and methanolMonofloral BPsThailandDPPH, ABTS, FRAPOnly DCM fraction from M. diplotricha showed strong AO potential (however less than ascorbic acid).Radical scavenging, ion reduction.[175]No correlation
70% EEMonofloral Lotus BPChinaIn vitro: GSH, SOD and MDA levels. In isoproterenol-injured cardiomyocytes: cell protectionSignificant increase in GSH and SOD activity, and significant decrease in MDA levels in the studied cell line.AO defense enhancement, prevention of free radical generation, cell protection against oxidative injuries and apoptosis.[15]NA
(*): [SH]: concentration of sulfhydryl groups; AAPH: 2,2′-Azobis(2-amidinopropane) dihydrochloride assay; ABTS: 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid assay; AO: antioxidant; ARE: antioxidant response element; BCB: β-carotene bleaching; BDNF: brain-derived neurotrophic factor; CAA: cellular antioxidant activity assay; CAT: catalase; CERAC: modified cerium(IV)-based antioxidant capacity assay; CHROMAC: chromium reducing antioxidant capacity assay; CUPRAC: cupric ion reducing antioxidant capacity assay; DCM: dichloromethane; DNA: deoxyribonucleic acid; DPPH: 2,2-diphenyl-1-picrylhydrazyl assay; DSS: dextran sulfate sodium; EE: ethanolic extract; FCC: ferrous ion-chelating capacity; FRAP: ferric-reducing antioxidant power; GSH-Px: glutathione peroxidase; GST: glutathione S-transferases; HB: hemoglobin; HSP: heat shock proteins; MDA: malondialdehyde; ME: methanolic extract; MPO: myeloperoxidase; NA: not available; NF-κB: nuclear factor kappa-light-chain-enhancer of activated B cells; NO: nitric oxide; NQO1: nicotinamide adenine dinucleotide phosphate (NAD(P)H) quinone dehydrogenase 1; Nrf2: Nuclear factor erythroid 2-related factor 2; ORAC: oxygen radical absorbance capacity assay; ORP: oxidation-reduction potential; OS: oxidative stress; PCL: photochemiluminescence assay; PON1: paraoxonase 1; POS: polycystic ovary syndrome; ROS: reactive oxygen species; RSA: radical scavenging activity; SOD: superoxide dismutase; TAC: total antioxidant capacity; TAS: total antioxidant status; TBARS: thiobarbituric acid reactive substance assay; TEAC: trolox equivalent antioxidant capacity; TFC: total flavonoid content; TOR: target of rapamycin; TOS: total oxidant status; TPC: total phenolic content; Txnrd1: thioredoxin reductase 1.
Table 3. Studies on BP anti-inflammatory activities published during the last four years.
Table 3. Studies on BP anti-inflammatory activities published during the last four years.
BP PreparationExperiment DetailsReported ResultsRef.
70% EE of unfermented and S. cerevisiae-fermented rape BP from ChinaIn a lipopolysaccharide-treated macrophage cell line: NO, COX-2, TNF-α (*), IL-1β and IL-6 levels.NO, COX-2, TNF-α, IL-1β, and IL-6 levels markedly decreased dose-dependently (fermented BP more potent in all tests.[70]
95% EE of Italian BP composed mainly from Castanea sativa (88.8%) and Hedera helix sp. (4.2%).Cell viability and gene expression of IL-8, COX-2, and ICAM-1 (*) were assessed in a TNFα-inflamed human colorectal adenocarcinoma cell line.Pretreatment with BP extract reduced IL-8, COX-2, and ICAM-1 levels and did not alter cell viability even at very high doses.[11]
Animals fed with BP from Turkey. Other products assessed (bee bread, honey, royal jelly and propolis).Bee products were administered separately to rat models of chronic inflammation. Pro- and anti-inflammatory cytokines were measured in the blood.BP increased anti-inflammatory cytokines IL-4, IL-10, and IL-1RA, and decreased pro-inflammatory cytokines TNF-α, IL-1ß, and IL-6. BP was more potent than all other bee products.[199]
Extraction with 90% ethanol of Fagopyrum esculentum BP from China.Colitis was induced by DSS in male mice. DAI and other inflammation markers (ICAM-1 expression and colon tissue imaging) were assessed.BP extract markedly reduced DAI; corrected DSS-induced loss of weight and colon weight and length, significantly reduced spleen swelling and lymphocytes and iCAM-1 expression; corrected damages in epithelial barrier and villi, and restored AO defense and activated/regulatory T-cell balance.[200]
Pulverized Brazilian BP was fed to zebrafish (botanical origin was not specified).In transgenic zebrafish experimentally-induced melanoma: Metagenomic analysis of gut microbiome, and assessment of pro-inflammatory mediators in gut.Significant increase in beneficial microbiota strains and a decrease in some known pathogenic strains. Unexpectedly, BP did not change tested pro-inflammatory mediators and induced a higher tumor growth than in control animals.[141]
Mice models fed with 90% EE of Fagopyrum esculentum BP from China. In high-fat diet- and streptozocin-induced diabetes mice: Pro- (TNF-α, IL-2 and IL-6) and anti-inflammatory (TGF-ß (*)) cytokines, and PI3K/AKT (*) in rat pancreas. Genomic study of colon microbiota.BP reduced liver infiltration of inflammatory cells, decreased gene expression of TNF-α and TGF-ß, and increased that of PI3K and AKT, and enhanced microbiota richness, diversity, and beneficial strain abundance. Other inflammation triggers markedly reduced (e.g., OS markers, liver injuries, steatosis)[201]
An extract of Lotus BP with 70% ethanol was added to a myocardial cell culture.Cardiomyocyte hypertrophy was induced with isoproterenol.BP inhibited the increase in pro-inflammatory cytokines (IL-6 and TNF-α) and the JAK2/STAT3 (*) signaling pathway, and increased anti-apoptosis related factors (lowered Bax and Caspases levels, and increased Bcl-2 and Bcl-2/Bax ratio (*)).[15]
Commercial BP was fed to rats. Botanical origin not identified.Previously PB-fed rats were treated by propionic acid to induce autistic state. Cytokines, OS markers, and gut microbiota were analyzed.In the rat brains, BP induced marked decrease in IFN-γ (*), IL-1α, and IL-6, and had no effect on IL-12, TNF-α, and VEGF (*). BP induced a significant decrease in fecal pathogen strains and protected animals against other inflammation comorbidities such as OS and glutamate excitotoxicity.[65]
BP, raw or fermented either spontaneously or by a selected inoculum, was used for in vitro experiments.BP samples added either to an in vitro model of gastrointestinal batch digestion, or to a human adenocarcinoma or keratinocyte cell line cultures. Pro-inflammatory mediators, ROS, intestinal barrier function and cell viability were assessed.Serum availability of phenolics increased by 22% with selectively fermented BP and not changed by raw and spontaneously fermented BPs. Inhibitory potential on Il-6, IL-8, MCP-1 and TNF-α was significant by all samples only in inflamed cells (selectively fermented > spontaneously fermented > raw). [80]
Extract from Chinese Camellia japonica BP with 75% ethanol, dissolved in methanol and water, and then fractionated with ethyl acetate and n-hexane.Hyperuricemic mice fed with the ethyl acetate fraction. Pro-inflammatory cytokines in serum and kidney, kidney histopathology, gut microbiota analysis and fecal SCFA (*) were assessed.All assessed cytokines (TNF-α, IL-6, IL-1β and IL-18) in animal serum and kidneys were decreased, TLR4/MyD88/NF-κB (*) and NLRP3/ASC/Caspase-1 (*) inflammatory pathways were both inhibited, microbiota diversity was enhanced, and levels of SCFA increased. BP reduced renal histological damages and interstitial infiltration of inflammatory cells. Persistent tissular alterations in allopurinol-treated mice surprisingly disappeared in BP-treated ones.[151]
BP water extract was administered orally to rats. Botanical and geographical origins were not indicated.A bone marrow/spleen suppression in rats was induced by doxorubicin. BP was administered at 100 and 200 mg/kg body weight. Inflammatory cytokines, oxidative and other hematological parameters, and apoptosis-related genes were measured.BP induced a significant decrease in PF4 (*), IL-6 and, IL-1β and a significant increase in serum GM-CSF (*), G-CSF (*), and IL-10. BP increased hematopoietic factors, and blood cells and platelet numbers, reduced OS and apoptotic mechanisms, and repaired histological injuries.[202]
A 70% EE of BP collected by the stingless bee Scaptotrigona affinis postica from Brazil. Botanical Origin not indicated.Paw edema was induced in mice either by Carrageenan (with indomethacin as standard) or Dextran (cyproheptadine as a standard). Antinociceptive effect was assessed using acetic acid or formalin.In the acute inflammation phase, BP reduced edema volume in a more potent manner than the two drug references. It also reduced nociceptive response more markedly than indomethacin.[171]
Methanolic extract of BP. Botanical and geographical origins not indicated.Air pouch was induced in rats and then carrageenan was injected in it with or without BP. Morphological and molecular inflammation markers were assessed.BP extract significantly reduced inflammatory exudate accumulation, leukocyte infiltration, granulation tissue formation, and angiogenesis. TNF-α and VEGF significantly lowered.[203]
Purified polysaccharide fraction (BPPF) of Fagopyrum esculentum BP from China.A microbiota dysbiosis was induced with ceftriaxone in mice. Effect of the BPPF on inflammatory mediators, intestinal structure and function, microbiota, and immune response were assessed.BPPF restored blood LPS (*) and thymus and spleen atrophies to the normal values. In colonic mucosa, inflammatory cell infiltration disappeared, goblet cells and mucus area were fully restored, structural alterations were corrected, TNF-α levels were not affected, and IL-6 and IL-1β levels were fully restored. Despite some differences with control group, BPPF restored microbiota diversity, richness and corrected its balance.[196]
Multistep and multi-solvent extracts of fresh monofloral BPs from Camellia sinensis, Nelumbo nucifera, and Brassica campestris.Molecular methods, metabolomics and a macrophage cell line with LPS-induced inflammation were used to study the anti-inflammatory potential of the extracts. C. sinensis BP was further studied in an LPS-induced acute lung injury mouse model.In macrophages, all extracts reduced NO release and IL-1β, IL-6, IL-10, iNOS (*), and COX-2 gene expressions, and increased HO-1 gene expressions (except N. nucifera BP on IL-1β, IL-6, and COX-2). MAPK (*) and NF-κB pathways were markedly suppressed by C. sinensis and B. campestris BP extracts. In all cited effects, C. sinensis BP was the most active and the richest in TPC. In the lungs, this extract reduced inflammatory cell infiltration, COX-2 and iNOS expression and NLRP3 inflammasome activation. All effects were more marked than dexamethasone used as standard.[204]
Commercial BP bought in Saudi Arabia was fed to rats (botanical and geographical origin not indicated).Neurotoxicity was induced in rats by prenatal exposure to methylmercury. Markers of neuroinflammation, along with other neurological parameters, were examined in rat brains after a BP diet.Brain IFN-γ significantly reduced by BP with a greater effect obtained when mothers were fed with BP before the offspring birth. Levels of many neurotransmitters, which may interfere in an interplay with neuroinflammation, were also significantly corrected.[34]
Chinese Camellia sinensis BP was treated with hexane. The residue was then treated with 70% ethanol and later with ethyl acetate.BP extract was applied on a DSS-challenged adenocarcinoma colonic monolayer cell line. inflammatory cytokine genes expression, gut barrier function, MAPK signaling pathway were studied.Remarkable increase in TGF-β1 and decrease in TNF-α and IL-6 gene expression. Alterations of monolayer integrity, tight junction disruption and gut permeability significantly corrected. MAPK signaling pathway was markedly suppressed.[162]
Extract of Chinses Schisandra chinensis BP with 75% ethanol.Extract was fed to obese mice models of high-fat-induced nonalcoholic fatty liver disease.IL-1β, TNF-α, NF-κB and iNOS markedly reduced in the liver and increases in serum IL-6 and TNF-α levels were completely inhibited. Shifts in microbiota diversity and abundance were corrected.[205]
Purified polysaccharide fractions from Chinese Lycium chinense BP.DSS-challenged macrophage cell line was treated by the polysaccharide fractions. Inflammatory mediators were then assessed.A significant increase in NO and TNF-α levels were obtained. IL-1β and IL-6 were also increased. The effects depended more tightly on the fraction type than the used dose.[138]
Brazilian BP collected by the stingless bee Melipona fasciculata was extracted with 70% ethanol. Botanical origin not identified.COX inhibition was performed in vitro. Paw edema was induced in mice either by Carrageenan (with indomethacin as standard) or Dextran (cyproheptadine as a standard). Antinociceptive effect was assessed using acetic acid or formalin.The extract inhibited COX-1 and, in a largely more potent manner (100% inhibition with 500mg BP/kg body weight), COX-2 activity. BP extract reduced edema volume in a more potent manner than the two drug references. It also reduced nociceptive response more markedly than indomethacin. [165]
75% EE from Chinese Brassica sp. BP.Mice models of DSS-induced colitis were fed with BP extract. Histomorphometry, inflammatory mediators measurement, and microbiota analysis were performed. Downregulation was very potent on IL-1β, and marked on IL-6, NF-κB, and IκB (*). BP extract abolished weight loss, colon shortening, spleen swelling, and villi, crypts, glandular, and epithelial alterations. The overall colitis DAI was markedly reduced. BP extract ameliorated gut microbiota diversity and the relative abundance of many beneficial genera, and completely reversed the abundance of some strains which was raised by DSS. [166]
Hamsters were fed with BP. Botanical and geographical origin were not indicated.BP was fed to animals after autism induction with propionic acid. Markers of neuroinflammation were evaluated in animal brain tissues. Fecal Clostridium difficile was searched.BP increased IL-10, completely abolished the propionic acid-induced increase in IL-6, and significantly decreased IFN-γ, IL-1α, and VEGF. TNF-α was slightly decreased. Effect on IL-12 was insignificant. C. difficile toxins not detected in BP-treated animals.[206]
(*): AKT: protein kinase B; ASC: apoptosis-associated speck-like protein; Bax: Bcl-2-associated X protein; Bcl-2: B-cell lymphoma 2; DAI: disease activity index; G-CSF: granulocyte colony-stimulating factor; GM-CSF: granulocyte-macrophage colony-stimulating factor; ICAM-1: intercellular adhesion molecule 1; IFN-γ: interferon gamma; iNOS: inducible nitric oxide synthase; IκB: i kappa B kinase; JAK2: Janus kinase 2; LPS: lipopolysaccharides; MAPK: mitogen-activated protein kinases; MyD88: myeloid differentiation primary response protein 88; NLRP3: nucleotide oligomerization domain-like receptor family, pyrin domain containing 3; PF4: platelet factor 4; PI3K: phosphatidylinositol 3-kinase; STAT3: signal transducer and activator of transcription 3; TGF-ß: transforming growth factor beta; TLR4: Toll-like receptor 4; VEGF: vascular endothelial growth factor.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kacemi, R.; Campos, M.G. Translational Research on Bee Pollen as a Source of Nutrients: A Scoping Review from Bench to Real World. Nutrients 2023, 15, 2413.

AMA Style

Kacemi R, Campos MG. Translational Research on Bee Pollen as a Source of Nutrients: A Scoping Review from Bench to Real World. Nutrients. 2023; 15(10):2413.

Chicago/Turabian Style

Kacemi, Rachid, and Maria G. Campos. 2023. "Translational Research on Bee Pollen as a Source of Nutrients: A Scoping Review from Bench to Real World" Nutrients 15, no. 10: 2413.

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop